Skip to main content

Jefferson Urology Year In Review 2021

Page 44

Jefferson Urology

1


Yearin 2021 Review Department of Urology For more information on how philanthropic gifts can help support our research, teaching and patient care missions contact: Leonard G. Gomella, MD, FACS The Bernard W. Godwin Professor of Prostate Cancer Chairman, Department of Urology Senior Director Clinical Affairs, Sidney Kimmel Cancer Center Thomas Jefferson University Enterprise VP for Urology, Jefferson Health 1025 Walnut Street, Suite 1100, Phila., PA 19107 215-955-1702 Leonard.Gomella@jefferson.edu P. Kenneth Brownstein, MD, FACS Department of Urology Director of Philanthropy Harold A. Honickman Physician Director of Jefferson Signature Services Office of Institutional Advancement Thomas Jefferson University and Jefferson Health 125 S. 9th Street, Suite 600, Philadelphia, PA 19107 215-503-2111 Kenneth.Brownstein@jefferson.edu Emma Laverty Assistant Vice President of Development Office of Institutional Advancement Thomas Jefferson University and Jefferson Health 125 S. 9th Street, Suite 600 Philadelphia, PA 19107 215-503-8679 Emma.Laverty@jefferson.edu “Jefferson Urology 2021 Year in Review” Design and Production Editor: Tricia Shea Editor in Chief: Leonard G. Gomella, MD Contributors: Shannon (Fields) Cremin Anne Lizardi-Calvaresi, DNP,CRNP, RNFA Barbara Devine Marissa Louge Sonny Figueroa, MD Mark Mann, MD Tricia Gomella, MD Ryan Mark, MD Lisette Hilton Matt Schiewer, PhD Scott Hubosky, MD Mat Thakur, PhD Kevin Kelly, DO Edouard Trabulsi, MD, MBA Emma Lafferty Patrick Shenot, MD Costas Lallas, MD Marlene Vallett Photography: Karen Kirchoff, Robert Neroni Cover Design: Andrew Gomella, MD Digital versions of “Jefferson Urology 2021 Year in Review” and other Department of Urology publications can be found at : www.jefferson.edu/university/jmc/departments/urology or search “Jefferson Urology” on the issuu.com web site Published by the Department of Urology Thomas Jefferson University 1025 Walnut Street, Suite 1101, Philadelphia, PA 19107 215 955 6961 (tel) 215 923 1884 (fax) Address Correspondence to: Editor, Jefferson Urology Year in Review at the above address Postmaster: Send address changes to the aforementioned address.

2

Year in Review

Copyright @2022 Thomas Jefferson University. All rights reserved.v 2.0


FEATURES 4 Mission Urinary Biome 6 SKCC GU Multidisciplinary Clinic Celebrating 25 Years 14 A New Era for Urology in Jefferson’s Specialty Care Pavilion RESEARCH 18 Update from the Philadelphia Prostate Cancer Biome Project BOOKSHELF 22 Jefferson Urology and the Merck Manual Books by Jefferson Urology Faculty MEETINGS & PRESENTATIONS 26 Virtual AUA Mid-Atlantic AUA Meeting Residents Surgical Skills Workshop on Prosthetics Sexual Medicine Society of North America 2021 Jefferson Health Wellness Webinar Dr. Gomella Interviewed on "Your Radio Doctor" 4th Annual Jefferson Urology Symposium

7

A

Chairman’s Letter

Year in Review 2021 Index

INTERNATIONAL NEWS 30 Dr. Hubosky in Dubai Dr. Chung to Speak at Israel Space Conference Jefferson India Center Dr. Vittorio Canale, Guest Resident Peruvian Urology Society Hong Kong University NOTABLE & NEWSWORTHY 32 New Technology Elevates Minimally Invasive Surgery Capabilities Methodist Fundraiser Supports Men's Health Program World News Tonight Prostate Cancer Spot Jefferson First in Region to Offer Newest PSMA PET Imaging Sidney Kimmel Cancer Center Launches Mobile Screening Van 35 Welcome New Jefferson Faculty Amazing Progress in Prostate Care 36 Faculty News 38 Pediatric Urology Update 39 Urology Basic Science & Clinical Research 42 Provider Spotlight 43 Department of Urology News 44 Visiting Professors & Guest Lecturers 48 Graduation & Awards 52 Alumni News 55 Student News 58 Residents & Fellows 60 Jefferson Urology Regional & Enterprise Updates 61 Year in Photos 70 Faculty Listing 71 Outpatient Practice Locations 72 Department of Urology Publications

Dear Friends, Welcome to our 2021 Jefferson Urology Year in Review, our third annual update. Our previous publications have been well-received within the Jefferson community and beyond. I am always proud to share the achievements of our academic Department of Urology and our community urology partners across Jefferson Health through this annual review. Urology’s expansion in the Jefferson Health System was a hallmark of 2021. In August 2021, we opened our full-time academic practice at Jefferson-Abington. This included hiring two new fellowship-trained JUP physicians, Drs. Whitney Smith and Patrick Gomella, who are featured on page 35. Whitney completed a fellowship in Female Pelvic Medicine and Reconstructive Surgery (FPMRS) at Wake Forest, and Patrick completed a Urologic Oncology Society Fellowship at the National Cancer Institute in Bethesda. Our urologic oncology-focused practice will continue at the SKCC Asplundh Cancer Pavilion as we expand services in our new office in the Price Building on the Jefferson-Abington Hospital campus. With the support of Jefferson New Jersey, in April of 2021, we opened a new expanded and freestanding urology office near Jefferson Cherry Hill Hospital. This office can now see patients five days a week focusing on general urology and specialty care including Men’s Health. On July 1, 2021, the well-established urology practice at the Jefferson Aria hospitals joined us as full-time members of Jefferson Health. With the addition of this Jefferson Community Physician group, along with our BuxMont community practice and our JUP providers, Jefferson Health now has a compliment of more than 30 general and specialist urologists and advanced practice providers. With Jefferson’s merger with Einstein Health, we look forward to future collaborations with our Urology colleagues at Einstein and their strong clinical and academic program. Our Urology specialty continues to attract many senior medical students. According to the American Association of Medical Colleges (AAMC), urology had a significant increase in the number of applicants, the largest increase in any medical or surgical specialty. At Jefferson, Dr. Patrick Shenot, our Residency Program Director, notes that applicants to Jefferson increased dramatically with a record 450 applicants this year. We had another strong year for SKMC students interested in Urology with nine out of ten seniors successfully matching in our highly competitive specialty (see page 55). Outside of our Urology world, there were many changes in our university and health system. Jefferson Health is now the largest healthcare system in the Mid-Atlantic region. Many of these changes are due to the efforts of our President, Dr. Steve Klasko. After eight years at the helm, Dr. Klasko has stepped down as President and CEO of Jefferson. His leadership was transformative taking Jefferson Health from 3 hospitals to 18 hospitals, creating a true undergraduate and graduate university with the merger with Philadelphia University and laying the groundwork for our new Specialty Care Pavilion and the Caroline Kimmel Research Building among other accomplishments. We wish Steve and his wife, Colleen, well and thank them for their time at Jefferson. Likewise, we extend our best wishes to Jefferson Emeritus Trustee Mr. Richard Haverstick as our Interim President and CEO while the national search takes place for Dr. Klasko’s replacement. Another noteworthy change is that Dr. Karen Knudsen, Director of the Sidney Kimmel Cancer Center and a joint Urology faculty member, has gone on to a much larger role as CEO of the American Cancer Society. Likewise, we extend our best wishes for her success in this new position. At press timewith thanks to Dr. Andy Chapman serving as interim director, we are awaiting the announcement of the next SKCC director. In 2021, we celebrated the 25th Anniversary of our SKCC GU Multidisciplinary Cancer Clinic. Our program has been influential nationally and around the world in how patients with prostate cancer and other urologic cancers are managed. On page 6, you can read about the history of our multidisciplinary cancer care model and the well wishes received from many prominent individuals on this anniversary. There are many other reasons to be proud of Jefferson’s Department of Urology. Take a moment to read about our cover story and the exciting International Space Station Research project led by Dr. Paul Chung (page 4), the contributions of our faculty to medical book publishing (page 23) and the famous Merck manual (page 22), our medical student programs (page 57), our alumni (page 52) and the progress in Jefferson’s Specialty Care Pavilion (page 14). The pandemic has forever changed everything we do each day in academic medicine, from our reliance on virtual ZOOM meetings to the expansion of telehealth. These changes will be with us for many years to come, and we have embraced these as essential elements allowing us to continue our research, teaching, and patient-care missions throughout the pandemic. Our Department of Urology 2021 Year in Review highlights the amazing accomplishments of our team working through the challenges of the pandemic as it enters its third year. If you have any questions or comments, my email is leonard.gomella@jefferson.edu. Thank you for taking the time to learn about our great department. Sincerely,

Leonard G. Gomella, MD, FACS The Bernard W. Godwin Professor of Prostate Cancer Chairman, Department of Urology Senior Director Clinical Affairs, Sidney Kimmel Cancer Center Enterprise VP for Urology, Jefferson Health Jefferson Urology

3


Dr. Paul Chung

For Paul H. Chung, MD, Associate Professor of Urology at Thomas Jefferson University, getting institutional review board (IRB) approval for his upcoming study on the urinary microbiome meant securing approvals from not only Thomas Jefferson University but also collaborating institutions in Israel and one literally out of this world, in space.

Associate Professor Department of Urology

Pictured: The International Space Station. Photo courtesy of NASA (www.nasa.gov/mission_pages/station/images/index) Cover: iStock Photo background courtesy Jefferson Research Communications

MISSION URINARY MICROBIOME Jefferson Researcher Prepares for Historic Study in Space

4

Year in Review Dr. Zvi Grunwald

Director of the Jefferson Israel Center


Dr. Chung is the principal investigator of the study, “Impact of Space on the Human Urinary Microbiome,” for which space travelers on the Israeli Rakia Mission will provide urine samples before, during and after their historic eight-day mission, barring any unforeseen circumstances. The space mission is set to leave Kennedy Space Center for the International Space Station in February 2022. The study’s findings could help unravel not only why astronauts are at higher risk for urinary retention, urinary tract infections and other urinary conditions, but also explain how changes in the urinary microbiome might impact some of the most common, bothersome urological symptoms on earth. Studies have linked changes in the urinary microbiome to lower urinary tract symptoms, UTIs and bladder pain syndrome. The risk for urinary issues during spaceflight is real, according to Dr. Chung. For example, an astronaut with urinary retention is 25 times more likely to have a UTI with a 17% infection rate per mission. For astronauts in space, knowledge from the study could help prevent these problems, which will become even more important when planning longer missions, including the multiyear Mars mission.

The only laboratory available for long-duration microgravity research, the International Space Station has furthered fundamental research in Alzheimer’s disease, Parkinson’s disease, cancer, asthma and heart disease. Research on low gravity’s impact on astronauts’ bones, muscles, hearts and more have led to novel insights into how the body functions. And spin-offs on technologies used in space, including water filtration and purification systems and heart monitoring devices, have benefited earthdwelling humans. ABOUT THIS UNIQUE MISSION Jefferson’s collaborative relationship with Sheba Medical Center, Tel Aviv, Israel, and one of the mission’s astronauts opened the door to this opportunity to conduct research on the Rakia mission, sponsored and led by The Ramon Foundation in conjunction with the Israel Space Agency in the Ministry of Science and Technology. One of four international businessmen piloting and crewing the Rakia mission is Eytan Stibbe, an Israeli entrepreneur, philanthropist and close friend of the first Israeli astronaut in space, Ilan Ramon. Ramon was among the seven astronauts who died in 2003 when the Space Shuttle Columbia broke apart during its re-entry to earth. Stibbe and Ramon served in the military together as fighter pilots.

“Our goal is to better understand the urinary microbiome,” Dr. Chung said. “Many people think urine is sterile but actually urine is not sterile. It has organisms inside of it. It was previously hard to understand what organisms might exist based on the type of technology we had. But newer technology, called next-generation sequencing that we will use in this study, is an alternative way to look for organisms. Basically, it looks at all the DNA within a sample and screens DNA for particular DNA strands.”

Stibbe is slated to be the second Israeli astronaut in space.

Scientists collecting urine and doing nextgeneration sequencing would compare the many DNA sequences revealed in the testing to a database of known sequences for microorganisms.

Organized by Axiom Space, a company dedicated to commercializing the space experience for consumers, the upcoming flight, called AX1, will be the first approved by NASA to go to the International Space Station manned entirely by private astronauts.

“In addition to collecting and studying urine specimens, we will be screening the space travelers for their urinary symptoms. If we see clinical changes, then perhaps we will see that the microbiome is changing as well,” he said. “We are using this opportunity to study the urinary microbiome in a completely different setting. There is no setting better than lowgravity space travel.” RESEARCH ON THE SPACE STATION CHANGES HEALTH CARE AT HOME Research by Dr. Chung and his team will be part of a long legacy of research in space. In fact, the International Space Station orbiting some 250 miles above earth has been a clinical site linked with many medical breakthroughs during the last 20 years.

The name of the Israeli space mission “Rakia” comes from entries in Ramon’s diary, when he wrote about the heavens and space travel. Rakia is the Hebrew term when translated in English would be something between the heavens and the sky. The Rakia Mission is characterized by important firsts, which include the following:

“There have been a lot of these missions with other companies, including SpaceX, but these space travelers went into orbit. This mission is one step beyond that; these are the first paying space travelers to go to the International Space Station,” Dr. Chung said. “Axiom’s goal is to build their own space station but first the company is setting up these types of missions, using rockets from SpaceX, Elon Musk’s company.” A GIANT LEAP FOR UROLOGY? Research in space on the urinary microbiome is novel and an opportunity for Thomas Jefferson University to pioneer research in space on the emerging area of how the microbiome impacts urological conditions.

It also is an important step in Dr. Chung’s career. Dr. Chung graduated from Northwestern University with a degree in electrical engineering, then graduated from Thomas Jefferson University, Sidney Kimmel Medical College in 2011. He completed a fellowship in the Clinical Research Training Program at National Institutes of Health; a general surgery internship and urology residency at University of Texas Southwestern Medical Center, Dallas; and a fellowship in Genitourinary and Reconstructive Surgery at the University of Washington Medical Center in Seattle. “I grew up in Dallas, Texas. Both of my parents have PhD backgrounds and worked in sciencerelated fields, which influenced me to pursue studies in electrical engineering and medicine. My interest in technology and devices led me in part to becoming a urologist and my research interests,” he said. In his fifth year as faculty at Thomas Jefferson University, Dr. Chung’s practice and research focus on trauma and reconstruction. “Within my practice as a reconstructive urologist, I focus on male genital reconstruction, men’s health issues, and cancer survivorship including erectile function and incontinence,” he said. His urinary microbiome research could have far-reaching impacts in urology, helping to better understand the microbiome of urologic prosthetic devices, which could help prevent infected implants, a common adverse event in penile implant surgery. “Personally, this is an opportunity to perform novel research in a setting that few will ever be able to experience. I think from the University’s perspective, it’s an opportunity for exposure, particularly with the national and international collaborations the University has,” Dr. Chung said. Dr. Chung’s research group includes Javad Parvizi, MD, and Emanuele Chisari, MD, in Jefferson’s Department of Orthopedic Surgery; Ben Boursi, MD, Department of Oncology, Sheba Medical Center, Tel-Hashomer, Israel; Harel Baris, MD, ARC Space Lab, Sheba Medical Center, Ramat Gan, Israel; Caleb Phillips, PhD, Department of Biological Sciences, Texas Tech University, Lubbock, Texas; and Curtis Nickel, MD, Department of Urology, Queen’s University, Kingston, Ontario. Dr. Chung’s study is one of 44 scientific experiments chosen in a competitive process by Ramon Foundation and Israel Space Agency. Two additional studies include Jefferson principal investigators, awardees Drs. George Brainard and Adam Dicker.

By Lisette Hilton Jefferson Urology

5


SKCC GU Multidisciplinary Clinic Celebrating

Years

The multidisciplinary program has served as a model for many other centers across the United States. Our Sidney Kimmel Cancer Center Genitourinary Multidisciplinary Clinic (GU MDC) was founded in 1996 by Dr. Leonard Gomella, Urology Chair at Jefferson and Dr. Richard Valicenti, now Chair of Radiation Oncology at University of California Davis in Sacramento, California. The 25th year of operation took place in 2021. The GU MDC was founded less than a year after the Sidney

Kimmel Cancer Center received its initial NCI Cancer Center designation. Our Multidisciplinary Genitourinary clinic we believe was the first formally described in the literature and is one of the best known programs of any of the NCI-designated Cancer Centers in the United States. Each week, urologists, medical oncologists, radiation

oncologists and a variety of support staff evaluate patients with urologic malignancies in a coordinated real time clinical setting. A dedicated navigator helps to streamline the clinical care. Prostate, bladder and kidney cancer are the top malignancies treated based on overall tumor frequency but other cancers, such as penile, testicular and adrenal malignancies are also seen. In addition to being one of the first of its kind (1), the program boasts many accomplishments. These are summarized in the accompanying time line. Noteworthy accomplishments include the first publication in 2010 demonstrating this combined care model improves survival outcomes in high-risk prostate cancer (3), the spinoff development of a Small Renal Mass Multidisciplinary Clinic (2) and the first Men’s Genetic Risk Program incorporating testing and counselling into a prostate cancer clinic in 2014 (4). In 2013, Men’s Health Magazine identified the Sidney Kimmel Cancer Center as one of the top 20 hospitals for prostate cancer care in the U.S. with our clinical team notes to be closely linked with basic scientists who work in the Sidney Kimmel Cancer Center research labs (see page 39). Our team published one of the first books in this area of multidisciplinary prostate cancer care. Prostate Cancer: A Multidisciplinary Approach to Diagnosis

Members of the SKCC GU MDC team including clinicians, residents, fellows and support staff gathered for a 25-year commenerative photo. In the front row are Dr. Adam Dicker, Radiation Oncology Chair, Dr. Kevin Kelly, Director of Solid Tumor Oncology for the Cancer Center and Dr. Leonard Gomella, Urology Chair representing the three core specialties who participate in the GU MDC. Our long standing pathologist Dr. Peter McCue and radiologist Dr. Ethan Halpern are seen behind Dr. Kelly. Dr. Andy Chapman, Acting Director of the Sidney Kimmel Cancer Center, and Alex Khariton, MBA, Vice President for Cancer Services, joined in the occasion. Radiation Oncologist Dr. Bobby Den has been a long time contributor and has led many clinical trials. Dr. Veda Giri leads the genetic testing, and Dr. Ed Trabulsi is curently the Clinical Director of the GU MDC with Cyrstal Sypherd, CPHT as navigator. Brian Ward coordinates the Small Renal Mass GU MDC along with Drs. Costas Lallas and Mark Mann. 6

Year in Review


Key SKCC individuals in this 1996 founding members photo include Dr. Leonard Gomella (4th from right), Dr. Richard Valicenti (3rd from left) and Dr. Adam Dicker (2nd from left). Also seen are the late Dr. S Grant Mulholland, former Jefferson Urology Chair, Dr. Steve Strup now Chair of Urology at the University of Kentucky and Dr. Mo Ismail Chief of Urology at the Wilmington, VA Medical Center.

A photo to commemorate the 10-year anniversary of the GU Multidisciplinary Clinic in 2006. Across the front row from left to right Dr. Adam Dicker, Dr. Richard Pestell, SKCC Director, Mr. Tom Lewis former TJUH CEO, Drs. Leonard Gomella, Richard Valicenti and Walter “Wally” Curran, Clinical Director of the Cancer Center. Some notables to pick out in the photo include our current Urology Nurse Practitioner Darlene Bewick, Drs. Costas Lallas, Deb Glassman, and Ed Trabulsi.

A 2015 photo of some of the key GU MDC clinical team members. From left to right, Kathy Burns, Drs. Jianqing Lin, Adam Dicker, Kevin Kelly, Bobby Den, Leonard Gomella, Mark Hurwitz, Ed Trabulsi, Costas Lallas, MaryKate Cellmer and Dr. Jeannie Hoffman-Censits.

In 2019 a “Meet the Team” photo was taken outside of the Bodine Center for Cancer Treatment. The Bodine Clinic has been the home base for the GU MDC since its inception. Some new additions in this photo include Dr. Veda Giri, genetic counselor Laura Gross, urologic oncologists Drs. Mark Mann and Ryan Mark. Nurse practitioners who support the clinic include Ann Donnelly and Anne Lizardi-Calvaresi along with long time GU MDC Coordinator Joanne Anderson.

Since 1996, more than 12,000 patients have benefitted from the care provided by our SKCC GU MDC care model.

Dr. Adam Dicker, along with other members of the GU Multisdisciplinary team, published Prostate Cancer: A Multidisciplinary Approach to Diagnosis and Management in 2014. This book highlighted many of the principles of multidisciplinary prostate cancer care developed in our clinic (Demos Medical/Springer). Many other chapters and monographs have been written about details of our operation and overall experience in other books and journals. Jefferson Urology

7


The SKCC Multidisciplinary Clinic has set the standard...serving as the benchmark for national comparison.

Jefferson’s Kimmel Cancer Center 2013 Men’s Health Magazine acknowledgement for best prostate cancer care.

Andrew Chapman, DO, FACP

and Management by Dr. Adam Dicker and associates was published by Demos Press in 2014. The optimum approach to presenting the concept of active surveillance to men with low risk prostate cancer was developed at the GU MDC in collaboration with Dr. Ron Myers (5). The demonstration of our successful multidisciplinary collaboration was one of the reasons that the Philadelphia Prostate Cancer Biome project came into existence. The Biome project supports multidisciplinary basic science translational research (see page 18).

many focusing on prostate cancer, can vary. This is now considered a standard approach to follow at many academic cancer centers. Many other centers that have published in this area of multidisciplinary care suggest that simultaneous encounters in a real-time clinic setting are becoming commonplace and optimize the clinic experience for all involved including the patient and their family. A recent addition to our program is the option for cases to be referred to a separate SKCC Molecular Tumor board for further review.

Our multidisciplinary program has served as a model for many other centers across the United States, and has become a common approach in European countries where they often refer to these as “Prostate Cancer Units.” See the comments by Prof C.H. Bangma from Erasmus University Medical Center in The Netherlands on page 11 for the European perspective on our GU MDC. The specific design of each multidisciplinary clinic, with

The Sidney Kimmel Cancer Center now has 11 other specialty disease specific multidisciplinary clinics in operation with each one suited to the needs of the patients and the disease specialists involved. Our overall multidisciplinary effort at Jefferson is coordinated by Valerie Csik, MPH, CPPS Director of Quality and Care Transformation for the Sidney Kimmel Cancer Center. The SKCC GU Multidisciplinary concept

Sidney Kimmel Cancer Center Genitourinary Oncology Multidisciplinary Clinic 1995-2021

Sidney Kimmel Cancer Center Receives NCI Designation

Year in Review

Small Renal Mass Clinic splits off from GU MDC (2)

SKCC Multidisciplinary Clinic design first published (1)

SKCC GU Multidisciplinary Clinic Established by Drs. Leonard Gomella and Richard Valicenti

8

originally developed in the mid-1990’s initially focused on the care of men with prostate cancer. The reasons were simple: the treatment options and decisions for prostate cancer can be extensive and, at times, controversial. The benefits of the MDC concept include the potential to improve patient outcomes, to provide patients with convenience of seeing multiple specialists during one visit, to enhance education of trainees and staff, to improve clinical trial accrual and to allow standardization of data collection. Clinical trial opportunities, pathology and imaging review during a pre-clinic conference have become our standard practice with the current operational structure of the GU MDC is shown in the accompanying figure on page 11. Details on how to establish a similar GU MDC are available in an upcoming book (Mark JR, Gomella LG. Creating a Multidisciplinary GU Cancer Clinic. In: Urologic Oncology: Multidisciplinary care for patients. Ed. Stratton KL, Morgans, AK. 2022. Springer.)

10-year MDC Gala celebration at the Hyatt on Broad Street with guest speakers and scientific program


LEFT: Participants in the 10 year GU MDC Symposium celebration in 2006 included members of the Department of Urology and the SKCC along with visiting professors Dr. Dan Petrylak from Columbia and Dr. Mike Koch from Indiana University.

ABOVE: The 10-year anniversary in 2006 was marked by a dinner symposium with guest speakers. In 2016, the GU MDC team received the Sidney Kimmel Medical College Dean's award for Team Science. From left to right (Front Row) Dr. Peter McCue, GU MDC Pathologist since 1996, Drs. Jianqing Lin, Costas Lallas, Jean Hoffman-Censits. (Back Row) Dr. Ethan Halpern, GU MDC radiologist since 1996, Drs. Mark Hurwitz, Kevin Kelly, Bobby Den and SKMC Dean Dr. Mark Tykocinski. Department Chairs Dr. Adam Dicker and Leonard Gomella who nominated the team were also acknowledged at the Union League ceremony. (Dr. Trabulsi was unavailable). First Prostate Cancer Clinic Genetic Counseling Program launched within the MDC by Dr. Veda Giri (4).

Journal of Oncology Practice: First demonstration of improved survival for men withi high-risk prostate cancer treated in the MDC setting (3).

ASCO GU 2020: Demonstration that the MDC approach can improve neoadjuvant chemotherapy compliance before radical cystectomy (6)

GU Multidisciplinary team receives SKMC Dean's Award

Group Publishers Multi D Book (Dicker, et al by Demos Press)

Shared Decision Making for Active Surveillance in the MDC setting poublished (5)

Celebrating 25 years of SKCC Multidisciplinary GU Care

Jefferson Urology

9


Dr. Gomella and colleagues have developed the blueprint for multi-disciplinary excellence. They have developed and executed a framework where patients, trainees, researchers and fellow clinicians all benefit immensely. This should be implemented everywhere. Gerald Andriole, MD, FACS Professor of Urology

Multidisciplinary teams allow for optimal coordination among health professionals and clear communication with patients across a wide variety of genitourinary malignancies with the majority of cases involving prostate cancer. Since 1996, more than 12,000 patients have benefitted from the care provided by our SKCC GU MDC care model. Even during the height of the pandemic, the GU MDC team rapidly pivoted to Jefferson’s robust telehealth infrastructure to continue cancer evaluations and care in a virtual setting. Over the years, the GU MDC team has also provided support for the annual Prostate Cancer Awareness screening program held each September. The GU MDC team is appreciative of the support of Jefferson’s leadership provided by our Sidney Kimmel Cancer Center leadership

and Thomas Jefferson University Hospital in particular. Please see the national and international recognition of our GU MDC by leaders in the field on page 6.

5. Myers RE, Leader AE, Censits JH, et al Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with LowRisk Prostate Cancer: a Pilot Study. J Cancer Educ. 2018 Feb;33(1):180-185. doi: 10.1007/s13187-016-1073-7.

REFERENCES 1. Valicenti RK, Gomella LG, El-Gabry EA, et al. The multidisciplinary clinic approach to prostate cancer counseling and treatment. Semin Urol Oncol. 2000 Aug;18(3):188-91.

6. Mark JR, Smentkowski K, Gomella LG et al, The Multidisciplinary Clinic Approach for Bladder Cancer Treatment in the Neoadjuvant Therapy Era (ASCO GU 2020, San Francisco, CA; manuscript in preparation).

2. Lallas CD, Scotland K, Zhang M, et al, Clinical Influences in the Multidisciplinary Management of Small Renal Masses at a Tertiary Referral Center Oncology Practics Vol. 3, 468-474, November 2016. 3. Gomella LG, Lin J, Hoffman-Censits J, et al. Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. J Oncol Pract. 2010 Nov;6(6):e5-e10. 4. Giri VN, Gross L, Gomella LG, Hyatt C. How I Do It: Genetic counseling and genetic testing for inherited prostate cancer. Can J Urol. 2016 Apr;23(2):8247-53

To refer a patient to a Multidisciplinary Clinic at SKCC, schedule an appointment, or speak with a navigator, call 215-955-8516.

A benefit of our multidisciplinary clinic approach is the ability to discuss patients in real time. Above Drs. Gomella, Dicker and Den in the Bodine Clinic are discussing a newly diagnosed prostate cancer patient. 10

Year in Review


Multidisciplinary GU Cancer Center Sidney Kimmel Cancer Center Thomas Jefferson Univeresity

WELL WISHES Comments and well wishes from colleagues near and far on the 25th Anniversary of the Sidney Kimmel Cancer Center GU Multidisciplinary Clinic “Dr. Gomella, over the past 25 years, your pioneering concept of a multidisciplinary approach to improve the care of patients with genitourinary cancer has been widely admired and served as a model across the U.S. and Europe. Congratulations!” Patrick C. Walsh, MD University Distinguished Service Professor Emeritus, James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD

c

“Warm congratulations to the Sidney Kimmel Cancer Center GU Clinic program on its 25th anniversary. Prof. Leonard Gomella and colleagues have been true visionaries, initiating and promoting the multidisciplinary cancer clinic in urologic oncology. This unit has been exemplary for us in Europe (Valdagni R, Eur J Cancer 2011), and has inspired us to create the prostate cancer networks based on the definitions for quality care in The Netherlands (www.anserprostaatcentrum.nl). The groups focus on genetic traits has also stimulated the field for progress in research and counselling patients. Please continue the valuable work!” Prof C.H. Bangma MD, PhD Professor in Urology Director Anser Prostate Network Honorary Chair for Value Based Health Care in Urology Erasmus University Medical Center, Rotterdam, The Netherlands “My congratulations to Drs. Gomella, Dicker and Kelly, along with the entire Sidney Kimmel Cancer Center GU Multidisciplinary Cancer Team, in achieving this significant milestone. Back in 2016, we recognized the importance of their work with the Dean’s Team Science Award, and their continuing contributions over the years have more than substantiated this confidence.”

Current 2021 organizational structure of the Multidisciplinary GU Cancer Clinic of the NCI designated Sidney Kimmel Cancer Center.

Mark L. Tykocinski, MD Provost and Executive Vice President for Academic Affairs Thomas Jefferson University The Anthony F. & Gertrude M. DePalma Dean Sidney Kimmel Medical College Philadelphia, PA

Jefferson Urology

11


The Sidney Kimmel Cancer Center pioneered the implementation and operation of the Multidisciplinary Genitourinary clinic and has served as a model for many to emulate. ...The improvements in patient care, as compared to traditional approaches, with this clinical model have been documented, published and replicated around the world. Congratulations on the first 25 years of outstanding work, and we look forward to you leading us into the next quarter century! Michael S. Cookson, MD, MMHC, FACS Professor & Chair, Dept of Urology Donald D. Albers Chair in Urology University of Oklahoma Health Sciences Center & The Stephenson Cancer Center Chief Surgical Officer, OU Health’s Stephenson Cancer Center Past President, Society of Urologic Oncology Oklahoma City, OK

“Cancer Care today is dependent on a multidisciplinary approach, which for the past 25 years, has been the cornerstone of the Sidney Kimmel Cancer Center in Philadelphia. The Urology Department has had a prominent role at the Sidney Kimmel Center, and is wellknown based on the various presentations, publications, symposia and seminars that have been initiated from work done at this prestigious focus of high quality research, innovations and ideas. Congratulations to this unique center for helping to disseminate what is not only the present but the vision for the future of urologic cancer care." Raju Thomas, MD, FACS, FRCS, MHA President, American Urologic Association Professor and Chair Department of Urology Tulane University School of Medicine New Orleans, LA "As former Executive Vice President of Oncology Services at Jefferson Health and Director of the Sidney Kimmel Cancer Center, I had the opportunity to interact with the leadership of the GU Multidisciplinary Clinic team on a regular basis. Drs. Gomella, Kelly and Dicker's long-term dedication to this outstanding program has made it a useful model for others to follow. In my new role as CEO of the American Cancer Society, I have even greater appreciation of how this Multidisciplinary Clinic approach serves the needs of patients and their families and promotes the best cancer care available. Congratulations to all on your 25th anniversary." Karen E. Knudsen, MBA PhD CEO, American Cancer Society and ACS CAN Philadelphia, PA

12

Year in Review

"I would like to extend my personal congratulations to the Sidney Kimmel Cancer Multi-Disciplinary clinic and its members for all that you have accomplished since your clinic's inception in 1996. With its 25 year history, it is notable that it is the longest running such clinic in any NCIdesignated Cancer Center. The list of the accomplishments of this clinic are numerous and important. It has become a role model for other such efforts nationwide and internationally. Congratulations on your 25th anniversary!" Robert C. Flanigan. MD, FACS Professor of Urology Past President, American Urologic Association Loyola University Health System and Loyola’s Stritch School of Medicine Chicago, IL “Professor Gomella is one of my heroes in Urology. I cannot think of many urologists who were able to achieve the same levels of perfection in patient management, mentoring young clinicians and researchers and being a wonderful individual to develop such a beneficial multidisciplinary program.” Francesco Montorsi MD, FRCS (Hon) Professor and Chairman, Department of Urology, Editor Emeritus, European Urology Vita e Salute San Raffaele University, Milan, Italy “Congratulations to Dr. Gomella and his group on their 25th anniversary of multidisciplinary urological cancer care. They are to be lauded for their advancements in genetics, chemotherapy and surgery. The multidisciplinary care interactions between urology, oncology and radiation therapy, have improved both survival and quality of life for all patients.” Daniel P. Petrylak, MD Professor of Medicine and Urology Smilow Cancer Center Yale University School of Medicine New Haven, CT "Thank you for including me in the 25 Year Anniversary acknowledgement of the GU Multidisciplinary Clinic program at the Sidney Kimmel Cancer Center. I am proud to say we were way ahead of our time, and we had the collective skills, collaborative spirit and insight to make multidisciplinary care happen." Richard K. Valicenti, MD Professor and Chair Department of Radiation Oncology University of California, Davis Sacramento, CA

“The SKCC GU Multidisciplinary Clinic has set the standard for delivering the highest quality comprehensive cancer care over the past 25 years, and thus serves as the benchmark for national comparison.” Andrew Chapman, DO, FACP Interim Executive Vice President Oncology Services Interim Enterprise Director and Chief of Cancer Services, SKCC Professor, Medical Oncology Co-Director, Jefferson Senior Adult Oncology Center Philadelphia, PA “Dr. Gomella and colleagues have developed the blueprint for multi-disciplinary excellence. They have developed and executed a framework where patients, trainees, researchers and fellow clinicians all benefit immensely. This should be implemented everywhere.” Gerald Andriole, MD, FACS Professor of Urology Director of the Brady Urological institute, National Capital Region, Johns Hopkins University Washington, DC & Baltimore, MD “I am proud to have been a small part of the initial multidisciplinary GU cancer clinic launched at Thomas Jefferson University in 1996. This was a novel concept when the clinic was conceived and launched in 1996. The success of the Thomas Jefferson’s/Sidney Kimmel Cancer Center Multidisciplinary Clinic is evident in that Multidisciplinary Cancer care has gone from a unique concept to incorporation into our AUA guidelines. At the University of Kentucky, our Markey Cancer Center Multidisciplinary Cancer clinic was modeled in the image of the Sidney Kimmel Cancer Center GU Multi-D clinic and has been successful as well. Congratulations to Dr. Gomella and the entire team at the Sidney Kimmel Cancer Center Multi-D clinic for their dedication and vision to a concept that has advanced Urologic Cancer Care across the US and beyond.” Stephen E. Strup, MD, FACS James F. Glenn Professor & Chair Department of Urology University of Kentucky Lexington, KY “For 25 years the multidisciplinary GU Oncology Clinic at TJU has epitomized three foundational collaborative principles— maximizing collective intelligence, inclusive collaboration, and open communication—for the benefit of patients. Bravo for setting a high standard and on a job well done!” Eric A, Klein, MD Emeritus Andrew C. Novick Distinguished Professor and Chair, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH


“Multidisciplinary care for genitourinary malignancies has evolved from cutting edge to standard of care. This is in large part due to pioneers such as Leonard Gomella and Rich Valicenti at the Sidney Kimmel Cancer Center who recognized the value in working together to develop protocols, streamline care and in doing so advancing treatment. Congratulations on 25 years of improving patient’s lives.” Adam S. Kibel, M. Chief of Urology Brigham and Women's Hospital/ Dana-Farber Cancer Institute Elliott Carr Cutler Professor of Surgery Harvard Medical School, Boston MA "The SKCC GU multi-disciplinary clinic is a major success story. Having managed over 12,000 GU cancer patients over a 25-year period is an enviable track record, second to none. Kudos to Dr. Gomella and the collaborative teams of urologists, medical oncologists and radiation oncologists in creating a role model for others to follow". Inderbir S. Gill, MD Distinguished Professor Chairman, Catherine & Joseph Aresty Department of Urology Executive Director, USC Institute of Urology Shirley & Donald Skinner Chair in Urologic Cancer Surgery Associate Dean for Clinical Innovation Keck School of Medicine, USC Los Angeles, CA “As a Jefferson Alumni, I am so proud to recognize Dr. Gomella and his Jeff Urologic Oncology Team for their pioneering and groundbreaking efforts to start a true multidisciplinary clinic for men with prostate cancer 25 years ago. In fact, our group used the JEFF model to initiate the first prostate multi-D clinic in the military health system at Walter Reed and the DoD Center for Prostate Disease Research (DoD-CPDR) also in the 1990’s. Later when I joined the Duke University group, we also built on the original JEFF and military experience. Prostate multi-D care is now routine, but 25 years ago it was a novel approach.” Judd W. Moul, MD, FACS James H. Semans, MD Professor of Surgery and Anesthesiology Division of Urologic Surgery Duke Cancer Institute Durham, NC

“The Sidney Kimmel Cancer Center GU multidisciplinary clinic has set a benchmark for collaborative care and integrated practices nationally and internationally. Highly innovative at the time of its design and implementation, this clinic has meaningfully impacted patient care and facilitated important research for patients with urologic malignancies. Congratulations to the team for this milestone in a practice that has significantly advanced our field.” Stephen A. Boorjian, MD, FACS Carl Rosen Professor in Urology Chair, Department of Urology Director, Urologic Oncology Fellowship Mayo Clinic, Rochester, MN "The GU Multidisciplinary Clinic at the Sidney Kimmel Cancer Center has been visionary in bringing together focused and balanced expertise from numerous specialties across the medical profession with a singular goal...improving outcomes for patients. Congratulations on your first 25 years!" Edward Schaeffer, MD, PhD Edmund Andrews Professor &Chair Department of Urology Northwestern University Chicago, IL “The first tumor marker in oncology (acid phosphatase), the first effective oral therapy for a cancer(estrogens), the most important tumor marker in oncology (PSA), and two Nobel prizes represent the progress in prostate cancer. During the last two decades, many new interventions and therapies were introduced. Multi-disciplinary care is now the standard. The SKCC GU Multidisciplinary clinic, launched in 1996, joins the above list of firsts by recognizing and actively promoting the value of a team approach. Congratulations to Dr. Gomella and his colleagues on being the leaders in this area.” E. David Crawford, MD Professor of Urology Chairman, Prostate Conditions Education Council University of California San Diego San Diego, CA “To the credit to the team at Jefferson, they were amongst the first to establish a GU Multidisciplinary Clinic in the country. They effectively set the standard which other institutions followed. The Sidney Kimmel Cancer Center GU Multidisciplinary Clinic was literally decades ahead of its time and helped changed the way we deliver GU cancer care.”

“I was pleased to learn that you have celebrated the first 25 years of service of the Sidney Kimmel Multidisciplinary Genitourinary Cancer Clinic. You are to be congratulated on your vision 25 years ago to establish this excellent model for prostate cancer care and then all genitourinary cancer as the model for others to emulate. In Melbourne, Australia we have adopted your model of care in our prostate cancer clinic.I did have the great privilege of visiting your Sidney Kimmel Cancer Center in 2019. "I especially congratulate you on your foresight in establishing the men's genetic risk program incorporating testing and counselling for prostate cancer. After my visit to you, we established a prostate cancer genomics screening clinic in Melbourne modelled on the Sidney Kimmel pathway. I wish you well for the next 25 years, Dr. Gomella. I am sure this innovative program will continue to flourish under your guidance. Sincere good wishes to you all.” Anthony Costello, AM, MD, FRACS, FRCSI, MBBS Professor Emeritus Urology Department Royal Melbourne Hospital Melbourne, Australia

Congratulations to the Sidney Kimmel Cancer Center Genitourinary Multidisciplinary Team for being a leader in patient care for the past 25 years! We look forward to your continued accomplishments. James Eastham, MD Chief, Urology Service Department of Surgery Memorial Sloan Kettering Cancer Center New York, NY

David F. Penson, MD, MPH Professor and Chair, Department of Urology Hamilton and Howd Chair in Urologic Oncology Vanderbilt University Medical Center Nashville, TN

Jefferson Urology

13


14

Year in Review


Jefferson Urology

15


16

Year in Review


Jefferson Urology

17


Research

UPDATE FROM THE

18

Year in Review


In the fight against cancer, research is our most powerful weapon. Jefferson faculty at Sidney Kimmel Cancer Center have literally written the first book for patients on prostate cancer (see page 23), developed and published the first paper describing the design of a multidisciplinary clinic for prostate cancer (see page 8), and they are continuing to rewrite the medical literature with further research and new discoveries. The Philadelphia Prostate Cancer Biome Project (PPCBP) is the newest chapter in our prostate cancer research. This project is a long-term, multi-disciplinary, multiinstitutional collaboration that studies the region’s prostatecancer biome, the biological-sociological-psychological ecosystem where it flourishes. The project partners with top cancer centers, hospitals, and universities in the Philadelphia

region to collect and process biospecimens and patient/ population data. Patients are tracked over years to understand the many factors that predict outcomes in the prostate cancer biome. The data will be used to develop new strategies to prevent, diagnose, and treat the disease, leading to better outcomes for years to come. The Biome is made possible by a generous philanthropic family gift. The overall direction of the program is the responsibility of Dr. Kevin Kelly Director, Division of Solid Tumor Oncology and Associate Director of Clinical Research, SKCC and Dr. Leonard Gomella, Chair Department of Urology and Senior Director for Clinical Affairs, SKCC in collaboration with the Philadelphia Prostate Cancer Biome Board of Directors.

Annual Advisory Board Meeting The PPCBP held its annual board in the fall of 2021 to review impressive accomplishments from completed pilot projects, new pilot projects on the horizon, advancements in the SKCC Biorepository, and exciting future directions. Dr. Steve Klasko, Jefferson President, joined the meeting to thank the Board members for their service and support of the Biome

project. He also discussed Jefferson’s exciting future plan such as the Specialty Care Pavilion and the newly announced Caroline Kimmel Biomedical Research Building, both that will enhance the future impact and importance of the Biome project.

The Philadelphia Prostate Cancer Biome Project (PPCBP) is the newest chapter in our prostate cancer research. Drs. Kevin Kelly and Leonard Gomella presenting to the PPCBP board members during a virtual fall meeting.

Dr. Steven Klasko participated in the PPCBP Board meeting. Jefferson Urology

19


Prostate Whole Mount Project COMING SOON: MULTIDISCIPLINARY AND ARTICIAL INTELLIGENCE (AI) AWARDS The Phialdelphia Prostate Cancer Biome Project will launch a new multidisciplinary request for applications in early 2022. These new awards will focus on multidisciplinary team science. Stay tuned for award detail updates on the website: www.jefferson.edu/ givebiomeproject GRANT APPLICATION INFORMATION To apply for a Biome Award and for further details, access the Jefferson InfoReady system: www.jefferson.infoready4. com/ #competitionDetail/1817617 Contact Shannon (Fields) Cremin, PPCBP Project Director, with any grant or research-related questions at sxf068@jefferson.edu or 215.955.8875. PHILANTHROPIC SUPPORT INFORMATION To learn more about how philanthropic support moves the Philadelphia Prostate Cancer Biome Project ahead and how you can help, contact Emma Laverty, Assistant Vice Presindet of Development at emma. laverty@jefferson.edu or 215.503.8679. MORE ONLINE Check out the Philadelphia Prostate Cancer Biome Project website to learn more about ongoing projects. www.jefferson.edu/ givebiomeproject

20

Year in Review

In 2020, backed by the PPCBP, the Sidney Kimmel Cancer Center Biorepository acquired 2,009 whole mount prostate cases spanning from 1989 to 2009. A whole mount is a wax tissue block containing an entire prostate. This method preserves the entire specimen, which is extremely valuable for future research efforts including diagnostic testing and drug development. Throughout 2021, the SKCC Translational Research Group & Biorepository has worked on organizing and annotating these valuable specimens under an ongoing IRB protocol. The team now estimates the full collection is up to 30,000 individual formalin fixed paraffin embedded tissue blocks. The prostate whole mounts are labeled with 2D barcodes, stored in drawers, and entered into the SKCC Biorepository database for high-tech specimen tracking. The SKCC Biorepository looks forward to completing catalog efforts on this vast collection in 2022. In the fall of 2021 in collaboration with the Department of Urology, we completed archiving the medical records of nearly 1700 of the whole mounts. This information will be de-identified by removing all personal health information and annotated with the matching barcoded prostate samples. This will provide an additional powerful resource to advance prostate cancer research.

Wax tissue blocks each containing an entire prostate will serve as a valuable resource for prostate cancer research.

Drawer stacks located in the SKCC Biorepository that hold thousands of paraffin embedded prostates.

The Sidney Kimmel Cancer Center Biorepository leadership responsible for overseeing the Biome prostate samples. From left to right: Dr. J. Ryan Mark, Clinical Director SKCC Biorepository, Danielle Wentworth, MS, Laboratory Manager, Shannon (Fields) Cremin, Biome Project Manager and Dr. Haifeng Yang, Biorepository Laboratory Director.


C

Rolling Pilot Award Program Continues into 2022 The PPCBP is continuing the Rolling Pilot Program for a second year. These awards are intended for Thomas Jefferson University\ Sidney Kimmel Cancer Center’s basic, clinical and population-based researchers in collaboration with investigators across the greater Philadelphia region and beyond to develop innovative solutions that will prevent, delay, or eradicate prostate cancer in men. Pilot applications are reviewed and awarded on a quarterly basis. Since launching in 2019, the Biome Project has received 22 applications and funded 13 pilot awards in the clinical, basic, and population science arenas. In 2021, the PPCBP’s first six awarded investigators completed their pilot projects. Follow this link www.Jefferson.edu/ givebiomeproject to see updated videos on their progress and future research goals. CURRENT ROLLING PILOT PROJECTS "Targeting Sigma1 to Restrict Lipid Uptake in the Prostate Tumor Microenvironment” by Dr. Felix Kim (Jefferson) "AR-Negative Cancer Cells and IL-1beta in Skeletal Metastasis” by Dr. Alessandro Fatatis (Drexel) "Organization of Whole Mount Prostate Cancer Cohort from African American and European American men at Thomas Jefferson University” by Dr. Priti Lal (Penn) “VPAC Targeted Cu-67-TP3805 Theranostic for Prostate Cancer” by Drs. Robert Den, Mathew Thakur and Dr. Edouard Trabulsi (Jefferson) "Targeting the AlphaVBeta3 integrin in Neuroendocrine Prostate cancer” by Dr. Lucia Languino (Jefferson) "Study of the Nucleoporin-Chk1 axis in lethal prostate cancer” by Dr. Veronica Rodriguez-Bravo (Jefferson) ROLLING PILOT AWARD SUMMARY The awards will be one (1) year in duration and will provide funding of $50,000 to $150,000 depending on the innovation of the application. Principle Investigator must be a member of Jefferson University, SKCC or a SKCC consortium member. Co-investigators outside of Jefferson University\SKCC are strongly encouraged. Funded Pilot Awardees are asked to submit six-month and final progress reports. Applications for the Pilot Awards will be accepted on a rolling basis. Submitted applications will enter a rolling review process to determine funding. APPLICATION REVIEW SCHEDULE (2021-2022) Reviews at Quarter End (deadline)

Estimated Funding Date

December 31, 2021

January 28, 2022

March 31, 2022

April 29, 2022

June 30, 2022

July 29, 2022

September 30, 2022

October 31, 2022

December 30, 2022

January 31, 2023

Jefferson Urology

21


Bookshelf

&

Jefferson Urology

Department of Urology Contributors to The Merck Manual that include both the "Professional" and "Home" editions. Leonard G. Gomella, MD: Urology Editor Paul H. Chung, MD: Genitourinary Tests and Procedures; How To Do Genitourinary Procedures Keara De Cotiis, MD: Catheterization of Children T. E. Sonny Figueroa, MD: Urinary Incontinence in Children Irvin H. Hirsch, MD: Male Reproductive Endocrinology and Related Disorders; Male Sexual Dysfunction J. Ryan Mark, MD and Thenu Chandrasekar, MD: Genitourinary Cancer Patrick J. Shenot, MD: Voiding Disorders; Penile and Scrotal Disorders

22

Year in Review

The Merck Manual reflects the mission to provide the best medical information.

patients, The Merck Manual expanded its reach by making all that material plus additional videos and resources available for free at merckmanuals.com and msdmanuals.com in nearly a dozen languages. In 2015, The Merck Manual went further to share trusted medical knowledge around the world with the creation of the Global Medical Knowledge 2020 project. With this ambitious and far-reaching initiative The Merck Manual is committed to making the best current medical information accessible to three billion professionals and patients on every continent. In order to accomplish that goal, The Merck Manual has dedicated apps for medical professionals and consumers, which are available in the world’s most popular languages. Each app is available at no cost and can be downloaded for offline use. Both the websites and the apps come with no ads, registration requirements, or other barriers to access.

The Merck Manual has committed to bring these resources to communities around the world that need them most. According to World Economic Forum data, nearly half the world’s population has no access to the internet. In the least connected countries, THE MERCK MANUAL: DELIVERING fewer than one in five are connected. Through GLOBAL MEDICAL KNOWLEDGE partnerships with organizations such as Books for Africa, more than 200,000 copies First published in 1899 as a small reference book for physicians and pharmacists, The Merck of The Merck Manual professional and home editions go to nongovernmental organizations Manual grew in size and scope to become one of the most widely used comprehensive medical (NGOs) for distribution to physicians, nurses and community health workers throughout resources for professionals and consumers. developing countries. The Merck Manual is As The Merck Manual evolved, it continually expanded the reach and depth of its offerings to distributing print editions and tablets prereflect the mission of providing the best medical loaded with apps to bridge the digital divide in parts of the world that need them most. information of the day to a wide cross-section of users, including medical professionals and These manual resources are authored by more students, veterinarians and veterinary students, than 350 medical experts and leaders in their and consumers. field, including many Jefferson physicians in several different specialties. Since 2010, Dr. Since its creation, The Merck Manual was Leonard Gomella has served as the Urology built to travel well. Compact, easy-to-use, Editor for the manual. Throughout the years, and comprehensive, it was designed to deliver other Jefferson Urology faculty have joined the trusted medical information wherever it esteemed The Merck Manual’s contributor list. was needed. Albert Schweitzer carried a copy to Africa in 1913, and Admiral Byrd carried a copy to the South Pole in 1929. These early expeditions underscored what’s become a longstanding commitment from The Merck Manual to ensure healthcare professionals and consumers around the globe have access to current, credible and trusted medical information. In the decades since, The Merck Manual has enhanced and expanded its efforts to deliver medical knowledge to all corners of the world. While the print edition became a go-to resource for countless physicians and

Melissa Adams, Director of Publishing, Merck Manuals contributed to this article.


Jefferson’s Department of Urology was founded in 1904 as the Department of Genitourinary Diseases with its first dedicated Chair, Orville Horwitz, MD. This makes Jefferson one of the oldest identified urologic disease centric departments in the United States. While many physicians were traditionally trained in “Genitourinary Surgery” in the early 1900’s, a defined Urology residency was established at Jefferson in 1946 by Dr. D.M. Davis, one of the well-known figures in modern urology. Our Department of Urology archives indicate that Dr. Davis produced the first book from our Department in 1953 titled “Mechanisms of Urologic Diseases”. Since the time of Dr. Davis, the scholarly products such as books produced by our faculty has increased greatly as the Department transformed from predominantly volunteer to more full-time medical college employed faculty. Beyond journal articles, our Jefferson Urology faculty have been involved in a wide variety of published books in the field of medicine. While many of these books are urology centric, some are medical books outside of the specialty of Urology.

In 2021, we reviewed our Departmental library and faculty files to identify medical books authored/edited by our faculty. Hundreds of chapters have been written by our faculty over the years and have contributed greatly to our scholarly contributions and are not included here. For books included here, our faculty member must have a prominent role in the published book as editor/associate editor and be identified in that role on the cover. We have included only books published by medical publishers that would be appropriate for inclusion in a medical school medical library. Select journals are included if the periodical is published in book form. A famous quote by our namesake Thomas Jefferson is, “I cannot live without books...” He made this statement shortly after the tenth and last wagon carrying his library left Monticello for Washington, D.C. Jefferson had sold his library to Congress to replace the congressional library that was destroyed when the British burned the United States Capitol on August 24, 1814. Congress, he felt, could not function without access to a proper reference

library, so he promptly offered his own. (http:// blog.monticelloshop.org/?p=2030, Accessed December 10, 2021). Just as in Jefferson’s time, books have been a mainstay of medical education and patient care for hundreds of years. Over the years, Jefferson Urology faculty have authored or edited nearly 2 dozen different titles with many published long term through numerous editions and others translated into foreign languages. While print books are still a major focus of medical publishers, online content is growing in this area. Many of the books noted here by Jefferson Urology faculty are currently available both in print and online or e-book versions, with the electronic version trend likely to continue into the future. This online trend is seen with our department’s involvement with the famous Merck Manual on page 22 of this 2021 Year in Review. In contrast to the U.S. medical readership, print books remain extremely popular outside of the US. Here is a sampling of books from our Sidney Kimmel Medical College Urology faculty. While the list is mostly in alphabetical order we start with the oldest book first.

Jefferson Urology

23


Bookshelf Mechanisms of Urologic Disease

This was the first book published by any Jefferson Urology faculty member. “Mechanisms of Urologic Disease” by Dr. DM Davis was published in 1953 by W.B Saunders in Philadelphia, with a purchase price of $4.50. A book review was published in JAMA on November 14, 1953. The reviewer noted: “This readable little volume gives a bird's-eye view of urologic problems with emphasis on the physiological processes and pathological changes involved. In contrast to most treatises on urology, instead of dividing the subjects on an anatomic basis, the author appropriately treats the subjects on the basis of eight different types of pathological changes.”

The 5-Minute Urology Consult Gomella LG, (ed.), 2015 3rd Edition Wolters Kluwer, Philadelphia, PA The following are excerpts from a review of the second edition by Dr. Paul Lange from the University of Washington and published in JAMA March 2011: “This excellent book does superbly what it intended to do: Quickly provide the reader with essential facts and action items needed to care for patients with almost any urologic problem….every urologic patient care environment should have a hard copy or the online version within easy reach. I recommend it highly.” Dr. Gomella edited all three editions with plans underway for the 4th edition.

Advanced Ureteroscopy: Treating Difficult Problems Hubosky SG, Grasso M, Traxer O, Bagley DH.2021, Springer Nature Switzerland From the book jacket: “This book considers all aspects of ureteroscopy and the dominant role that it plays in the treatment of many urologic disorders. Most diseases of the ureter and renal collecting system must be considered for ureteroscopic diagnosis and/or treatment. This book explores advancements of instrumentation such as endoscopes, ancillary devices, endoscopic lithotripters, and ablative devices. It also illuminates the most current diagnostic and therapeutic techniques, including pre- and postoperative treatment, metabolic management, and the role of chemotherapy in the upper tract. Further, this book examines less common indications for ureteroscopy such as strictures, foreign bodies, and diagnostic dilemmas.”

Basic and Advanced Prostate Brachytherapy Dicker, A, Merrick, G, Waterman, F, Valicenti R and Gomella, LG (eds.) 2005, Taylor and Francis, Ltd. London From the publishers website: “Prostate brachytherapy has evolved into a sophisticated treatment modality, used either as monotherapy or in combination with external beam radiation therapy for the treatment of prostate cancer. This book covers both basic and advanced techniques for prostate brachytherapy and is appropriate for the practitioner involved with permanent radioactive seed implants. Topics include: patient selection,

24

Year in Review

equipment decisions, treatment planning, operative techniques, post-implant evaluation and follow-up after implant. The accompanying CD-ROM, with video clips, is an invaluable teaching tool. The text is for urologists, radiation oncologists, medical oncologists and medical physicists.” This was also published in Japanese.

Chemotherapy and Immunotherapy for Genitourinary Malignancies: A Primer for Urologists and Advanced Practice Providers Trabulsi EJ, Lallas CD and Calvaresi AE (Eds). 2021 Springer Nature, Switzerland This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. The book is a resource for urologists, uroradiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects. A focus of the book is directed towards the role of advanced practice providers in administering this care.

Gomella and Haist's Clinician’s Pocket Reference Gomella, LG, Haist, SA (Eds.) 12th Edition, 2022 McGraw Hill, New York, NY The “Clinician’s Pocket Reference” was originally published as “So You Want To be A Scut Monkey” by the University of Kentucky College of Medicine in 1979. The book was originally developed by students at the University of Kentucky. In 1983 the name was changed to the “Clinician’s Pocket Reference” when the 4th Edition was published by Appleton-Century-Crofts, Norwalk, CT. The book is a general reference for medical students and other health care providers for guidance at the start of clinical training. It has been a medical student “go to” reference book for many years and has been published by a series of legacy publishers (Appleton and Lange, now McGraw Hill). It has been referred to as the “manual of manuals” for learning patient care. The latest 12th edition (2022), has been renamed “Gomella and Haist’s Clinician’s Pocket Reference” in recognition of their long standing editorial leadership of the book. Over the years, various editions of the “Clinician’s Pocket Reference” have been translated into 6 different foreign languages. The Portuguese language translation of the fourth edition was the first in 1983. Here are just a few examples of the translations.

Clinician’s Pocket Drug Reference Gomella, LG, Haist SA, GelhotAdams A (eds.) 13th Edition, 2016 McGraw Hill, NY, NY This small pocket drug guide was published from 2002 until 2016 by McGraw Hill. It was a general drug reference covering the most commonly prescribed agents in the US. Often featured as a companion book to the “Clinician’s Pocket Reference.”

Diagnóstico y Manejo del Cancer de Prostata Meza Montoya L, Gomella L and Solsona Narbon E, Eds 2017 Grijley Publishers, Lima, Peru In 2017 Dr. Gomella was invited to collaborate with the Peruvian Asociacion Peruana para el estudio de Cancer Urologico and the National Cancer Institute of Peru on a Spanish language book dedicated to prostate cancer care in that country.

EMS Pocket Drug Guide Gomella, PT, (Ed), 2nd Ed. 2013 McGraw Hill Medical, NY Dr. Patrick Gomella, Assistant Professor of Urology and Surgery, has extensive experience in emergency medical services and is a certified EMT-P (Paramedic). During medical school he completed this drug guide for EMS providers in the field.

Glenn’s Urologic Surgery Gomella LG, Associate Editor

5th Edition 1998 Lippincott-Raven, Phila., PA Gomella LG, Associate Editor

6th Edition 2004 LWW, Philadelphia, PA Gomella LG, Associate Editor

7th Edition 2010 LWW, Philadelphia, PA From the publisher’s web site: “The world’s preeminent surgeons present step-by-step descriptions of all current operative procedures for each region of the genitourinary tract and provide the background information surgeons need to ensure successful outcomes. More than 1,300 detailed illustrations demonstrate surgical anatomy and techniques. The Seventh Edition highlighted laparoscopic procedures with brand new chapters on robotic surgery, nanotechnology, and laparoscopic and robot-assisted laparoscopic prostatectomy.” Dr. Gomella served as Associate Editor for laparoscopy for the 5th, 6th and 7th Editions.

Handbook of Urological Diseases In Children Gonzalez R, Ludwikowski BM. 1st Edition 2010. World Scientific Publishing Company, Singapore This manual provided a quick reference on pediatric urologic problems for medical students and physicians in training. It was authored by Dr. Ricardo Gonzalez, Professor of Urology at Jefferson and the AI Dupont Children’s Hospital. You can read more about the life of Dr. Gonzalez and his contributions to pediatric urology and on page 54 of this 2021 Year in Review.


Laparoscopic Urologic Surgery Gomella, LG, Kozminski, M, Winfield, H., (eds.) 1st Edition 1994. Raven Press, New York, NY Laparoscopic surgery began to expand in the early 1990’s. The laparoscopy program in urology at Jefferson was initiated by Dr. Gomella in 1990 with guidance from Dr. Craig Winkle, Vice-Chair of Obstetrics & Gynecology. “Laparoscopic Urologic Surgery” was the first color atlas dedicated to this rapidly evolving field. This book provided a guide to the use of laparoscopic techniques in urologic surgery. It provided essential information on patient selection and perioperative management, on laparoscopic instrumentation and video systems, and on basic techniques including microlaparoscopy and use of lasers and electrosurgery. The book also described a variety of laparoscopic urologic procedures several years before the introduction of laparoscopic radical prostatectomy and robotic assisted laparoscopy. The book was also published in Italian.

Multidisciplinary Approach to Prostate Cancer Dicker AP, Kelly WK, Zaorsky N, Trabulsi EJ (Eds.), 2014 Demos Medical, New York, NY With an emphasis on multidisciplinary collaboration and decisionmaking, this practical resource reflects the extraordinary advances in the treatment of prostate cancer during the past five years. Approximately thirty international, leading-edge investigators describe the most current evidence-based approaches to prostate cancer treatment. The book provides a comprehensive view of the entire spectrum of prostate cancer management from initial screening through novel and experimental treatments that have the potential for a major impact on practice. See also page 7 of this 2021 Year in review for more information on this book and the history of our SKCC GU Multidisciplinary Clinic.

Oxford American Handbook of Urology Albala, D, Morey, A Gomella, LG and Stein J (eds), 2010 Oxford University Press, New York, NY From the Publishers web site: “The Oxford American Handbook of Urology provides authoritative, point-of-care guidance on all aspects of the field, covering both benign and malignant conditions, as well as medical and surgical management. Incorporating diagnosis and treatment advice from established, published guidelines as well as drawing from the experience of four seasoned urologists, the book's concise and accessible format quickly guides the reader to desired information on common signs and symptoms.”

Prostate Cancer Genetics: Changing the Paradigm of Care

The Clinics Atlas of Office Procedures: Office Urology

Gomella LG and Giri V (Eds.), Urologic Clinics, Elsevier 2021, Phila., PA

Hirsch IH, Guest Editor 2002, WB Saunders, Philadelphia, PA This was part of a Urologic Clinics of North America series that focused specifically on in-office based procedures in Urology. Topics included prostate biopsy, cystoscopy, urodynamics and others. Dr. Hirsch served as guest editor.

The Urologic Clinics of North America publishes Clinics Articles in book form. In 2021, Drs. Gomella and Giri were invited to serve as guest editors on an edition dedicated to prostate cancer genetics.

Recovering From Prostate Cancer Gomella, LG and Fried, JJ, 1993. Harper-Collins Press, New York, NY This paperback book was the first written for the general public that specifically focused on the topic of prostate cancer. Dr. Gomella partnered with Philadelphia Inquirer science writer John Fried. The book antedated others written by high profile experts in the field.

Smith’s Textbook of Endourology Smith, AD, Badlani, GH, Bagley, DH, et al: 1st Ed. 1995 Quality Medical Publishing, St. Louis, MO Dr. Bagley served as Associate Editor on the first edition of this book now considered to be the standard endourology reference. The editors of this first edition have been referred to as the “the founding fathers of endourology.”

Surgery on Call Lefor, AT, Gomella, LG, 4th Edition. 2005, McGraw Hill, New York, NY This book was primarily used by surgical house officers to provide rapid information on common surgical problems. The first edition was published in 1990 by Appleton and Lange and subsequently by McGraw Hill. It was released in an Australian English version and was translated in to several foreign languages with the Portuguese version shown here. This book was part of a larger “On Call” Series from Appleton and Lange/McGraw Hill. This series included Internal Medicine, OB/GYN, Pediatrics, Critical Care and Emergency Medicine. In addition to this book, Dr. Gomella served as the editor for the entire series.

Upper Urinary Tract Urothelial Carcinoma Grasso M and Bagley DH, 2015, Springer, Philadelphia PA From the publishers web site: “This book will have references to all current perspectives, such as diagnostic modalities, endoscopic treatments, surgical treatments, adjuvant therapies and so forth. It will be a useful source of treatment guidelines and a strong frame of reference for designing innovative therapies. This book will show multimodality treatment plans, and will be of great interest to many medical subspecialists who encounter complex patients.”

Ureteroscopy Huffman, JL, Bagley, DH and Lyon, ES, 1988 WB Saunders, Philadelphia, PA The first book on ureteroscopy from the team that were considered the pioneers and the earliest contributors to this technique. Publishers book description: “Practical guide to urologic endoscopic procedures for the removal of stones and tumors that do not require abdominal incisions. Covers applications and contraindications of techniques utilizing flexible endoscopes and laser equipment. Also details instrumentation, upper urinary tract anatomy for the ureteropyeloscopist, urinary dilation, diagnostic and therapeutic techniques, post-operative care, and management of complications. Includes line drawings depicting techniques and patient positions.”

Urologic Endoscopy: A Manual and Atlas Bagley DH, Huffman JL, and Lyon ES.1985, Little, Brown & Company, Boston, MA The following comments were noted in a 1985 review in the British Journal of Surgery: “Bagley, Huffman and Lyon are internationally recognized authorities on endourology, the term now commonly used to cover all forma of urological endoscopy including percutaneous renal surgery and ureterorenal endoscopy…”…” it is the best book of its kind….” “The expense of the book ($95) is easily justified by its contents and lavish production. It would form a useful and upto-date edition in the library of any clinician involved in urological practice.”

Jefferson Urology

25


Meetings and Presentations Virtual AUA September 10-13, 2021 The annual meeting of the American Urologic Association was scheduled to be held as an in-person meeting in Las Vegas, Nevada. Two weeks before the meeting, the decision was made to convert to a virtual event. Most sessions were held, but events such as moderated poster and abstract sessions, were completed without real time moderators. The following were Department of Urology faculty, residents and students contributions to our major annual Urology meeting. See page 43 for details on the AUA Course “Urologic Care for the Advanced Practice Provider” CoDirected by Anne Lizardi-Calvaresi, DNP, RNFA. A complete listing of Jefferson Urology contributions is shown here.

Even with a virtual program, the AUA provided the AUA Daily news each day of the meeting.

POSTERS & PODIUM SESSIONS Podium: PD10-12 Contrast-Enhanced Ultrasound as a Novel Technology for the Pre-and Post-Operative Evaluation of Urethral Strictures. Joon Yau Leong, Priscilla Machado, Corinne E. Wessner, Edouard J. Trabulsi, Ethan J. Halpern, Flemming Forsberg, John R. Eisenbrey, Paul H. Chung, Philadelphia, PA. Podium: PD65-01 Prostate-Specific Antigen Testing in the Disabled Population: A CrossSectional Analysis of the Health Information National Trends Survey (Hints) Joon Yau Leong, Philadelphia, PA; Ruben Pinkhasov, Syracuse, NY; Thenappan Chandrasekar, Philadelphia, PA; Oleg Shapiro, Michael Daneshvar, Thomas Sanford, Gennady Bratslavsky, Hanan Goldberg, Syracuse, NY. Moderated Poster: MP35-10 Next-Generation Sequencing Appears to Recharacterize Biofilm From Infected Penile Implants: Have We Been Wrong? Paul H. Chung, Erica Mann, Joon Yau Leong, Philadelphia, PA; Gerald Henry, Bossier City, LA. Podium: PD17-05 The Impact of A Positive Family History of Hereditary CancerAssociated Malignancies on Outcomes of Active Surveillance for Prostate Cancer. Adam Schneider, Nicholas Bowler, Ryan Fogg, Joon Yau Leong, Philadelphia, PA; Andrew Gusev, Adam Feldman, Michael Blute, Anthony Zietman, Douglas Dahl, Jason Efsathiou, Boston, MA; Thenappan Chandrasekar, Philadelphia, PA; Keyan Salari, Boston, MA . Podium: PD46-10 Risk of Secondary Malignancies After Pelvic Radiation: A Population-Based Analysis. Andrew Salib, Connor McPartland, James R. Mark, Costas D. Lallas, Edouard J. Trabulsi, Leonard G. Gomella, Thenappan Chandrasekar, Philadelphia, PA. 26

Year in Review

Podium: PD24-06: The Effect of the COVID-19 Pandemic on Urology Match by Location. Andrea Quinn (Podium Presenter), Erica Mann, Jared Raikin, Cassra Clark, Jessica Clark, Alana Murphy, Patrick Shenot, Costas Lallas. Moderated Poster: MP57-08: Molecular Testing with Next-Generation Sequencing Appears to Identify Biofilm on Penile Prostheses Better than Traditional Cultures: The New Gold Standard? Paul H. Chung, Joon Yau Leong, Whitney Stanton, Niccole Diaz, Caleb D. Phillips, Gerard D. Henry. Panel Discussion: The Future of Urologic Oncology: How will the Role of Urologic Cancer Surgeon be affected by Advances in Technology and Science. Moderator: Taneja S Panelists: Salami S, Trabulsi E, Shuch B, Lee C. Panel Discussion: App Utilization & Scope of Practice; Calvaresi A Panelist. MP22: Imaging/Radiology: Uroradiology II; Poster Session Moderators: Porter C, Trabulsi E, Porpiglia F MP28: Benign Prostatic Hyperplasia: Epidemiology & Evaluation Poster Session Moderators: McVary K, Gomella LG, Chughtai B. VO8: Notes/Less: Video Session Moderators – Lallas C, Ogan K, Herrel Lindsey.

EDUCATIONAL COURSES AUA Office of Education Seminar: Genetic Testing in Advanced Prostate Cancer (Gomella LG, Faculty Member) in: “Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion.” Joint AUA/SUO Seminar. Instructional Course: “Urologic Care for the Advanced Practice Provider”. Co-Directed by Anne Lizardi-Calvaresi, DNP, CRNP, RNFA (See program details on page 43) Instructional Course: “Advanced Ureteroscopy: Overcoming Challenging Problems”. Grasso M (Director) Faculty: Bagley DH, Traxer O, Hubosky, SG. Instructional Course: “Genetic Testing in Prostate Cancer: Understanding Clinical Implications for Early Detection, Localized Disease, & CRPC”; Morgan T (Director), Faculty: Gomella LG and Cheng H. Instructional Course: “Multi-Parametric Ultrasound in the Diagnosis of Prostate Cancer” Fulgham P (Director); Faculty: Trabulsi E, Loch T. Instructional Course: “Urologic Care for the Advanced Practice Provider Evaluation and Management of Urethral Stricture Disease”. Speaker: Chung P. Instructional Course: “Chemotherapy & Immunotherapy for the Urologist & Advanced Practice Provider”: Lallas C (Course Director); Faculty: Trabulsi E and Calvaresi A.

Transitioning from an in-person meeting to virtual did not lessen the impact of this major, annual urological meeting.


Mid-Atlantic AUA Meeting October 14-16, 2021, National Harbor , MD Jefferson Urology was well represented at the Mid-Atlantic American Urologic Association Annual meeting at National Harbor, MD, in September 2021. As most people’s first in-person meeting attendance since the pandemic, everyone’s spirits were high. Notable achievements include Dr. Andrew Salib (PGY5) who anchored his team’s victory in the annual resident Jeopardy Bowl competition, for which he and his teammates will move on to compete at the annual AUA Resident Competition in New Orleans. Announcements included the selection of Dr. Costas Lallas as President-Elect of the Mid-Atlantic Section, and the continuation of Dr. Anne Calvaresi as the APP representative to the Mid-Atlantic AUA Executive Board. Jefferson Urology faculty, residents and students had numerous scientific contributions at the meeting, with a total of 12 abstract presentations (poster and podium). Our Jefferson Urology Scholars were actively involved in the meeting program. Dr. Lallas served as a podium panel moderator for a discussion on management of surgical complications, and Drs. Akhil Das, Paul Chung and Thenu Chandrasekar served as session moderators. A complete listing of Jefferson Urology presentation and abstracts is noted here. MID-ATLANTIC AUA PRESENTATIONS Quinn AM, Scott ER, Morano S, Karp A, Mann E, Boyd K, McPartland C, Schneider A, Singh A, Desai V, Chandrasekar T, Mann MJ, Trabulsi EJ, Desai V, Lallas C: The Effect of 3D Printed Models on Surgical Planning and Outcomes for Partial Nephrectomies. Moderated Poster Presented at: 2021 Mid-

Atlantic Section of the AUA National Meeting. October 14-16, 2021, National Harbor, MD. Quinn AM, Mann E, Mark JR, Mann MJ, Trabulsi EJ, Lallas C, Gomella L, Chandrasekar T: Persistence of Opioid Reduction Habits 1 Year After Implementation. Display Poster Presented at: 2021 Mid-Atlantic Section of the AUA National Meeting. October 14-16, 2021, National Harbor, MD. Quinn AM, Mann E, Le Roux M, Clark C, Lallas CD: Virtual Urology Focused on Teaching Non-Urology Students. Display poster Mann E, Quinn AM, Glick L, Han T, Wessner C, Wang S, Nam K, Smentowski K, Eisenbrey J, Gomella LG, Trabulsi EJ, Lallas C, Mann MJ, Mark JR, Forsberg F, Lyshchik A, Halpern E, Chandrasekar T: Contrast-Enhanced 4D Ultrasonography for the Evaluation of Complex Renal Cysts. Moderated Poster Mann E, Quinn AM, Clark C, Bowler N, Mann MJ, Mark JR, Lallas C, Den R, Trabulsi EJ: A Review of SpaceOAR Complications and Influential Patient Characteristics. Mann E, Berry K, Quinn AM, Mark JR, Chandrasekar T, Trabulsi EJ, Lallas C, Gomella LG, Mann MJ: Do 5-alpha Reductase Inhibitors Effect the Diagnostic Accuracy of MRI-Fusion Biopsies? Display Poster Chandrasekar T, Streeper NM, Quinn A, Keith C, Syed K, Kutikov A, Danella J, Ginzburg S, Lanchoney T, Tomaszewski J, Trabulsi E, Reese A, Smaldone M, Uzzo R, Guzzo TJ, Raman JD, Bernstein A, Lee DJ: Qualitative Evaluation of Differing Opioid Sparing Protocols Across the Pennsylvania Regional Collaborative: Understanding Barriers and Facilitators. Moderated Poster.

Dr. Andrew Salib (PGY5) with a poster he presented at the Mid-Atlantic AUA meeting in October 2021, discussing challenges with bladder cancer management during the shortage of BCG.

Salib A, Kloneicke E, McPartland C, Calvaresi AE, Chandrasekar T, Lallas CD, Trabulsi EJ, Gomella LG, Izes JK: Treatment Failure and Disease Progression of Non-Muscle Invasive Bladder Cancer During BCG Shortage. Tidwell T, Salib A, Berry K, Chung PH: Comparison of the Psychosocial impact of penile implant and intracavernosal injection therapy for erectile dysfunction using the selfesteem and relationship (SEAR) questionnaire. Moderated Poster. Salib A, McPartland C, Mark JR, Trabulsi EJ, Lallas CD, Gomella LG, Chandrasekar T: Resident Prize Essay Podium Presentation: Risk of Secondary Malignancies after Pelvic Radiation: A Population-Based Analysis. Leong JY, Schultz J, Zhan T, Marks J, Chung PH. General Surgeons' Comfort and Urologists’ Perceptions of Bladder Trauma Management. Moderated Poster Leong JY, Wessner CE, Machado P, Trabulsi EJ, Halpern EJ, Forsberg F, Eisenbrey JR, Chung PH: Shear Wave Elastography: Novel Methods for the Evaluation of Urethral Stricture Disease. Display Poster.

RESIDENTS' BOWL Congratulations to the winning team! Jack Farhi, MD University of Virginia; Alex Nourian, MD - Albert Einstein Medical Center; and Andrew Salib, MD - Thomas Jefferson University. Dr. Andrew Salib (PGY 5) helped secure the Mid-Atlantic AUA spot in the National AUA Residents Bowl this coming May 2022 in New Orleans, LA. Jefferson Urology

27


Meetings and Presentations

Residents Surgical Skills Workshop on Prosthetics On December 2 and 3, 2021, Dr. Paul Chung arranged for the residents to participate in a surgical skills workshop on the placement of the inflatable penile prosthesis. The program was supported by an educational grant from Coloplast. Visiting speaker was Dr. Gerard Henry, a world renowned expert in urologic prosthetics used to treat a variety of conditions such as erectile dysfunction and incontinence. He is based in Bossier City, Louisiana near Shreveport and is part of the

Willis Knighton Health System. Dr. Henry has been President of the Louisiana Urologic Society and the Society of Urologic Prosthetic Surgeons and has published and presented extensively in the field of urologic prosthetic surgery. Following didactic lectures, the residents worked under the supervision of Drs. Chung and Henry with models in the Alumni Hall anatomy labs to practice the proper surgical technique for the inflatable penile prosthesis. Residents working with a hydrogel model for the inflatable penile prosthesis surgical technique workshop.

Dr. Paul Chung with PGY2 resident JY Leong.

Dr. Gerard Henry demonstrating the proper prosthesis implantation technique on a model in the Jefferson Alumni Hall anatomy lab.

Sexual Medicine Society of North America (SMSNA) 2021 Paul H. Chung, MD and Joon Yau Leong, MD (PGY2) attended the 22nd Annual Fall Sexual Medicine Society of North America (SMSNA) meeting held October 21-24 2021, in Scottsdale, AZ. Jefferson abstracts presented included: “Penile Implant Bacterial Biofilm Profiles Vary By Surgery Indication: An Opportunity to Optimize PeriOperative Care.” “A Comparison of the Psychosocial Impact of Penile Prosthesis and Intracavernosal Injection Therapy for Erectile Dysfunction Using the Self-Esteem and Relationship (SEAR) Questionnaire.” “A Free Listing Assessment of Sexual Function and Relationships for Penile Prosthesis and Intracavernosal Injection Therapy for Erectile Dysfunction.”

Drs. JY Leong and Paul Chung at the SMSNA Fall meeting in Scottsdale. 28

Year in Review


Jefferson Health Wellness Webinar

Fourth Annual Jefferson Urology Symposium Our annual Jefferson Urology Symposium was held in a virtual format on Friday April 30, 2021. The theme of this 4th Annual CME event was: “Focus on Urinary Incontinence and the Surgical Management of Benign Prostatic Hyperplasia.” The virtual symposium combined didactic lectures, case based discussions and interactive question and answer sessions and included guest faculty and Jefferson faculty. In August, 2021 Symposium Proceedings were published in the Canadian Journal of Urology International. Planning is underway for our 5th annual Symposium in 2022. JEFFERSON UROLOGY 4TH ANNUAL SYMPOSIUM AGENDA Dr. Paul Chung participated in a webinar that focused on the management of Erectile Dysfunction. Dr. Joceline Fuchs from the MidLantic Urology practice also participated. According to Nicholas Coffey, Marketing Director for Jefferson Health “This was one of the most successful webinars with one of the highest registrations we’ve had for a patient webinar. Interest was so high that 89 questions were submitted before the live event, the largest number of questions we’ve had for a webinar.”

Dr. Gomella Interviewed on “Your Radio Doctor” Dr. Marianne Ritchie, Clinical Associate Professor in Jefferson’s Division of Gastroenterology, hosts a weekly Sunday radio show titled “Your Radio Doctor.” On June 27, 2021. Dr. Leonard Gomella was a guest on the show and discussed issues surrounding prostate cancer. “Your Radio Doctor” broadcasts live every Sunday at 10am EST on WPHT Talk Radio 2010 AM. Listen via radio, online, or on your cell phone by downloading the Radio.com app. (www.yourradiodoctor.net/about/)

Office-based Therapy for BPH – Prostatic Urethral Lift (PUL) Procedures and Water Vapor Therapy for BPH: Tips, Techniques and Outcomes

Claus Roehrborn, MD UT Southwestern Medical Center Dallas, TX

Should HoLEP be the New Gold Standard for the Surgical Management of BPH?

Mitchell Humphreys, MD Mayo Clinic, Phoenix, AZ

HoLEP Techniques: Tips and Tricks to Help Shorten the Learning Curve

Akhil K. Das, MD Sidney Kimmel Medical College

Aquablation and New Upcoming Technologies for BPH

Claus Roehrborn, MD UT Southwestern Medical Center Dallas, TX

Pelvic Organ Prolapse (POP) and Urinary Incontinence: Current Surgical Strategies

Sandip Vasavada, MD Cleveland Clinic, Cleveland, OH

Evaluation and Management of a Female Patient with Urinary Incontinence

Alana Murphy, MD Sidney Kimmel Medical College

Management of Urinary Incontinence Associated with Neurogenic Bladder Disorder

Patrick Shenot, MD Sidney Kimmel Medical College

The Management of Post Prostatectomy Urinary Incontinence

Akhil K. Das, MD Sidney Kimmel Medical College

This Jefferson Urology Symposium CJUI issue (Volume 28, Supplement 2 August 2021) is available as a free download. Visit www.canjurol.com Jefferson Urology

29


International News Dr. Hubosky in Dubai

Dr. Chung to Speak at Israel Space Conference

As Principal investigator on one of the 2022 Rakia Mission space station scientific studies, Dr. Paul Chung was invited to participate in the 17th Ilan Ramon International Space Conference in Israel. The conference is held in honor of Ilan Ramon, the first Israeli astronaut who perished in in the fatal mission of the Columbia shuttle, in which he and six other crew members were killed in the re-entry accident. Details on Dr. Chung’s upcoming International Space Station research study can be found on page 4.

30

Year in Review

Dr. Mike Grasso, 1992 Jefferson residency graduate along with Dr. Scott Hubosky at the Société Internationale d’Urolgie (SIU) in Dubai, UAE, in November 2021. Dr. Scott G. Hubosky, Professor of Urology, attended the 41st Congress of the Société Internationale d’Urolgie (SIU) held in Dubai, United Arab Emirates on Nov.14, 2021. This was one of few academic meetings actually held as an “in-person” event during the last two years. Dr. Hubosky, together with Jefferson Urology alum, Dr. Michael Grasso III of New

York Medical College and European endourology expert, Dr. Olivier Traxer of Sorbonne University in Paris, served as faculty for the instructional course, “Advanced Ureteroscopy.” Updates on the latest ureteroscopic instrumentation, as well as stone and upper tract tumor treatments, were presented, along with strategies to avoid complications.


Jefferson India Center PERUVIAN UROLOGY SOCIETY Dr. Leonard Gomella served as a faculty member for the Peruvian Urologic Society. The virtual ZOOM webinar meeting was held on July 16, 2021. The meeting focused on the latest developments in genetics and genomics in the management of prostate cancer. The meeting presentations were simultaneously translated into Spanish.

Drs. Mat Thakur and Leonard Gomella with Dr. Richard Derman, Director, Global Health Research and Professor, Obstetrics & Gynecology, Dr. Lauri Romanzi who recently joined Jefferson’s College of Population Health and Vice-Chancellor of KLE University in Belgaum, India, Dr. Vivek Saoji. Dr. Vivek Saoji, Vice Chancellor of KLE University in Belgaum, India and home to Jawaharlal Nehru Medical College, visited Jefferson in December, 2021. Drs. Gomella and Thakur reviewed progress in our joint Urology research program in the urinary detection of bladder and prostate cancer.

The lab effort in India is led by Dr. Raj Nerli, Chair of Urology at KLE. The group along with Drs. Derman and Romanzi also engaged in preliminary discussions to develop joint Jefferson/KLE training programs for residents and fellows.

Dr. Vittorio Canale Guest Resident

HONG KONG UNIVERSITY The HKU School of Professional and Continuing Education (HKU SPACE) is a secondary education institution in Hong Kong. The School is a private subsidiary of the publicly funded University of Hong Kong. The HKU School specializes in professional education. During their May 2021 multi-day workshop "Advanced Workshop on Genomic Testing and Genetic Counselling for Hereditary Cancers", Dr. Leonard Gomella was a faculty member for this internationally broadcast program. Dr. Gomella was asked to address “Prostate Cancer and the Genetics of Disease Risk and Management” and participated in a virtual question and answer session with participants from around the world.

Drs. Gomella, Lallas and Marino presenting a certificate to visiting Italian Urology resident Dr. Vittorio Canale. Dr. Vittorio Canale participated in a specially arranged 6-month observership in our Department. Dr. Canale is a 2017 graduate from the University of Rome La Sapienza Medical School and is currently a senior resident in Urology at the Policlinico Umberto Hospital of the University of Rome. Dr. Canale’s visit was facilitated by Dr. Ignazio Marino, Professor of Surgery at SKMC and Executive Director of Jefferson’s Italy Center. Dr. Costas Lallas served as his primary mentor while at Jefferson. According to Dr. Marino

“The Department of Urology at Jefferson is recognized nationally and internationally as having a premier urology training program. I look forward to having other residents from Italy spending time with Urology’s outstanding faculty and hope one day to provide Jefferson’s residents the opportunity to participate in one of the Italian urology programs. While at Jefferson, Dr. Canale was engaged in a project studying the role of novel biomarkers in the diagnosis of upper tract urothelial carcinoma with Drs. Hubosky and Gomella.

Jefferson Urology

31


Notable and Newsworthy New Technology Elevates Minimally Invasive Surgery Capabilities Earlier this year the Center City division replaced its robotics surgery equipment with the latest da Vinci® Surgical System, which provides a magnified, high-definition 3-D image and translates the surgeon’s hand movements into precise micro-movements. Essentially, this platform extends the capabilities of surgeons’ eyes and hands. Our surgeons use the robotics system for many different procedures, from appendectomies to liver and pancreas resections, and heart valve repair. The newer systems expand access and utilization for robotic surgery at TJUH and allow our surgeons to explore the full potential of this technology. Minimally invasive procedures make operations easier for the team and allow the patient to leave the hospital sooner, experience less pain and get back to living their lives. Costas D. Lallas, MD, FACS, Vice Chair of Education and associate director of the Urology Residency Program, was the first to perform robotic surgery at Jefferson in 2005. He has since performed thousands of robotic procedures using the technology. Dr. Lallas shared with Rich Webster, RN, MSN, President of TJUH, that the surgeons have been very happy about the upgraded equipment: “It’s like we’re kids in a candy store.”

Methodist Fundraiser Supports Men’s Health Program The 12th Annual Methodist Hospital Foundation Runway Fashion fundraiser was held virtually this year. The Department of Urology and all of our collaborating providers were most grateful for this support. The Jefferson Men’s Health Program is directed by Dr. Perry Weiner, Clinical Associate Professor of Urology. According to Dr. Weiner, “Jefferson’s Men’s Health Program is designed to provide men with a comprehensive and preventive approach to healthcare. Our healthcare services are provided in accordance with the recommendations of the American Urological Association. Patients are evaluated using a multidisciplinary approach.” The initial evaluation is performed by a urologist with extensive experience in Men’s Health. Appropriate testing may be ordered based on the patient’s particular needs. Specialties available, in addition to urology, include preventive cardiology, sports medicine, diabetes management, and sleep medicine. After conducting individual evaluations, contributing physicians create an optimal treatment plan with specific recommendations for each patient.Additional facilitated consultations are available for ENT, dermatology, screening colonoscopy, concussion, integrative medicine, and all other Jefferson specialties. For additional information, or to schedule an appointment with the Men’s Health Program, call 215-503-7240, 1-800-JEFF-NOW or visit JeffersonHealth.org/MensHealth.

World News Tonight Prostate Cancer Spot In the fall of 2021 Jefferson Health sponsored public service announcements on prostate cancer screening. Dr. Leonard Gomella served as the spokesperson for Jefferson Health and the Sidney Kimmel Cancer Center. These ran during ABC’s World News Tonight broadcast.

Dr. Gomella’s TV spot on World News Tonight addressing prostate cancer screening. 32

Year in Review


Jefferson First in Region to Offer Newest PSMA PET Imaging indicate Ga-68 PSMA-11 PET is sensitive and highly specific in the detection of prostatic metastases even with very low prostate-specific antigen levels. However, with this good news, this first approval was limited to only two California institutions. Several other prostate cancer specific PET scans have been available including C-11 choline, and F-18 fluciclovine. These are different from PSMA scans and they target different metabolic abnormalities present in prostate cancer cells. These prostate PET imaging agent have some limitations as they are currently only approved for use in the setting of recurrence following local therapy. The PSMA based scans are considered by many to be the leading PET molecular target to detect prostate cancer.

Dr. Kevin Kelly, Professor of Medical Oncology and Urology and Associate Director of Clinical Research, SKCC Other than skin cancer, prostate cancer is the most common cancer in American men. The American Cancer Society U.S. estimates for 2021 are 248,530 new cases of prostate cancer with 34,130 deaths. Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer, with 1 man in 41 dying of this disease. While computed tomography (CT) scans, magnetic resonance imaging (MRI) scans and bone scans are conventional methods commonly used to image patients with prostate cancer, these approaches are limited in detection of prostate cancer lesions outside of the prostate (metastasis) particularly when the PSA is very low or the sites of spread are very small. Positron emission tomography (PET) scans can detect early signs of cancer. Radioactive tracer that detects diseases cells is injected, then an anatomic study, such as a CT scan, is combined with the PET radionuclide images. This combination PET-CT scan produces 3 dimensional images that allow more accurate diagnosis. In December 2020, the FDA approved Gallium-68 PSMA-11 PET in the management of prostate cancer. This is a PET scan that identifies a specific protein called Prostate Specific Membrane Antigen (PSMA) on the cell surface of the prostate cancer cells. This allows clinicians to see the prostate cancer when routine bone or CAT scans cannot. The approval is based on multiple studies that

In May 2021, the FDA approved a second PSMA PET imaging modality, PylarifyTM (piflufolastat F- 18, Lantheus). Soon after, Jefferson Outpatient Imaging was the first in the Mid-Atlantic region to offer this latest imaging for prostate cancer. As of late December 2021, more than 70 patients have been imaged at Jefferson. PylarifyTM is indicated for PET imaging in men with suspected metastasis who are candidates for initial definitive therapy and with suspected recurrence based on elevated PSA. According to Dr. Kevin Kelly, Professor of Medical Oncology and Urology, Associate

Director of Clinical Research, Sidney Kimmel Cancer Center, “The arrival of PSMA-PET imaging at Jefferson and the Sidney Kimmel Cancer Center is terrific for patients. We believe that the ability of this imaging agent to detect the earliest evidence of prostate cancer metastasis or recurrence after definitive treatment will have a major impact on how we manage our patients. In just a few months of use, we have seen it provide information that impacted the management of many men with prostate cancer. All of us who care for men with prostate cancer at the SKCC are most appreciative of the efforts of Dr. Vijay Rao, Jefferson’s Chair of Radiology, and Dr. Charles Intenzo Chief of Nuclear Medicine and Molecular Imaging to make this exciting new imaging technology available as quickly as possible after FDA approval”. To schedule a patient for PSMA PET imaging at Jefferson please call 215-503-4923. EXAMPLE OF PSMA PET-CT IMAGING In the image below, the patient had newly diagnosed aggressive prostate cancer. Standard CT and MRI imaging did not reveal any obvious cancer outside of the prostate. The left panel is a standard CT image of the pelvis without any definitive lymph node metastasis. The right sided panel PET-CT scan using PylarifyTM (piflufolastat F- 18) shows evidence of prostate cancer in a lymph node near the prostate (bright spot indicated by the arrow) confirmed at the time of radical prostatectomy.

We believe that the ability of this imaging agent to detect the earliest evidence of prostate cancer metastasis or recurrence after definitive treatment will have a major impact on how we manage our patients. Dr. Kevin Kelly

Left image routine pelvis CT. Right image is the piflufolastat F-18 PSMA PET CT scan showing a positive lymph node at the arrow.

Jefferson Urology

33


Notable and Newsworthy Sidney Kimmel Cancer Center Launches Mobile Screening Van Dietz & Watson Funds Mobile Cancer Screening Program at Jefferson Health Sidney Kimmel Cancer Center is launching a Mobile Cancer Screening program to better serve vulnerable populations in Greater Philadelphia. The mobile unit will deploy the latest imaging technology to detect cancers of the breast, prostate, head and neck, as well as melanomas. It will also provide patient education and connection to additional cancer center resources, such as the smoking cessation program and cancer clinical trials. The initiative was made possible by a $1.4 million gift from Dietz & Watson. “The Mobile Cancer Screening program allows Jefferson to bring high-quality, preventive cancer screening directly to areas where health care is not easily accessible,” said Bruce A. Meyer, MD, MBA, president of Jefferson Health. “About 25 percent of households in Philadelphia don’t have their own transportation for health care appointments. By going directly to our neighbors who need help, we will increase rates of early detection throughout the city. We are incredibly grateful

to Dietz & Watson for their commitment to the community and for partnering with Jefferson to make this possible.” Dietz & Watson is a fourth generation, family-owned business and a trusted brand in Philadelphia. The company takes a caring and hands-on approach to their neighbors as well as their family business, supporting numerous community initiatives. The Mobile Cancer Screening program plans to work with community and business partners who may have a sizeable immigrant or limited Englishspeaking workforce or patient clientele. There will be no fee to bring the screening unit to a business or organization. The initial screening van activities have already been launched with a focus on breast cancer screening. The 45-foot-long vehicle has private changing rooms and a mammogram area staffed by a certified mammography technologist from Jefferson Health. Equipped with the latest in advanced imaging technology,

it will feature 3-D Screening Mammography, which takes multiple X-rays of breast tissue to recreate a 3-D picture of the breast. The next phase of the Screening Van initiative will involve a prostate cancer screening and other early detection programs. The program will offer general information on prostate cancer detection and treatment options. According to Dr. Leonard Gomella, Chair of Urology and Senior Director for Clinical Affairs at the SKCC, “PSA blood testing will be offered, and the effort will be in collaboration with our long-standing IRB approved screening initiative sponsored nationally by the Prostate Conditions Education Council (PCEC). Since the early 1990’s, Jefferson and the Sidney Kimmel Cancer Center have provided prostate cancer screening opportunities to thousands of men with the administrative support of the PCEC”. Dr. Mark Mann, Assistant Professor in the Department of Urology, will be the primary lead in the prostate cancer component of the screening van.

Sidney Kimmel Cancer Center’s Mobile Cancer Screening Program will deploy the latest imaging technology to areas where health care is not easily accessible.

Sidney Kimmel Cancer Center Mobile Screening Van sponsored by Deitz and Watson.

34

Year in Review


Welcome New Jefferson Faculty Please welcome our new full time Department of Urology faculty members Whitney Smith, MD and Patrick Gomella MD, MPH. Drs. Smith and Gomella are primarily assigned to our expanded JUP practice at Abington/Asplundh and will work in coordination with Drs. Chandrasekar, Mann and Lallas. Drs. Smith and Gomella will also participate in the teaching, research and research activities on the Jefferson Center City campus. Our new JUP full-time practice began seeing patients at the Asplundh Cancer Center, Willow Grove, in August 2021. The Abington 302 Price Building renovations for Jefferson Urology are set to be fully operational in early 2022. Our Sidney Kimmel Cancer Center Urology cancer care providers will continue seeing patients at the Asplundh Pavilion.

Amazing Progress in Prostate Cancer

WHITNEY SMITH, MD Dr. Whitney Smith is an Assistant Professor in the Department of Urology. She graduated from Rutgers University in Piscataway, NJ with a B.S. in Biomedical Engineering, and received her M.D. from The New Jersey Medical School in Newark, NJ. Her general surgery internship and urology residency were completed at Thomas Jefferson University Hospital. She served as Chief Resident in Urology at Jefferson from 2017-2018. Dr. Smith went on to complete a two-year fellowship in Female Pelvic Medicine and Reconstructive Surgery at Wake Forest Baptist Health in Winston-Salem, NC under Drs. Catherine Mathews and Gopal Badlani. Her clinical fellowship included the care of both female and male patients. Dr. Smith has clinical and research interests in robotic surgery, voiding dysfunction, diversity and inclusion, and improving resident education. She is looking forward to returning to the Department of Urology and will be primarily based in our full-time practice at Abington Hospital. PATRICK GOMELLA, MD, MPH Dr. Patrick Gomella is an Assistant Professor of Urology with a joint appointment in the Department of Surgery. He earned his B.S. in Biology from the Pennsylvania State University and remained active in emergency medical services as an EMT with the University Ambulance Service, serving as the Company Supervisor his senior year. After completing paramedic training, he became a nationally certified EMT-P. At Thomas Jefferson University, he earned a Master’s Degree in Public Health followed by a medical degree from Sidney Kimmel Medical College. He completed a residency in urologic surgery at George Washington University. Following residency, he was a Society of Urologic Oncology fellow for two years with the Urologic Oncology Branch at the National Cancer Institute in Bethesda, Maryland and completed an additional year at the NCI. Dr. Gomella is excited to return to the Delaware Valley to provide general and advanced specialty urologic care in the Jefferson Health System. In addition to continuing his urologic oncology research, he has a particular interest in medical education and looks forward to training the next generation of urologists.

Dr. Gomella was interviewed by the journal Oncology in early 2021. He discussed the advances in prostate cancer over the last 10 years. The full text of the interview is available online: www.cancernetwork.com/ view/journal-redefiningprostate-cancer-care

Jefferson Urology

35


Faculty Notes PROMOTIONS Congratulations to the following Department of Urology faculty members on their recent Sidney Kimmel Medical College promotions: Dr. Paul Chung promotion to Associate Professor Dr. Akhil Das promotion to Professor Dr. Scott Hubosky promotion to Professor BOARD CERTIFICATION Congratulations to Thenu Chandrasekar, MD, Assistant Professor in the Department of Urology, who received his Board Certification in Urology. PHILADELPHIA MAGAZINE TOP DOCTORS 2021 Every year, Castle Connolly surveys tens of thousands of practicing physicians across the United States by email and mail to ensure our list always reflects the latest in quality care. After a doctor is nominated, each doctor is screened to confirm whether he or she meets Castle Connolly high standards. The following faculty in the Department of Urology have been recognized in this year’s group of Castle Connolly “Top Doctors” as published in the Philadelphia Magazine: Deborah Glassman, MD Leonard G. Gomella, MD Joseph K. Izes, MD Costas D. Lallas, MD Alana Murphy, MD Patrick J. Shenot, MD Edouard J. Trabulsi, MD LEONARD G. GOMELLA, MD, FACS Dr. Gomella has been invited to serve as a 2022 grant reviewer for NCI’s Early Detection Research Network (EDRN). The EDRN is a national infrastructure to discover, develop, and validate biomarkers and imaging methods for early cancer detection and risk assessment.

36

Year in Review

Dr. Gomella was also asked to participate in an Independence Blue Cross (IBX) podcast on prostate cancer. The IBX podcast host, Peter Panageas, related the story of his father who recently passed away from prostate cancer. The podcast was aligned with “Movember”, an annual November event when men are encouraged to grow facial hair to increase awareness of men’s health initiatives and to donate to various charities. The November 30, 2021 podcast was live on iHeartRadio, Apple & Google podcasts, and Stitcher. An archival broadcast is available on Spotify (https://open.spotify.com/ episode/6ByD8IOYehg6LpADtdukIx). DEBORAH T. GLASSMAN, MD, FACS Congratulations to Dr. Deb Glassman on being named one of Castle Connolly’s Exceptional Women in Medicine for 2021 in addition to her recognition as a Philadelphia Magazine “Top Doctor”. The Exceptional Women in Medicine awardees are recognized annually, based on peer nominations and outstanding accomplishments and dedication to the field of medicine. These women have contributed to the advancement of healthcare through clinical care, research, community service, education and/or leadership. Dr. Glassman heads the Department of Urology telehealth initiatives and was recently appointed one of Jefferson’s Telehealth Quality leaders. PERRY R. WEINER, DO, MSc, FACOS Congratulations to Dr. Weiner for being recognized as a Top Doctor in South Jersey Magazine. Dr. Weiner is Clinical associate Professor of Urology and is head of the Men’s Health and Wellness program at Jefferson. The Men’s Program has recently been growing in New Jersey through our expanded Cherry Hill office. The Methodist Hospital Foundation Fall Runway Event was dedicated to support the Men’s Health Program in South Philly (See page 32).

ALANA M. MURPHY, MD, FACS Dr. Murphy has been asked to serve on the American Board of Urology Examination Committee. The Committee has oversight of the two-part exam process that leads to Board Certification in Urology. Applicants must have completed an approved Urology residency program and is a first step in the certification process, which is the successful completion of the Part 1 Qualifying Examination. After meeting certain specific criteria including unrestricted medical licensure, assessment of clinical practice through practice logs, acceptable peer review, and the 16-month practice requirement in a single community, the applicant must successfully complete the oral Part 2 Certifying Examination to become board certified in Urology. EDOUARD J. TRABULSI, MD, MBA, FACS Dr. Trabulsi has been asked to serve on the Department of Defense (DoD) Prostate Cancer Grant Review Panel. Since 1997, the Prostate Cancer Research Program of the DOD has been dedicated to supporting research focused on eradicating prostate cancer, and specifically seeks to promote innovative, groundbreaking research with near-term clinical relevance. It also seeks to develop the next generation of prostate cancer investigators through mentored research. Dr. Trabulsi served on two reviews this past year, including as chair of one of the Early Career Investigator and Physician Research Award panels in August, as well as a member of the Prostate Cancer Clinical Trial Consortium (PCCTC) funding mechanism panel in November. This was the 9th year that Dr. Trabulsi has served as a reviewer for the DOD CDMRP program. COSTAS D. LALLAS, MD, FACS The Mid Atlantic Section of the American Urology Association (MAAUA) has chosen Dr. Lallas to serve as President. After service as President-elect, he will begin his one-year term as President in October 2022. Dr. Lallas has been a Mid-Atlantic AUA Board member since 2018. He also completed one of the highly competitive AUA Leadership programs in 2016. The AUA is divided into 9 North American Sections. The Mid Atlantic Section covers portions of Pennsylvania and New Jersey along with the states of Delaware and Virginia and the District of Columbia. Other Jefferson Urology faculty who have served as Mid-Atlantic AUA Presidents include Drs. D.M. Davis, Theodore Fetter, S. Grant Mulholland, Leonard G. Gomella, and Edouard J. Trabulsi.


SOCIETY OF ACADENIC UROLOGY APPOINTMENTS The Society of Academic Urologists (SAU) formed in 2016 when the Society of University Urologists and the Society of Urology Chairpersons and Program Directors voted to merge. SAU provides academic urologists with a forum to discuss, review, and potentially resolve critical issues in all aspects of academic urology. The SAU’s educational programs provide a forum to examine, discuss, and establish policy for academic urology practice. Sessions cover faculty development, urologic education, academic health policy, and clinical and laboratory research. SAU communicates and collaborates with the AUA, ABU, ACGME, AAMC, RRC, AUA Office of Research, and the ACS to review and improve academic urology and address the economic and legislative policies that affect it. Additionally, SAU gives academic urology a voice in the AUA Match program, which connects medical students interested in becoming urologists with urology programs. SAU uses a portion of the dues it collects to help support AUA Match and make it possible. Dr. Pat Shenot has been appointed Chair of the Assessment /USMLE Committee. In addition, the following Jefferson urology faculty have been asked to serve as members of other SAU Committees: Dr. Alana Murphy: Virtual Residency Interview Committee Dr. Costas Lallas: Avoidance of Bias & Discrimination in Resident Recruitment & Training Committee MATHEW L. THAKUR, PhD, FSNMMI, FNAI, FACNM, FICNM, FARR Congratulations to Dr. Thakur who has been honored with a Albert Nelson Marquis Lifetime Achievement Award. This award is presented to less than 5% of Marquis Who’s Who listees, and is selectively bestowed on the basis of career longevity, philanthropic endeavors, and lasting contributions to society. Dr. Thakur is Professor of Radiology, Radiation Oncology and Urology and Director, Laboratories of Radiopharmaceutical Research, Molecular Imaging and Biofluid Diagnostics. Dr. Thakur, along with co-PI Dr. Ed Trabulsi, is leading a multiyear NCI grant to study the role of the VPAC receptor in the non-invasive detection of prostate cancer.

A FIRST IN MEDICAL PUBLISHING According to Jason Malley, Executive Editor in the Professional Publishing Group McGraw-Hill Education, “I am not sure there has been two books in the field of medicine where both the husband and wife have named books.” Having a named book is not easy to achieve in medical publishing, as it usually requires multiple successful editions, international presence, and an editor with name recognition. Mr. Malley is referring to two of McGraw-Hill’s popular medical publications: Gomella’s Neonatology and Gomella and Haist’s Clinician’s Pocket Reference. Dr. Tricia Gomella is a Part-time Assistant Professor of Pediatrics at Johns Hopkins University School of Medicine. Her neonatology book was started while she was a neonatology Fellow at the University of Kentucky and was first published in 1988. When the 8th Edition was released in 2020, after 32 years of editing the book, she was honored with her name in the title. Dr. Leonard Gomella, Department of Urology Chair, has a long-standing, popular medical student book along with his co-editor Dr. Steve Haist, the Associate Dean at the University of Kentucky College of Medicine Northern Kentucky Campus, that was first formally published in 1981. Originally due out in 2021, pandemic related delays moved their book to a 2022 release date with the 12th Edition renamed to recognize their long-standing commitment to the book through 40 years of publication. Both of these books have been translated into multiple foreign languages, with Gomella’s Neonatology published in 13 different languages and Gomella and Haist’s Clinicians Pocket Reference published in 6. As noted by Mr. Malley, “While the medical publishing world has become accustomed to eponymous titles such a Harrison’s Principles of Internal Medicine or Schwartz’s Principles of Surgery, a husband and wife team in this category in two different specialties is a first in the world of medical publishing.”

Jefferson Urology

37


Pediatric Urology Update

AI DuPont Children’s Hospital is part of Nemours Children’s Health. Jefferson Urology residents and SKMC students have clinical rotations at the Wilmington, Delaware facility. Dr. Sonny Figueroa, Chief, Division of Pediatric Urology Nemours Children’s HealthDelaware, provided updates from the Pediatric Urology Division at Alfred I. duPont Hospital for Children in Wilmington, Delaware.

The Division of Pediatric Urology hosted Dr. Michael Metro as the 2021 William Ferris Lecturer in Pediatric Urology in October. Details on this visiting professorship can be found on page 46.

Jennifer Hagerty, DO, has received an invitation to participate in the Urology Residency Review Committee.

CLINICAL ACHIEVEMENTS IN NEONATAL CIRCUMCISION

Ahmad Bani Hani, MD, continues as Chair of the Pediatric Committee, Public Education Council of the AUA Urology Care Foundation. He has been in that important position since 2019. Dr. Bani Hani had three abstracts at the Societies for Pediatric Urology (SPU) Fall Conference in Miami, FL, December 2021. The SPU bring together a variety of related groups such as the Society for Fetal Urology, American Association of Pediatric Urologists, International Children's Continence Society and others. Its purpose is to promote pediatric urology, appropriate practice, education as well as exchanges between practitioners involved in the treatment of genitourinary disorders in children.

Under the direction of Dr. Keara De Cotiis, the Pediatric Urology Division at Nemours Children’s Health-Delaware has a new initiative to improve access to neonatal circumcisions. The Pediatric Urology team started a dedicated circumcision clinic in addition to those scattered throughout our Nemours clinics already to accommodate our growing referral base. Every Wednesday there are 9-12 circumcision slots with parents receiving a thorough prep sheet so they are quite comfortable prior to the procedure. The circumcision clinic was extended down to our Nemours Milford location, where it is possible to do between 6-8 procedures during those clinics. The program offers Mogen, Gomco, and Plastibell circumcisions depending on

the provider or parent preference. After the procedure, parents get a care packet as well as instructions for home care. The team has performed over 300 neonatal circumcisions in 2021, averaging around 75 circumcisions/year previously. According to Dr. De Cotiis “This program has been a success by allowing trained pediatric urologic surgeons to offer this care to newborn infants. We should be on target to do almost 400 office circumcisions by the end of the year.”

This program has been a success by allowing trained pediatric urologic surgeons to offer this care to newborn infants. We should be on target to do almost 400 office circumcisions by the end of the year. Dr. Keara De Cotiis

Pediatric Urology faculty along with Urology residents pose here with 2021 Visiting Professor Dr. Michael Metro. See page 38 for details. 38

Year in Review


Urology Basic Science and Clinical Research SCHIEWER UROLOGY LAB As we close out another calendar year still mired in a pandemic, Dr. Schiewer notes: “I am reminded about why we do what we do in the lab: to try to positively impact the lives of cancer patients and their family members. The students in the lab are both thriving and striving towards the goal of benefitting human health.” Moriah Cunningham, who is a PhD student in the Cell Biology and Regenerative Medicine Program, is making progress on better understanding the mechanisms that underlie response to PARP inhibitors in prostate cancer. Her work has the potential to uncover strategies to use this class of drug with greater precision. Moriah is in the midst of putting together her thesis committee, and is nearly finished with all required coursework, which will give her increased time to pursue her research. Latese Evans, who is both a Master of Science student and a Research Technician in the lab, is making progress on understanding the molecular underpinnings that lead to differences between male and female bladder cancer patients. She is investigating the roles that hormones play in bladder tumors, and whether these mechanisms could be taken advantage of for therapeutic benefit. We are also excited that Latese has made the decision to continue her studies in the lab and pursue her PhD degree beginning next year. Candice Bizzaro, who is a PhD student in the Biochemistry and Molecular Pharmacology Program, is currently rotating in our lab as part of the process in deciding which lab to conduct her thesis research. She has spent the last several weeks investigating a novel combination treatment strategy for bladder cancer management that builds on the standard of care. The initial results seem promising!

Schiewer Urology Lab in the Bleumle Life Science Building team members: Candice Bizzaro (PhD Rotating Student), Matt Schiewer, PhD (Lab Principal Investigator), Moriah Cunningham (PhD Student), Latese Evans (MS/Research Assistant) VPAC PROJECT UPDATE Funded by the NIH, our joint UrologyRadiology research group is continuing work to develop a simple and reliable method that uses voided urine and targets a genomic biomarker, VPAC, to detect prostate cancer. VPAC (combined vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide family of cell surface receptors) is expressed in high density only on malignant prostate cancer cells shed in urine, using a specific biomolecule developed in our laboratory. A microscopic examination of the shed cells distinguishes malignant cells from normal epithelial cells efficiently and depicts prostate cancer with >95% accuracy. The Co-PI’s are Drs. Thakur and Trabulsi. Drs. Tripathi and Manisha Kumari in Dr. Thakur’s lab perform these innovative studies and urology research fellow Dr. Cass Clark is primarily assigned to the

clinical component of the study. Dr. Thakur is Director, Laboratories of Radiopharmaceutical Research, Molecular Imaging and Biofluid Diagnostics and Professor of Radiology, Radiation Oncology and Urology and Dr. Trabulsi is Professor of Urology and Vice Chair for research. We are pleased to also report some new findings from our Jefferson India Center collaborators at KLE in Belgaum, India. Following Dr. Thakur’s visits to KLE and reviewing their techniques, they have been able to validate clinically our VPAC prostate cancer detection work and have also identified that bladder cancer shed cells can also be detected in the urine using the VPAC shed cell assay. The concept of VPAC shed cell detection on a wide variety of epithelial malignancies was developed by Drs. Mat Thakur and Leonard

Moriah and Latese are also working on a collaborative project where they are investigating the potential of novel therapeutic strategy in the context of advanced prostate cancer. The preliminary results to uncover the mechanisms by which this combination is effective, and identify which patients might benefit have excited us. Work continues on the identification of genomic signatures that may provide insight into why certain patients develop muscle invasive bladder cancer following pelvic radiation therapy. This past year has been an exciting time of discovery in the lab, and we are excited about what the future will bring. Dr. Scheiwer is currently in the midst of recruiting a postdoctoral fellow, and, as always, the lab is in pursuit of grant funding. We are grateful for the support of the Department of Urology and the SKCC.

Drs. Thakur, Trabulsi and Clark in Dr. Thakur’s lab with the fluorescent confocal microscope used to detect VPAC positive cells in urine. Jefferson Urology

39


Urology Basic Science and Clinical Research Gomella, Chair of the Department of Urology, and the technology has been licensed by Thomas Jefferson University. The latest VPAC publications are: Nerli RB, Ghagane SC, Bidi SR, Thakur ML, Gomella L. Voided urine test to diagnose prostate cancer: Preliminary report. Cytojournal. 2021 Oct 2;18:26. Nerli RB, Ghagane SC, Rangrez S, Chandra S, Thakur ML, Gomella L. Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors. Indian J Urol. 2021 Oct-Dec;37(4):345-349. PURC (PENNSYLVANIA UROLOGIC RESEARCH COLLABORATIVE) As one of the original five founding members of PURC, Jefferson Urology remains at the forefront of collaborative multi-institutional urologic outcomes research in Philadelphia. As a result of the prolific success of the endeavor, after a rapid expansion to include all academic institutions in Pennsylvania, as well as institutions from New Jersey (Cooper, CINJ) and pending groups from Connecticut (Yale) and Virginia (UVA), it has been renamed USCOPE (Urologic Surgeons Comparing Outcomes Pursuing Excellence). This physician-led prostate cancer quality improvement collaborative effort strives to reduce variation in care; measure, understand, and influence treatment outcomes; improve patientcentered decision-making; and provide reliable, sustainable platform for data collection for benchmarking and practice level quality improvement initiatives. Dr. Ed Trabulsi has served as the Jefferson Physician champion and has been in a leadership position of the group since its inception, serving on the executive council and various subcommittees. Together with Drs. Mark Mann and Thenu Chandrasekar, as well as the student research scholars who abstract and input data on our prostate cancer patients, Jefferson Urology maintains a prominent role in USCOPE. From this initiative, Jefferson has been named in multiple published manuscripts as well poster and podium presentations regionally and nationally. The most prominent of recent publications was published in JAMA Oncology in July 2021 on Prostate Cancer Racial Treatment Disparities during the COVID crisis (https://hcifonline.org/ wp-content/uploads/2021/07/Assessmentof-Prostate-Cancer-Treatment-AmongBlack-and-White-Patients-during-theCOVID-19-Pandemic.pdf.) (See page 18.)

40

Year in Review

CLINICAL TRIALS This past year, 2021, has been another challenging year for healthcare. Staffing, equipment, and medication shortages have met a surging backlog of patients as the Jefferson community has confronted the reality of the continued Covid-19 pandemic. Despite these hurdles, the Department of Urology has continued its commitment to clinical research and has enrolled a large number of patients in clinical trials as we ourselves gain familiarity with novel technologies. Our partnership with medical oncology, radiation oncology and others in the Sidney Kimmel Cancer Center allows a wide array of therapeutic clinical trial opportunities outside of the Departments portfolio to be made available to our patients. Our multidisciplinary GU Oncology team meets several times a month with our SKCC partners including, Dr. Kevin Kelly, Director, Division of Solid Tumor Oncology and Associate Director of Clinical Research, SKCC and Dr. Bobby Den Associate Professor of Radiation Oncology, Cancer Biology and Urology. Christine Hubert Assistant Director, Clinical Trials Office assists in urology centric clinical trials coordination across departments. The unique challenges this year has presented has allowed our faculty to focus mainly on our investigator initiated clinical trials. Dr. Lallas completed enrollment for his study using 3D printed models of patients’ kidney and renal masses for surgical planning prior to partial nephrectomy. Dr. Chandrasekar met his enrollment goal evaluating the ability of different contrast enhanced ultrasound techniques to predict histologic grade of renal cell carcinoma, and Anne Lizardi-Calvaresi, DNP, CRNP, RNFA Director of Clinical Operations, doubled enrollment in her IIT therapeutic trial of Vitamin B6 for men suffering from hot flashes secondary to androgen deprivation. The work on the VPAC urine test for prostate cancer continues with more than 180 patients enrolled this year on our NCIfunded grant. This year we also had the unique experience as the first center in the area to offer PSMA PET CT to men with prostate cancer. Access to this exciting new imaging modality provided the unique opportunity to be one of 6 sites selected to partner with the National Cancer Institute (NCI) examining the role of PSMA imaging to predict recurrence after prostatectomy for high-risk prostate cancer (NCT03976843). In 2021, 14 of our patients were able to access this novel prostate specific PET imaging modality before the FDA formally approved piflufolastat-F18 in May (for more on PSMA PET for prostate cancer see page 33). Our involvement in cutting edge, novel medical technologies will continue in 2022. SunRISE 1 (NCT04640623), combining PD-1 inhibition with a novel chemotherapeutic intravesical implant for patients with BCG-unresponsive NMIBC, has just opened for enrollment. We also are looking

Dr. Ryan Mark and Olivia Dahlgren are responsible for the oversight of clinical trials in the Department of Urology. Many of the Department of Urology clinical trials are carried out in collaboration with the Sidney Kimmel Cancer Center specific protocols. forward to studying an innovative way to use a light activated therapeutic agent for endoscopic management of upper tract urothelial cancer (NCT04620239). This is a phase 3, open label, single arm study of padeliporfin (TOOKAD® a vascular-targeted photodynamic therapy) in the treatment of Upper Tract Urothelial Carcinoma (UTUC). The ENLIGHTED study will recruit patients with low-grade noninvasive upper tract urothelial carcinoma in either the kidney or the ureter. While this has been a rough year in healthcare, we have been fortunate to benefit from a strong department and a Jefferson Health system wide commitment to the clinical research mission which has allowed us to weather personnel and supply shortages outside of our own department’s control. As our Jefferson community gets closer to business as usual, we have many exciting and novel treatment strategies that we will soon be able to share with our patients. I encourage you to review the searchable list of our available clinical trials at Jefferson’s Study Information Portal (SIP, for short http://ctmssip.tju.edu/sip/SIPMain). If you have a patient you would like to refer or require more information on a particular trial, contact Dr. J. Ryan Mark (james.mark@ jefferson.edu), Director of Clinical Trials for the Department of Urology, or our department clinical trials coordinator Olivia Dahlgren (Olivia.Dahlgren@jefferson.edu).


DEPARTMENT OF UROLOGY AND SIDNEY KIMMEL CANCER CENTER GU CLINICAL TRIALS FOR CALENDAR YEAR 2021

y

h c

CRPC: Castration resistant prostate cancer; MIBC: Muscle Invasive Bladder Cancer; NMIBC: Non-Muscle Invasive Bladder Cancer; PCCTC: Prostate Cancer Clinical Trial Consortium; PCORI: Patient-Centered Outcomes Research Institute. Thanks to Christine Hubert for assisting with this table.

Jefferson Urology

41


Provider Spotlight Suzanne Barron, RN, MSN, CRNP Suzanne Barron, RN, MSN, CRNP, started her nursing career 25 years ago as a medicalsurgical nurse on the urology/transplant unit at Thomas Jefferson University. Today, a nurse practitioner partner in the inpatient urology service, Barron has worked alongside Department of Urology attendings, residents, students and nurses, as she advocates for and educates patients. Suzanne also serves as a preceptor for nurses in Nurse Practitioner training programs. She graduated with a bachelor’s degree in nursing from The College of New Jersey, then received a master’s of science in nursing, a nurse practitioner degree, as well as her postmaster's nurse practitioner certificate in acute care adult/gerontology, at Thomas Jefferson University. Unlike today, Barron says, there were not a lot of nursing jobs in 1997. We asked what drives her, professionally and personally. What makes you want to come to work every day? Barron: I feel the attending doctors are fantastic to work with. I enjoy working in a teaching hospital with residents and seeing their growth throughout the years. I like to be able to help with the urology service patients giving them good care and knowing that their transition to home is going to be as easy as possible in this crazy health care environment. It’s also good to know that I am supported by all the other urology attendings and especially Dr. Gomella who hired me as a NP in the department 13 years ago! Being at Jefferson is a good mix. It is like a community hospital yet is a teaching hospital connected to a pretty big university in an urban setting. The diverse population that we serve drives me to come to work every day. I feel like I’m always learning something new. How did you get through 2020 and 2021 professionally and personally? Barron: I have three kids, ages 9 to 18. My oldest is at college now, but during the pandemic, he was a high school senior and my other ones were in third and fourth grades. So, personally it was challenging because they were working virtually from school. My husband is in the financial business, and thank goodness he has been able to work from home.

42

Year in Review

Here at Jefferson, ever since Hahnemann University Hospital, which was nearby, closed in 2019, we have been extra busy.

Barron: I like to visit my son in Washington, D.C., at college. And I love the beach—“the Shore,” as we call it in New Jersey.

During the pandemic, we did not have urology units, so our patients have been all over, placed on various units with newer nursing staff and different nursing staff that are not always familiar with urology patients. Our hospital has had to have a lot of patients stay overnight in the post-anesthesia care unit and short procedure area, which has also been challenging.

But I also have enjoyed camping during the pandemic. We have been camping to Lake George and the Poconos.

But the residents, attendings and nursing staff have really come together as a team and tried to do the best we can under the circumstances. The residents that I work with and my professional partner, the other inpatient urology nurse practitioner, Fatuma Doka, have kept a positive outlook on things, which has helped us to stay afloat.

It is no fun living on the floor of a tent without a mattress. We learned that the hard way.

What areas in urology do you find particularly interesting? Barron: I find it all super interesting. I love our bladder cancer patients that come in to get their bladders removed. They have an urostomy or a neo-bladder, and there is a lot of teaching with that. But, I also like the patients that come in for same-day surgery for benign prostatic hyperplasia (BPH) and our short stay robotic prostatectomy patients. They usually are pretty healthy individuals, but I still feel they need a lot of education in what their post-op course is going to entail. What do you think are your strengths as a nurse practitioner? Barron: I am a good patient advocate and teaching and communication are my strengths. I have a good bedside manner with patients. I communicate with the residents and with the attending surgeons effectively. I feel that I try to do what’s best for the patients, using all my resources to give them the best possible care. What do you like to do outside hospital walls?

Glamping or camping? Barron: Not glamping. We camp in an eightperson tent with two blow-up mattresses, but not more than two days a time.

Camping is a lot of work, but we enjoy it as a family. I’m in charge of the s’mores and keeping the kids occupied while my husband sets everything up. Contributed by Lisette Hilton


Department of Urology News Scott T. Bowes, MBA, FACHE Award Congratulations to Scott Bowes on his American College of Healthcare Executives Recognition Program Service Award. The announcements was made by Michael J. Fosina, FACHE, Chairman, American College of Healthcare Executives Board of Governors. The award recognizes contributions to healthcare leadership excellence and volunteer service.

Brittany Redman, BSN, RN On May 1, 2021, Brittany received the Thomas Jefferson University Hospitals “Quality Caring Award.” Brittany was recognized for her qualities that exemplifies outstanding nursing care. In particular her nomination letter highlighted “her dedication to her patients, most of whom are wheelchair-bound or require ambulatory assistance, always feel comfortable and at ease while under her care.” Brittany works in the Department of Urology outpatient office in center city. Congratulations to Brittany on this honor and becoming a new mother in 2021.

program was held virtually in association with the AUA annual meeting (see page 26). The program drew a total of more than 1,300 attendees and was Co-directed by Anne Lizardi-Calvaresi, DNP and Jim Kovarik, PA-C. Both are members of the American Urological Association Education Committee and have directed the program in 2020 and 2021. The programming was aimed at the novice to seasoned urological NP/ PA, allied health professionals, and nurses. Courses included routine topics covering oncology, surgery, voiding dysfunction/infections, men's health, practice management, urodynamics, infertility/sexual medicine, and urolithiasis and timely topics such as Advanced Prostate Cancer Management, Evaluation of Small Renal Masses, and Tobacco/ THC/Vaping Impact on Urologic Disease. The program additionally included a large number of podium presentations, consisting of 10-12 minute focused presentations/case scenarios. Lizardi-Calvaresi and Kovarik have been named co-directors for next year's AUA APP course to be held in New Orleans, LA in May, 2022. The “Urologic Care for the Advanced Practice Provider” was featured in the AUA Daily News during the 2021 virtual meeting.

Anne Lizardi-Calvaresi, DNP, CRNP, RFNA Leads Program at the 2021 AUA Meeting The Urologic Care for the Advanced Practice Provider program consisted of three-day programming with a kickoff Saturday event in May 2021, and a two-day program on September 11-12, 2021. The

Barbara Devine Service Award Congratulations to Barbara Devine for 35 years of service to Jefferson and the Deparment of Urology. Barbara has been with the Department of Urology college office since she first joined Jefferson. In addition to her acomplishments as a valued employee, Barbara also just became a first time grandmother.

Barbara Devine and her new granddaughter, Moira Jade.

Advanced Practice Providers Vivian Ngo and Leah McDermott Vivian Ngo, PA completed her Bachelor of Science in Health Science at the University of the Sciences in Philadelphia, PA, and Master of Science in Physician Assistant Studies at Pace University, Pleasantville, NY. Vivian joined Jefferson Urology in the fall of 2021 and has been working with our physicians at the Asplundh Cancer Pavilion. Vivian notes “I came back home to Philadelphia to be close to family and friends as well as to serve the community I grew up in. I am looking forward to working with Urology in the new office in the Price building on the Abington campus.” Leah McDermott, PA is a South Jersey native and graduate of Rutgers University. Leah is excited to start her career as a PA with the Urology team. According to Leah “As a provider, it is important to cultivate a trusting environment with my patients that focuses on education and selfadvocation. I am excited to become a part of the Jefferson team and dive into the world of urology!” Jefferson Urology 43


Visiting Professors and Guest Lecturers DEPARTMENT OF UROLOGY 2021 ZIMSKIND VISITING PROFESSOR MARCH 3 & 4, 2021 Stephanie Kielb, MD Our distinguished 2021 Zimskind Virtual Visiting professor was Dr. Stephanie Kielb. Dr. Kielb is Professor of Urology, Medical Education and Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine, Chicago. Dr. Kielb is a board-certified urologist with a subspecialty certification in female pelvic medicine and reconstructive surgery. She is a professor of urology, medical education, and obstetrics and gynecology at Northwestern University Feinberg School of Medicine and the Division Chief of Reconstructive Urology, Neurourology, and Pelvic Medicine at Northwestern Medicine. She has been the residency program director in the Department of Urology since 2007 and sits on the Northwestern University McGaw Graduate Medical Education Committee. She is member of the ACGME Residency Committee for Urology and an assistant editor for the Journal of Urology. Dr. Kielb is a recognized expert in voiding dysfunction and incontinence, pelvic organ prolapse, neurourology, and congenital urology. She is the urologic director of the multi-disciplinary adult spina bifida clinic at Shirley Ryan Ability Lab (the number 1 rated rehabilitation hospital in the country), sits on the Shirley Ryan Ability Lab Medical Advisory Board and serves as a consulting physician there. Dr. Kielb is also the medical director of the Northwestern Medicine Transitional Adult Congenital Genitourinary Clinic (TRAC), a multispecialty clinic for patients with a variety of conditions including spina bifida, bladder and cloacal exstrophy, epispadias, anorectal malformations and many others. She is a founding member of the American Urological Association Working Group on Congenitalism and has published extensively on the needs and outcomes of this patient population.

Dr. Kielb is also committed to global health outreach, serving as mission leader and sitting on the medical director board of the International Organization for Women and Development, a charity devoted to obstetric fistula repair and medical education in Kigali, Rwanda since 2012. We were pleased to offer this CME approved program virtually in March of 2021. 2021 DAVID M. DAVIS VISITING PROFESSOR JUNE 18, 2021 Colin P.N. Dinney, MD, W.A. “Tex” & D. Moncrief, Jr. Distinguished Chair in Urology, University of Texas MD Anderson Cancer Center Houston, Texas After skipping 2020 due to the pandemic, we were pleased to offer the 2021 David M. Davis Visiting Professor in a virtual format with Dr. Colin Dinney. Dr. Dinney is Professor and Chairman of Urology University of Texas MD Anderson Cancer Center. He served as the Director of MD Anderson’s Bladder Cancer SPORE from 2001-2019 and maintains an active clinical practice specializing in bladder cancer and a research laboratory focused on understanding the biology of bladder cancer metastases and on the development of novel therapy for bladder cancer. His group played a pioneering role in developing preclinical models of spontaneous bladder cancer metastasis and used these models to identify the mechanisms regulating metastasis and for preclinical therapeutic studies. His group developed intravesical nadofaragene firadenovec (adenoviral mediated interferon-α gene therapy) for the treatment of BCG unresponsive nonmuscle invasive bladder cancer. A Phase 3 trial was conducted by the SUO-CTC (Society of Urologic Oncology Clinical Trials Consortium) and the drug is currently working through the FDA approval process with Jefferson contributing a significant number of patients on that trial. Currently his laboratory is working to improve interferon gene therapy by identifying biomarkers that predict sensitivity or resistance, by testing novel vectors that might improve transfection efficiency and activity, and by evaluating novel combination strategies. Dr. Dinney served on the Society of Urologic Oncology Executive Committee and was the Founding President of the SUO’s Clinical Trial Consortium and is the current Chair of the SUO CTC Bladder Cancer Committee. Dr. Dinney is the SPORE’s Liason to SWOG’s GU Executive Committee. He is also a former member of the National Institutes of Health, Genitourinary Steering Committee, and served as the Urology Chair for the Bladder Cancer Task Force from 2016-2019. Dr. Dinney presented two lectures “Neoadjuvant Therapy for MIBC in the Genomics Era” and “Therapy for High-risk NMIBC”. His visiting professorship also included residents presentation reviewing the diagnosis and management of Urology cases.

Chief residents Drs. Tom Hardacker, Chris Caputo and MJ Counsilman posing with our “vitual” 2021 DM Davis visiting professor Dr. Colin Dinney (see page 65 for details on this photo). 44

Year in Review


Visiting Professorships ABOUT THE PAUL ZIMSKIND MD, PHD VISITING PROFESSORSHIP The Visiting Professorship and Lecture are in honor of Dr. Paul Zimskind, a 1957 graduate of Jefferson Medical College, who was Chair of the Department of Urology from 1967 until his untimely passing in 1976. Dr. Zimskind was a pioneer in the development of the field of urodynamics and led studies on the dynamics of normal and abnormal urinary function using pressure readings and fluoroscopic motion pictures of urinary tract activity. As a charter member of the Urodynamics Society, he was honored by the Society through the creation of the Zimskind Award. The award is given to an individual who, within ten years of completing residency or fellowship has made significant contributions to the field of neurourology through basic science or clinical research. The Urodynamics Society is now known as the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) with over 700 members. This biennial program is made possible through the dedication of Dr. Max Koppel (JMC/SKMC 57) and Dr. Michael Lewitt (JMC/SKMC 74). They led the efforts to establish the endowment that supports the program to honor the contributions of Dr. Zimskind to the field of Urology. ABOUT THE DAVID M. DAVIS VISITING PROFESSORSHIP Dr. David Melvin Davis (1886-1982) was Chairman of the Department of Urology at Jefferson Medical College from 1935 to 1951. He received his MD degree at Johns Hopkins University in 1911. After internship at the Baltimore City Hospital, he became an Assistant in Pathology at Hopkins for two years (1913 and 1914), and then a Pathologist and Director of Research of the Brady Urological Institute (1914-1917). He was made Associate Editor of the Journal of Urology at the time of its inception in 1917. During World War I in 1914, Dr. Davis served as the Bacteriologist to the American Ambulance Hospital at Neuilly-sur-Seine, France, and later as First Lieutenant in the Medical Corps. For those 2 years he was first attached to the British Army and later with the American Expeditionary Forces, where he rose to the rank of Major. Back at the Brady Institute of Johns Hopkins, Dr. Davis spent a year of research on the gonococcus organism, completed a residency in Urology, and then spent 2 years preparing the manuscript of Practice of Urology as a co-author with his famous mentor, Dr. Hugh H. Young. In 1924, he was made Head of Urology in the new

medical school at the University of Rochester, where he organized the department. In 1928, he resigned to return to Baltimore as an Associate of Dr. Hugh Young. Curiously, in 1930 he went to Phoenix, Arizona, where he abandoned academic urology for private practice.

PREVIOUS DAVID M. DAVIS VISITING PROFESSORS 2020

None (COVID)

During the interlude (1930-1935) of this brilliant academician in Arizona, he served as Visiting Urologist at the Desert Sanitarium at Tucson. Dean Ross V. Patterson became interested in Dr. Davis as a candidate for the vacant Chair of Urology at Jefferson and received impressive letters of recommendation from Hopkins and the University of Rochester where Dr. Davis had served. Thus, his appointment to the Chair followed with 16 fruitful years at Jefferson. As an investigator, teacher, clinician, and authority in urologic surgery, Dr. Davis became known throughout the world. Shortly after his arrival, the Department of Genito-Urinary Diseases (founded in 1904) changed its name to the Department of Urology. The teaching system was modified by a gradual reduction of didactic lectures and emphasis on small groups with student participation.

2019

David F. Penson, MD

2018

Stephen Y. Nakada, MD

2017

Michael L. Blute, Sr, MD

2016

Victor W. Nitti, MD

2015

Robert C. Flanigan, MD

2014

John M. Barry, MD

2013

Alan Wein, MD, PhD (hon)

2012

E. David Crawford, MD

2011

William D. Steers, MD

2010

Eric A. Klein, MD

2009

Arthur L. Burnett, MD

2008

Sandip Vasavada, MD

2007

Margaret S Pearle, MD, PhD

2006

Gerald L. Andriole, Jr, MD

2005

H. Barton Grossman, MD

Under Dr. Davis’s leadership, advanced training in Urology was established. The first residencies at Jefferson started in 1937 in Obstetrics, and the Department of Urology established one in 1939. World War II caused a delay in increasing the number of residents, but a second residency position was created in 1946 and a third in 1947. In 1948, an arrangement with Professor John H. Gibbon, Jr. provided a year of training in General Surgery before beginning three years in the Urologic Residency.

2004

Gerald H. Jordan, MD

2003

Judd Moul, MD

2002

J. Curtis Nickel, MD

2001

Shlomo Raz, MD

2000

Larry I. Lipshultz, MD

1999

Ralph V. Clayman, MD

1998

William R. Fair, MD

1997

John M. Fitzpatrick, MD

1996

Howard M. Pollack, MD

Dr. Davis was most unhappy that the rules of the Board of Trustees at that time caused his compulsory retirement to Emeritus status at age 65 in 1951. The Class of 1952 presented his portrait to the College. He remained active in practice, research, and authorship of articles for another 17 years until December 31, 1968, at which time he was 82 years of age. He died in 1982 at the age of 96.

1995

Robert M. Weiss, MD

1994

John P. Donohue, MD

1993

Paul C. Peters, MD

1992

Michael Marberger, MD

1991

Edward J. McGuire, MD

1990

Karlheinz Kurth, MD

1989

E Darracott Vaughn, MD

Mr. John O’Donnell, a patient of Dr. Ken Brownstein and trustee of the charitable Maneely Trust, made a sizable contribution to the Department of Urology in the name of David M. Davis, MD. With support of this David M. Davis fund, the Annual Visiting Professorship was established in 1981 in his honor and a listing of prior honorees can be found on the accompanying table. Due to the pandemic there was no DM Davis program held in 2020, and it was held again in 2021 using a virtual ZOOM format.

1988

Richard D. Williams, MD

1987

Mr. Robert Whitaker

1986

David C. Utz, MD

1985

Ralph A. Straffon, MD

1984

Bernard Lytton, MD

1983

Willet F. Whitmore, MD

1982

Frank Hinman, Jr., MD

1981

John D. Young, MD

Jefferson Urology

45


Visiting Professors and Guest Lecturers VIRTUAL GRAND ROUNDS DEPARTMENT OF UROLOGY: NOVEMBER 4, 2021 The Department of Urology had the pleasure of a Virtual Grand Rounds presented by Dr. Kevin R. Loughlin this past November. Dr. Loughlin is Professor Emeritus, Harvard Medical School, Boston, MA. He received his A.B. from Princeton University, M.D. from New York Medical College, M.A.(Hon) from Harvard University and M.B.A. from Boston University. He was the secretary of the New England section of the AUA from 2002-2007 and served as its president in 2008-2009. Dr. Loughlin’s honors have included receiving the Alumnus KEVIN LOUGHLIN, MD, MBA Medal of Honor from New York Medical College PROFESSOR EMERITUS, HARVARD in 2003, the Joseph B. Dowd Lifetime Achievement MEDICAL SCHOOL, BOSTON, MA Award from the NEAUA in 2008 and the AUA Distinguished Service Award in 2019. He serves on the editorial boards of Urologic Oncology, the Canadian Journal of Urology and Urology. Journal activities include serving as editor-in-chief

of the Urologic Clinics of North America since 2020. From 2011-2017, he served as a trustee of the American Board of Urology and was ABU vice president from 2016-2017. During his time as a trustee, he was the ABU representative to the American Board of Medical Specialties Health Policy Committee. He served as a member of the AUA board of directors from 2011-2015 and has also served on the NCCN Prostate Cancer Early Detection Panel. Dr. Loughlin has authored over 300 articles in the medical literature and is the author or editor of 15 books. As professor emeritus at Harvard Medical School, he is currently a visiting scientist at the Vascular Biology Laboratory at Boston Children’s Hospital. Dr. Loughlin’s grand rounds lecture was titled: “Serum Testosterone and Prostate Cancer: The Controversy Continues.”

10TH ANNUAL P. KENNETH BROWNSTEIN, MD, VISITING PROFESSORSHIP & LECTURE: NOVEMBER 10 & 11, 2021 Dr. J. Stuart Wolf (pictured) is Professor, Department of Surgery & Perioperative Care in the Dell Medical School at the University of Texas at Austin and served as our 10th Annual P. Kenneth Brownstein Visiting Professor. He is also Medical Director of UT Health Austin’s Ambulatory Surgery Center Associate Chair of Clinical Integration and Operations and the Chief of the Division of Surgical Subspecialties for the Dell Medical School Department of Surgery and Perioperative Care. Dr. Wolf

graduated medical school from Northwestern University in Chicago, did his Urology residency at the University of California San Francisco and an Endourology Fellowship at Washington University in St. Louis with endourology and laparoscopy pioneer Dr. Ralph Clayman. Following his training, Dr. Wolf had a notable career at the University of Michigan where he served as Director of the Division of

Endourology, Director of the Endourology/ Laparoscopy Fellowship, and Associate Urology Department Chair for Surgical Services at the University. An author of more than 300 peer-reviewed articles and videos, and more than 150 invited publications, he has served on the editorial boards of 11 journals and has been awarded numerous research grants. Some of his honors include being named the inaugural David A.

Dr. Ken Brownstein with 2021 Brownstein Visiting Professor Dr. Stuart Wolf and Dr. Scott Hubosky. 46

Year in Review


L. William Ferris Visiting Professor Dr. Michael Metro with our urology residents following his grand rounds presentation “Adult reconstruction of Pediatric Urological Conditions”. Bloom Professor, University of Michigan Department of Urology, serving as Trustee on the American Board of Urology and being elected to the American Association of Genitourinary Surgeons (AAGUS). As part of our annual Brownstein program, Dr. Wolf supervised an in person journal club that addressed a wide variety of J. STUART WOLF, JR., MD, FACS topics from urology guidelines, techniques in endourology and resident wellness. The title of his Thursday morning Brownstein lecture was “Endourology Controversies: Lower Pole Stones, Large Stones, and Role of Stents and Guidewires in Ureteroscopy.”

DIVISION OF PEDIATRIC UROLOGY VISITING PROFESSOR 2021 L. WILLIAM FERRIS LECTURESHIP: OCTOBER 13 & 14, 2021 On October 13 and 14, the Division of Pediatric urology hosted Dr. Michael Metro as the 2021 L. William Ferris Lecturer in pediatric Urology. Dr. Mike Metro is an adult urologist who specializes in reconstructive urology and is Associate Professor of Urology and the Director of Reconstructive Urology at Temple University in Philadelphia. On October 13, Dr. Metro presented the William Ferris Memorial Lecture at AI Dupont Nemours Pediatric Hospital in Wilmington titled “Gender Affirming Surgery”. The lecture was followed by resident case presentations. On October 14, he presented “Adult Reconstruction of Pediatric Urological Conditions” at Grand Rounds in the Department of Urology at Thomas Jefferson University.

Lectureships ABOUT THE WILLIAM FERRIS, MD MEMORIAL LECTURESHIP The L. William Ferris, MD Memorial Lectureship in Pediatric Urology was established in honor of Dr. Ferris, Director of The Wilmington Medical Center’s Department of Urology, who passed away in 1982. A graduate of The University of Virginia and Tufts Medical School, Dr. Ferris entered private practice in 1960, after completing his residency at The Wilmington Medical Center. He was known by his colleagues as a skilled and compassionate physician and surgeon, instrumental in elevating The Medical Center’s ability to treat pediatric urology patients. The Delaware Academy of Medicine and Nemours/Alfred I. duPont Hospital for Children co-sponsor this lecture in order to perpetuate Dr. Ferris’ legacy of innovation in the area of pediatric urology. ABOUT THE P. KENNETH BROWNSTEIN LECTURESHIP The P. Kenneth Brownstein Lectureship is held annually in honor of Dr. Ken Brownstein, who is Clinical Assistant Professor of Urology and The Harold A. Honickman Physician Director of Jefferson Signature Services. He is a graduate of Hahnemann University School of Medicine (Now Drexel University College of Medicine). Dr. Brownstein began his Urology residency in 1972 and has been at Jefferson ever since. The first Brownstein lectureship was held in 2012 in recognition of his long-time service to Jefferson.

Jefferson Urology

47


Graduation and Awards GRADUATING CHIEF RESIDENTS 2021

2021 UROLOGY GRADUATION AND AWARDS Our 2021 Urology Graduation and Awards ceremonies were held in a limited venue this year with the events broadcast to a larger audience by ZOOM. Our official year end graduation party was held outdoors at the home of Drs. Tricia and Lenny Gomella in Chadds Ford following the group meeting recommendations at the time. The following graduates and award winners gathered immediately after our DM Davis Virtual Visiting Professorship on June 18, 2021 with Dr. Shervo’s graduation taking place later in the fall. MAX KOPPEL RESIDENT ACHIEVEMENT AWARD Presented to the Urology Resident with the Highest In-Service Exam: Joon Yau (JY) Leong, MD DOLORES SHUPP BYRNE SKMC SENIOR UROLOGY AWARD The award is voted upon by the Urology faculty to recognize the senior student who has demonstrated extraordinary commitment to Urology: Emily Bochner, MD JEFFERSON UROLOGY SCHOLARS Andrea M. Quinn, BA and Erica J. Mann, BA ENDOUROLOGY SOCIETY FELLOW Abhay Singh, MD ENDOUROLOGY FELLOW Asaf Shvero, MD (graduation October, 2021) CHIEF RESIDENTS GRADUATION Chris Caputo, MD MayJean (MJ) Counsilman, MD Tom Hardacker, MD, MBA

CHRISTOPHER CAPUTO, MD, CHIEF RESIDENT Christopher Frank Caputo was born in Spring Lake Heights, NJ and lived in Lincroft, NJ throughout his childhood. He attended Christian Brothers Academy high school in Lincroft, NJ, where he was on the varsity wrestling team. Beginning at age 8, he began learning music beginning with trumpet and baritone horn, and would go on to participate in multiple extracurricular bands during primary school. During high school, he also learned how to play guitar, and he performed with a rock and roll band in college. He attended Lehigh University in Bethlehem, PA for college, where he was a member of Sigma Phi Epsilon fraternity, and graduated with a B.S in Chemistry. After graduation, he worked for BASF Fuel Cell, Inc. in Somerset, NJ where he was a staff scientist participating in research on hydrogen fuel cells. Chris next attended Temple University School of Medicine, and graduated with honors in the Alpha Omega Alpha society. He met his future wife, Danielle, through a medical school classmate during this time. During medical school, he enjoyed his general surgery rotations and started his fourth year with a sub-internship in Urology, which is when he made the decision to pursue the field. He was attracted to the variety of diseases treated, endoscopic cases, and robotic surgery. He did his intern year in general surgery at Temple University Hospital, and transfer to Thomas Jefferson University Hospital to complete his urology residency. Chris and Danielle’s daughter, Cecelia Grace Caputo, was born during his 5th year of residency on 4/24/20. After graduation, Chris will go in to private practice in the LUGPA group Urology of Central Pennsylvania, located in Harrisburg, Pennsylvania. MAY JEAN COUNSILMAN, MD, CHIEF RESIDENT May Jean “MJ” Counsilman, MD was born in Clovis, California and shortly thereafter moved to Connecticut. At age 6, Dr. Counsilman moved to Shanghai, China where she attended Shanghai American School, returned to Connecticut at age 11, and subsequently attended the University of Connecticut on a full merit-based scholarship. She graduated Magna Cum Laude with a B.S. in Psychology and minor concentrations in Neuroscience and Chemistry. She attended Jefferson Medical College (Sidney Kimmel Medical College), and was inspired to go into the field of urology as a 3rd year student, and fortunately matched to stay at Jefferson for residency. After residency, she is doing a one-year fellowship in Minimally Invasive Urologic Surgery at Beth Israel Deaconess Medical Center in Boston, MA. She will also participate in an intensive seven-week course in clinical effectiveness through the Harvard School of Public Health. At the end of her fellowship year, she will join our Jefferson Health Community Urology practice at Jefferson Aria in northeast Philadelphia. THOMAS HARDACKER, MD, MBA, CHIEF RESIDENT Thomas James Hardacker, MD, MBA, was born in Buffalo, New York before moving to Indianapolis, Indiana at age 5. He has 3 younger siblings: Kyle, Pierce and Rachel. He grew up playing several sports, but baseball ultimately became his athletic passion. In high school, he was team MVP as well as an All-North first team selection in addition to being team captain. He then attended Kenyon College, where he was a four-year starter, two-time AllConference member and team captain his senior year. It was at Kenyon College where Dr. Hardacker developed a passion for the sciences. His parents, James, an orthopedic spine surgeon, and Doris, a pediatric anesthesiologist, ultimately inspired him to pursue a career in medicine. He attended Indiana University School of Medicine, where he completed his Medical Degree and Master of Business Administration. Dr. Hardacker developed an interest in surgery while a medical student at IU, and ultimately chose Urology after his third year rotation. Drs. Richard Rink, Mark Cain, Rosalia Misseri, and Michael Koch were instrumental in his choosing Urology as a specialty. When not working, Dr. Hardacker enjoys photography, travelling, and spending time with his wife, Sarah, and dog, Morton. He has retained his Buffalo roots, as he is an avid Bills fan and on most Sundays in the fall, can be found watching their games with his homemade chicken wings (accompanied by bleu cheese, of course). Following graduation, Dr. Hardacker will begin his career at Urology of Indiana in Indianapolis.

48

Year in Review


GRADUATING FELLOWS 2021 ABHAY SINGH, MD ENDOUROLOGY SOCIETY FELLOW Abhay A Singh, MD was born and raised in Maryland, before moving to New Jersey. He attended Duke University for undergraduate college where he joined the Army ROTC program and obtained a degree in computer science. The Army granted him an education delay to allow him to attend medical school, which he did at Robert Wood Johnson Medical School in Piscataway and Camden, NJ. During this time, he was a Bard Urology scholar and started down a path of Urology. He was the class president and graduated with AOA and Gold Humanism honors. He matched to his alma mater, Duke University, for his urology residency training following a year of surgical internship at Walter Reed Army Medical Center. After his residency he was stationed to Fort Benning, Georgia where he was a staff urologist at Martin Army Medical Center as well as serving on the Pharmacy and Therapeutics committee, Provider Health Program Committee and was the Urology GME coordinator. He and his co-urologist helped the practice grow and they became the two most productive urologists in the military. After two years he PCS’d (permanent change of station) to Fort Belvoir, Virginia where he became an Assistant Professor at USUHS and eventually took on the role of Chief of Urology while also serving as the Physician Cochair of the Patient Safety Committee as well as the surgical representative to the Risk Management committee. He was honorably discharged in 2020 before matriculating as the Endourology fellow at TJUH.

Dr. JY Leong receiving the Koppel award from Dr. Pat Shenot with Dr. Max Koppel in attendance.

When he is not working, Dr. Singh enjoys spending time with his wife Bhavana, their families, and their dog, Archie. He also enjoys playing basketball and hiking. Next year, he is headed to Penssylvania’s Lehigh Valley where he will work in the St. Luke’s hospital system. He is excited to be practicing with one of his former co-urology residents, Zachariah Goldsmith, MD as well as a former graduate of the Thomas Jefferson Endourology Fellowship, Daniel Verges, MD. The fellowship is partially funded by a grant from Boston Scientific. ASAF SHVERO, MD ENDOUROLOGY FELLOW Asaf Yosef Shvero, M.D. was born and raised in Givat Shemu’el, Israel. After completion of his high school studies, Dr. Shvero joined the Israeli Defense Force where he served for 4.5 years. During his military service, he decided to pursue the medical profession following his father Jacob who is a well-known E.N.T surgeon in Israel. Dr. Shvero completed his bachelor’s degree in health sciences and carried on to complete his medical studies at the Bruce Rappaport School of Medicine, Technion Institute of Technology, Haifa, Israel. Just before starting his studies, he met Dana, who was then a 3rd-year dentistry student, and later became his wife. He and Dana have a girl, Shir, and two boys, Ido and Oren. Early in his medical training, he was fascinated with Urologic surgery and was fortunate to be accepted for a residency program at the Department of Urology in Sheba Medical Center, Israel. During his 6-year residency, he also completed an associate degree in Bioinformatics and Computational Biology at Bar-Ilan University, Israel. His residency was very fulfilling and productive clinically and academically. During this time, he fell in love with the field of Endourology under the mentorship of Dr. Nir Kleinmann (a former TJUH Fellow - Class of 2013) and Dr. Harry Winkler. After completing his residency, Dr. Shvero continued as an attending endourologist in Sheba Medical Center before starting his Endourology Fellowship program at TJUH. During his fellowship, Dr. Shvero’s family remained home in Israel. After completion of his fellowship, Dr. Shvero completed his 12 month endourology fellowship in October of 2021 and returned to Israel to join the Endourology service at Sheba Medical Center, led by Dr. Kleinmann, and continue the Jefferson tradition overseas.

Dr. Emily Bochner, SKMC 2021 receiving the Dolores Shupp Byrne SKMC Senior Urology Award virtually from Dr. Costas Lallas from her new residency location in Dallas, Texas.

Andrea Quinn, SKMC 2022, receiving her plaque recognizing her time as a Jefferson Urology Scholar for 2020-2021.

Jefferson Urology

49


Graduation and Awards

1

2

3

4

5 50

6 Year in Review


1 Dr. Gomella with the Department of Urology very happy residents and fellows. 2 Dr. Shervo receiving his certificate from Drs. Gomella and Hubosky. Dr. Shervo returned to Sheba Medical Center in Israel and joined our former endourology fellow, Dr. Nir Kleinmann. 3 It was a perfect June evening to hold the 2021 Graduation celebration outdoors complete with musical entertainment.

7

4 The graduates were given a chance to speak during the event with Dr. Hardacker’s comedy monologue shown here. 5 Dr. Shervo was also the proud recipient of a custom bobble head seen here with Dr. Tricia Gomella. 6 Dr. Abhay Singh was our 20202021 Endourology Society and Robotics Fellow seen here with Dr. Lallas who is Co-Director of the fellowship program along with Dr. Scott Hubosky.

8

7 Dr. Asaf Shervo presented at grand rounds as part of his fellowship graduation in the fall. His family and colleagues were in Israel and participated by ZOOM. 8 As a final going away gift our June 2021 graduates received a custom 5 pound Hershey Chocolate bar. 9 A urology tradition has been the presentation of custom bobble head dolls to our graduating trainees. The Bobble head project is under the supervision of Dr. Tricia Gomella, with masks being a unique addition this year. From left to right, graduates Drs. Singh, Hardecker, Caputo and Counsilman.

9

Additional year-end award ceremony and graduation photos can be found in the Photo Gallery starting on page 63. Jefferson Urology

51


Alumni News

Michael J. Erhard, MD, MBA

Mihir Shah, MD

2021 JEFFERSON UROLOGY ASSOCIATION ACHIEVEMENT AWARD Michael J. Erhard, MD, MBA Executive Vice President and Physician in Chief, Florida Operations Nemours: Children’s Health System The Department of Urology was pleased to present the 2021 Jefferson Urology Alumni Achievement Award to Michael J. Erhard, MD, MBA. Dr. Erhard was appointed Physician in Chief for Nemours in Florida in 2017. His medical leadership role includes responsibilities for Nemours physician practices throughout northeast, northwest and central Florida, as well as Nemours Children's Hospital in Orlando and hospitalists and neonatologists serving affiliated hospitals from Central Florida to Florida’s panhandle. Dr. Erhard's 25 years of service and physician leadership with Nemours spans the campuses both in the Delaware Valley and Florida. A native of the Philadelphia area, Dr. Erhard received his undergraduate degree from the University of Notre Dame and earned his medical degree from Jefferson Medical College, (Sidney Kimmel Medical College), where he began his journey with Nemours as part of his urology training. After completing his Surgery and Residency in Urology (1995) at Thomas Jefferson University Hospital, he completed a Pediatric Urology Fellowship at the University of Florida, a joint program with Nemours in Jacksonville. Dr. Erhard is board certified by the American Board of Urology (ABU) and holds a subspecialty certificate from the ABU in pediatric urology. Dr. Erhard specializes in spina bifida, urologic reconstruction and minimally invasive surgery. He was one of the

first in the country to adopt the use of robotics in pediatric urology, and was a pioneer in both robotics, and ureteroscopic treatment of stones in children. Dr. Erhard was also the founding lead surgeon for the Foundation for Children, a non-profit Florida based organization which focused on correcting congenital anomalies in orphaned children of the Crimean Peninsula, and also helped train local physicians. He led the surgical teams missions beginning in 2007 and ending in 2014 with the annexation by the Russian Federation. Dr. Sonny Figueroa, Chief of Pediatric Urology, Division of Pediatric Urology Nemours/A. I. duPont Hospital for Children, noted that “having been involved with his training and continuing to work with him in the Nemours Children’s Health System, we are very proud of Mike and what he has accomplished. His Jefferson Urology Alumni Achievement Award is well deserved.” Previous award winners are Dr. Steve Strup (2019), and Dr. Marty Dresner (2020). There has been one other historic Alumni award given to Dr. Ken Brownstein during the Department of Urology Centennial Celebration in 2004. The Department looks forward to making this Alumni award an annual event. ALUMNI NEWS BRIEFS Mihir Shah, MD Mihir is a graduate of the University of Medicine and Dentistry of New Jersey in Newark in 2003 after completing his B.S. in Biomedical Engineering at Rutgers University in New Jersey. Mihir joined Jefferson as a general surgery resident in June of 2013 and

Gerald L. Andriole, MD, FACS

Yew-Lam Chong, MD 52

Year in Review

Dr. Erhard participated in a virtual alumni award ceremony on June 18, 2021 during the DM Davis Visiting Professorship with Dr. Pat Shenot is “presenting” Mike with his award. Dr. Gomella is holding a custom cardboard cut-out likeness that is reported to be “the next best thing to being there.”


completed his urology residency at Jefferson in 2018. He then completed a fellowship in minimally invasive urologic surgery at the USC Institute of Urology in Los Angeles, CA. Since July 2020 he has been on the staff at Christiana Hospital where he has become an integral part of Sidney Kimmel Medical College teaching faculty primarily working with family medicine residents rotating with him. We look forward to his work further solidifying our relationship between SKMC Department of Urology and Christiana. Gerald L. Andriole MD, FACS Gerald L. Andriole MD will be joining Johns Hopkins. Dr. Andriole will be Professor of Urology and Director of the Brady Urological institute in the National Capital Region, Johns Hopkins University starting January 2022. He will be leading Hopkins Urology efforts in the region and will also continue his efforts in prostate cancer research, clinical care and education. Dr. Andriole most recently was the Robert K. Royce Distinguished Professor and Chief of Urologic Surgery at Washington University School of Medicine in St. Louis. He is a world leader in prostate cancer. Dr. Andriole received his medical degree in 1978 from Jefferson Medical College (Sidney Kimmel Medical College) after completing its 5-year accelerated medical program in conjunction with Pennsylvania State University. He trained in surgery at Strong Memorial Hospital at the University of Rochester and completed urology residency at Brigham and Women’s Hospital and Harvard Medical School. Subsequently, he was a fellow in Urologic Oncology at the National Cancer Institute in Bethesda, Maryland under Dr. Marston Linehan. At Washington University, Dr. Andriole had over 35 years of clinical and academic research contributions in the areas of BPH and prostate cancer screening, prevention and imaging. He has contributed well over 450 peer-reviewed publications. Dr. Andriole has been the recipient of numerous awards including the Outstanding Achievement Award from the Urologic Oncology Branch of NCI, Distinguished Alumni Award from Jefferson Medical College, the Distinguished Clinician Award from Washington University in St Louis and most recently the Richard Williams, MD Prostate Cancer Research Excellence Award from the American Urological Association Urology Care Foundation.

Andrew Pridjian, MD Dr. Pridjian is a 2013 graduate of Sidney Kimmel Medical College and completed his Urology residency at Jefferson in 2019. In the summer of 2020, Dr. Pridjian completed a fellowship in Advanced Robotics and Urologic Oncology at University of Southern California, and started working at Urology Specialists of Atlanta in Sandy Springs, Georgia. In practice, he concentrates on minimally invasive oncology primarily. Dr. Pridjian’s hospital systems include Northside Hospital as well as Emory St. Joseph's hospital. He completed 100 robotic oncology cases during his first year in practice. He was featured in an Instagram posting honoring USC doctors during COVID. Yew-Lam Chong, MBBS, MRCS, MMed, FAMS A former Endourology Fellow at Jefferson, Dr. Yew-Lam Chong serves as Senior Consultant of the Department of Urology, Tan Tock Seng Hospital. Concurrently he is the Chairman of the Division of Surgery and holds Adjunct Associate Professorship at the NTU-Lee Kong Chian School of Medicine and Adjunct Assistant Professorship at the NUS Yong Loo Lin School of Medicine. He serves as an International Editorial Member of the Canadian Journal of Urology. As a member of the Tan Tock Seng Hospital senior management team, his additional responsibilities include the Clinical Director of Emergency Planning, Clinical Director of JOINT (Joint Oncology Innovations Taskforce) and Director of the NHG-JHSI (National Healthcare Group - Johns Hopkins Singapore Institute). Dr. Chong completed his undergraduate medical training at the National University of Singapore in 1995, obtained Membership at the Royal College of Surgeons Edinburgh in 2001, Masters in Medicine (Surgery) in 2002 and completed a Urology residency training in 2006. From 2007 to 2008, he received fellowship training at the Thomas Jefferson University Hospital, Philadelphia, USA, under the mentorship of Drs. Demetrius Bagley and Leonard Gomella. His fellowship focused on Endourology, Advanced Laparoscopic Urologic Surgery and Robot-Assisted Laparoscopic procedures. Upon returning to Singapore in 2008, he was appointed as faculty and Consultant Urologist at Tan Tock Seng Hospital, and helped develop a range of new surgical capabilities at the hospital. This included development of the hospital’s inaugural robotic prostatectomy program from December 2008, enhancing the role of flexible ureteroscopy in upper urinary tract diseases, PCNL and other advanced laparoscopic procedures.

Outside of work, Yew-Lam is active in the army reserve. He graduated from the premier officer command training course at the Singapore Armed Forces Command and Staff College in 2009, received the National Day Award Commendation Medal (Military) in 2013 and currently holds the rank of Senior LieutenantColonel, was the former Commanding Officer of the 8th Combat Support Hospital from 2012 to 2017, and currently serves as the Senior Formation Officer in the Singapore Armed Forces HQ Army Medical Services. He looks forward to seeing his Jefferson colleagues at upcoming meetings. JEFFERSON UROLOGY ALUMNI ASSOCIATION Our urology alumni, student, residents, fellows and faculty, should let us know if you have any general news announcements to share. If you do, please contact Dr. Paul Chung, Director Jefferson Urology Alumni Association (paul. chung@jefferson.edu). We are committed to keeping connected to our urology alumni across the United States and internationally. Update your contact and other information by using the following link https://tinyurl.com/ jeffersonurology or by using the QR code below on your cellphone. Alumni may also directly contact our office by phone (215-955-6961) or email Barbara.Devine@jefferson.edu to update their information. Specific questions on the Jefferson Urology Alumni Association can be directed to Dr. Paul Chung or Dr. Leonard Gomella, Chair of the Department of Urology (leonard. gomella@jefferson. edu). Jefferson Urology Alumni Association QR Code for Directory Updates.

Jefferson Urology

53


Alumni News: In Memoriam

Dr. Ralph Veenema, Jefferson Medical College (Sidney Kimmel Medical College), Class of 1945.

RICARDO GONZALEZ, MD

On March 23, 2021, our former and esteemed colleague and friend, Dr. Ricardo Gonzalez, died after a long battle with metastatic prostate cancer, at the age of 77 years. Dr. Gonzalez joined the faculty at the Nemours/Alfred I duPont Hospital for Children and the Department of Urology at Thomas Jefferson University in 2002. Prior to his arrival in the Philadelphia area, he had been Professor and Chief of Pediatric Urology at the University of Miami, and before that appointment he was Chief of Pediatric Urology at the Michigan’s Children’s Hospital in Detroit, where he worked with our former colleague Dr. Julia Barthold. When the opportunity to add a faculty member was made possible, Dr. Barthold contacted Dr. Gonzalez, who came to Wilmington initially as a visiting professor in 2001, and then joined the faculty in 2002. At duPont, he quickly started a Fellowship in Pediatric Urology, and during his tenure, 7 fellows completed the two-year clinical fellowship. Along with the Fellowship, he also established a pediatric laparoscopic surgical program, a skill he learned, and mastered, after his 60th birthday. Like all challenges in his life, he approached laparoscopy with curiosity, passion, intensity and superlative skill. Upon his retirement from duPont in 2008, he moved to Salzburg and then Hannover Germany with his wife Dr. Barbara Ludwikowski, where he continued to operate and teach until his untimely death. His contributions to pediatric urology have been significant and durable, and he influenced legions of pediatric urologists and pediatric surgeons in North and South America and throughout Europe. As noted in the Memorial in the Journal of Pediatric Urology, Dr. Gonzales “was a man of extraordinary talent who spoke 5 languages and during his diverse life taught urology in 3 of them,” and, upon his death, “Pediatric Urology lost one of it’s most talented and imaginative surgeons and educators.” Along with his wife, he edited the “Handbook of Urologic Diseases in Children,” which is a featured book on page 24 of this Year in Review. Thanks to Dr. Sonny Figueroa for his contribution.

54

Year in Review

RALPH JAMES VEENEMA, MD Ralph James Veenema, MD, former Chief of Urologic Oncology at Columbia Presbyterian Medical Center in New York City, passed away Friday, Dec. 14, 2018, in, Cromwell, Connecticut. He was 97. Born Dec. 13, 1921, in Prospect Park, New Jersey, he received a bachelor's degree from Calvin College in Michigan where met and married his wife, Henriette (Henis) E. Van der Molen on Sept. 19, 1944.

In 1945, Dr. Veenema received his medical degree from Jefferson Medical College (now Sidney Kimmel Medical College) and served his internship at Paterson General Hospital in Paterson, New Jersey. In 1946, he was commissioned a Captain in the United States Army Medical Corps and served his country at Army hospitals in Alexandria, Louisiana, and Jackson, Mississippi. After receiving his honorable discharge from the military in 1948, he joined the staff at Columbia Presbyterian Medical Center in New York City initially as a pathology resident but in 1949 he switched to Uology and after his training he served on the faculty of Columbia Presbyterian Medical Center Squier Urological Clinic from 1953 – 1987. At the time of his retirement in 1987, he was urology surgical attending at Presbyterian Hospital in New York City and was professor emeritus of urology at Columbia University College of Physicians and Surgeons. He was a member of the American Association of Genitourinary Surgeons and President of the New York Section of the AUA form 1970-1971 and published 104 papers including how to perform a perineal prostate cup biopsy in 1962. He and his wife retired to their farm in Deposit, NY from their home of 35 years in Glen Rock, New Jersey. ShiRaLoKen Farm was well known for its high quality Angus breeding stock. In 1997, Ralph and Henis retired from farming and moved fulltime to Cooperstown, NY. In May 2006, Ralph suffered the loss of his beloved wife, Henis. Dr. Veenema is survived by two daughters and sons-in-law, Shirley Ann and Jim Sheldon of Boston, Massachusetts and Lois Ruth and Bill Byrne of Traverse City, Michigan; two sons and daughters-in-law, Ralph J. Veenema Jr. and Janet of Rocky Hill, Connecticut and Kenneth R. Veenema, MD, and Tener of Baltimore, Maryland in addition to 13 grandchildren and eight great-grandchildren. Thanks to Drs. John Wei and David Bloom, University of Michigan, for their contributions.


Student News RESULTS OF 2021 SIDNEY KIMMEL MEDICAL COLLEGE UROLOGY MATCH

SKMC UROLOGY MATCH 2021 According to Dr. Charles A. Pohl, Vice Dean of Student Affairs and SKMC Professor of Pediatrics “Congratulations to the Department of Urology on another great urology match. This is one of the more competitive specialties with most SKMC students getting one of their top choices and all of them entering great programs. I am very pleased that 90% (9/10) of SKMC students matched when compared to an 80% match rate nationally for US seniors and a 74% match rate overall.” Urology programs are in an early match to allow individuals to be assigned in general surgery intern positions when the general match takes place in March each year.

SKMC CLASS OF 2021

UROLOGY PROGRAM

Emily Bochner

University of Texas-Southwestern University

Nicholas Bowler

George Washington University

Jessica Clark

Temple University

Ryan Fogg

Virginia Commonwealth University

Ernest Gillan

Rutgers New Jersey

Yitzchak Katlowitz

Maimonides Medical Center

Brent Perry

Geisinger Medical Center

Sage Vincent

Thomas Jefferson University

Kevin Xie

State University of New York - Buffalo

JEFFERSON UROLOGY RESEARCH SCHOLARS The Jefferson Urology Research Scholar program was established in 2017 to prepare medical students for a urology residency and to encourage careers as a physician/ scientist. Intended as a “gap year” before Year 4 of medical school, the one-year, full-time program provides students with opportunities to work alongside clinical leaders in the field, garnering invaluable insight while obtaining a career-changing experience. In addition to their research programs, they have the opportunity to participate in all Department of Urology grand rounds and lectures.

fulfill his dream of becoming a physician. He was particularly drawn to Urology because of the wide scope of urologic practice as well as the cutting-edge techniques employed, and is excited to contribute to the field as a research fellow. Some of his current projects include a prostate cancer staging database, a prospective study on advanced ultrasound techniques, and a retrospective study of transgender patients and their experiences with urologic care. Outside of medicine, his hobbies include reading, writing, cycling, exploring music, and playing chess.

Jefferson urologists have a long history of moving the field forward through contributions, such as inventing the first uroflowmeter, pioneering the earliest uses of laparoscopy and minimally invasive surgery in urologic practice, performing the first research in detecting circulating micrometastasis in prostate cancer using molecular techniques, establishing multidisciplinary clinics to care for GU malignancies and performing the first adult bladder augmentations in the world using bladder tissue engineering. The Scholars program is coordinated by Dr. Costas Lallas, Vice Chair for Education. For information on our Jefferson Urology Scholars Program, please contact Dr. Lallas (costas.lallas@ jefferson.edu). Andrew Denisenko and Andrew Shumaker are our 2021-2022 scholars.

ANDREW SHUMAKER Andrew “S” is originally from Boca Raton, Florida and currently studies medicine at Tel Aviv University Sackler School of Medicine’s New York/American program. His

ANDREW DENISENKO Andrew “D” graduated from Bloomsburg University of Pennsylvania with a double major in Biology and Russian, and a minor in chemistry. After working as an emergency room scribe for a year, he was accepted to Geisinger Commonwealth School of Medicine to

undergraduate education was at the University of Florida with a focus in Middle Eastern studies. He then went on to receive a master’s degree in Physiology and Biophysics from Georgetown University. Andrew has loved the field of urology since the beginning of his medical education. He particularly enjoys reconstructive urology but also has done previous research in pediatric urology. He is grateful for the opportunity to continue his research efforts as a Jefferson Urology Research Scholar and is eager to continue collaborating with the department faculty and working alongside his two new friends, Andrew “D” and 2021-2022 research fellow Dr. Cass Clark. When not in the department, Andrew enjoys listening to jazz, learning history and wood carving.

Andrew Denisenko and Andrew Shumaker are our 2021-2022 Jefferson Urology Research Scholars. Jefferson Urology

55


Student News JEFFERSON UROLOGY SOCIETY The Jefferson Urology Society (JUS) is a student run interest group that provides opportunities for medical students to learn more about the field of urology. The goal of the society is to expose medical students to all things urology. This is done through outreach programming during all phases of medical school. This includes urology lectures for preclinical students, a robotics demonstration for clinical students, and longitudinal research and mentorship opportunities throughout medical school. The society is working to establish a new externship program to allow for students to receive more clinical exposure to urology in medical school. The JUS plays a role in engaging students in urology early in their medical education. Any questions or comments can be directed to urology.society@students.jefferson.edu. The following are some of the activities of the Jefferson Urology Society (JUS) over the last year. •

•

•

Urology General Interest Meeting: Hosted by Dr. Lallas and JUS students, this program exposed students to the broad field of urology covering the scope of urologic diseases and their medical and surgical treatments. Topics covered also included questions about lifestyle, compensation, residency, and an average day of a urologist. Table at Fall Career Fair: Collaborated each year by students in the JUS and Jefferson urology residents, the Fall Career Fair is an opportunity for upper year medical students to explore urology as a potential career path. Robotics Lecture and Demonstration: This is one of the best attended events that the Jefferson Urology Society hosts every year.

A ZOOM shot of a recent Jefferson Urology Society board meeting. Top left to right Secretary: Bowen Yao (SKMC 2022); Upper Class Liaison: Joseph Schultz (SKMC 2023) and Treasurer: Connor McPartland (SKMC 2023). Bottom left to right: President: Jared Raikin (SKMC 2022), Event Coordinator: Kaitlin Berry (SKMC 2022) and Lower Class Liaison: Samuel Alfonsi (SKMC 2024).

56

Year in Review

Students participate in a lecture about the history of robotic surgery in urology followed by a demonstration on a Da Vinci robot by Dr. Costas Lallas in an operating room. Students get a rare opportunity to use the robotic simulator. Unfortunately, due to COVID19 restrictions we were unable to run this event in 2021 but are looking forward to this event returning this upcoming spring. •

•

Urology Journal Club: This summer the JUS society will have its first student run journal club. Junior medical students will start the journal club by presenting the relevant anatomy and physiology, followed by senior medical students presenting a landmark and controversial academic paper. Further discussion will be facilitated by Dr. Lallas to provide students with the skills of presenting papers. Winter Urology Externship: This is a new program offered to 2nd year Jefferson Medical students interested in Urology and allows expanded exposure to Urology. Students who are accepted will have the opportunity to attend a 2-week urology externship during winter break before their clinical rotations begin. Students will spend time in clinic, the OR, helping manage patients on the floor, and attending lectures. Basic skills will be taught such as catheter placement, knot tying and suturing. We believe this early clinical exposure will draw new students to the field of urology.

The 2021-2022 Jefferson Urology Society Officers are: President: Jared Raikin (SKMC 2022) VP Research: Adam Schneider (SKMC 2023) VP Clinical: Kabir Malkani (SKMC 2022) Secretary: Bowen Yao (SKMC 2022) Treasurer: Connor McPartland (SKMC 2023) Event Coordinator: Kaitlin Berry (SKMC 2022) Upper Class Liaisons: Jessica Bulafka (SKMC 2023), Joeseph Schultz (SKMC 2023) Lower Class Liaison: Samuel Alfonsi (SKMC 2024) Faculty Advisor: Costas Lallas MD (JMC 1998)


As part of the new Winter Urology Externship, students had the opportunity to participate in the OR. Here is second year extern student Kelly McGuigan with urology residents Drs. Anthony Tokarski and Radhika Ragam during an endourology case. The externship program is under the Direction of Jared Rankin, Jefferson Urology Society President. The Externship block was held over the year-end Holiday break. STUDENT MENTORSHIP Jefferson Urology has a long history of active engagement with students throughout all years of medical school. This is one of the reasons why we are consistently amongst the programs with the highest number of students matriculating into urology nationwide. Historically, a clinically heavy surgical specialty will be most represented in the clinical years of medical school, i.e. the 3rd and 4th years (or Phase 2 and 3 of JeffMD, the newly implemented SKMC curriculum). Urology, however, now represents an established portion of one of the 7 core blocks taught in the preclinical first 2 years (Phase 1) of JeffMD. In doing so, the SKMC students have 9 dedicated Urology-centric lectures from Urology faculty in the Endocrine-Reproductive Block of Phase 1. In alignment with other medical schools including SKMC, the Department of Urology has started outreach programs to select undergraduate institutions and students to offer a dedicated shadowing and mentorship program during a summer of undergraduate studies (preferably between the Sophomore and Junior undergraduate years). We piloted this program this past Summer, inviting Peyton Stauffer, a student studying biochemistry at Villanova University, to spend 6 weeks of her summer shadowing in the department. Her

chief mentor was Dr. Lallas, although she was able to spend time with multiple staff members to gain a comprehensive appreciation of the specialty. Peyton spent time in clinic, the operating rooms, and attended conferences. She had a dedicated research project with the Research Fellows of the Department and was able to get her name on an academic product. In all, the pilot was wildly successful and positively impacted her impression of Urology and medicine as a whole. We are hoping to use the experience that we gained this past summer to continue outreach programs to colleges and universities local to Philadelphia. This will dovetail nicely with the MAAUA initiative to offer scholarships to URM undergraduate students in both historically black and conventional institutions, to spend a summer shadowing staff urologists at academic institutions. The notable goal of this program will be to attract underrepresented minorities into medicine in general, and hopefully into Urology in particular. In these efforts, Jefferson Urology hopes to continue to be a national leader in mentorship, while focusing attention on inclusivity to remain at the forefront of medical education for decades to come. The program is under the direction of Dr. Costas Lallas, Vice Chair for Education.

Peyton Stauffer from Villanova University.

Jefferson Urology

57


Residents and Fellows* CHIEF RESIDENTS (PGY 6) Victor Kucherov, MD Medical School: University of Rochester School of Medicine & Dentistry Undergraduate: University of Rochester Interests: Biking, film making, spending time with family, cooking

Ben Rudnick, MD Medical School: Sidney Kimmel Medical College Undergraduate: Vanderbilt University Interests: Traveling with my wife, rooting for my beloved New York sports teams, exploring the Philly restaurant scene

Alex Uhr, MD Medical School: Sidney Kimmel Medical College Undergraduate: University of Pittsburgh Interests: Playing with my dog, traveling, playing and watching basketball and golf

Edward Kloniecke, MD, MHA Medical School: Sidney Kimmel Medical College Undergraduate: University of Scranton Interests: Skiing, Eagles and Phillies, craft beer and bourbon, coffee, Philly food scene, traveling

Andrew Salib, MD Medical School: Robert Wood Johnson Medical School Undergraduate: Rutgers University Interests: Traveling, craft beer, reading

Anthony Tokarski, MD Medical School: Sidney Kimmel Medical College Undergraduate: Pennsylvania State University Interests: Video and photo editing

Brian Calio, MD Medical School: Sidney Kimmel Medical College Undergraduate: University of Delaware Interets: Eagles football, movies, Fantasy sports, golf

Halle Foss, MD Medical School: Medical College of Wisconsin Undergraduate: St. Olaf College Interests: Tennis, coffee, card/board games, exploring new bars and restaurants

Radhika Ragam, MD Medical School: Rutgers New Jersey Medical School Undergraduate: The College of New Jersey Interests: Golf, snowboarding, movies, beer gardens, biking on the Schuylkill River Trail

Courtney Capella, MD Medical School: Sidney Kimmel Medical College Undergraduate: Dickinson College Interests: Plants, National Parks, and Peloton

Maria D'Amico, MD Medical School: Boston University School of Medicine Undergraduate: Columbia University Interests: Yoga, Peloton, traveling, the beach

Joon Yau (JY) Leong, MD Medical School: Sidney Kimmel Medical College Undergraduate: International Medical University Kuala Lumpur, Malaysia Interests: Hieroglyphics, Oreos, being "niceee"

Mauro Dispagna, MD Medical School: SUNY Upstate Medical University's College of Medicine, Syracuse Undergraduate: University of Central Florida Interests: Soccer, Formula-1 racing, traveling, wine

Zachary Prebay, MD Medical School: Medical College of Wisconsin in Milwaukee Undergraduate: University of Michigan Interests: Michigan football, reading, coffee, running

Sage Vincent, MD Medical School: Sidney Kimmel Medical College Undergraduate: University of Richmond Interests: Powder skiing, Peloton, happy hour, Denver Broncos football

PGY 5

PGY 3

PGY 2

PGY 1 (INTERNS)

*Note: There is no PGY-4 year due to the transition to a five-year residency program. 58

Year in Review


Jefferson Urology Fellows 2021-2022 Our Jefferson Urology Fellow in Endourology and Robotic Surgery for the 2021-2022 academic year is Dr. Aseem Malhotra. Our fellowship is sponsored Born in India, Aseem immigrated to the United States at the age of eleven. He completed his undergraduate studies at Temple University. He was enrolled in the Bachelors in Science/MD accelerated program and graduated Summa Cum Laude with a degree in Biology. Aseem then received his medical degree at the Lewis Katz School of Medicine at Temple University. His interest in Urology was piqued when he was assigned to the urology service during a week on his general surgery core rotation. He went on to complete his residency training at The University of Pennsylvania. ASEEM MALHOTRA, MD Dr. Malhotra is excited to join Jefferson Urology in this role. He intends to make the most of his fellowship experience to expand the breadth of his robotic training and further refine his skills in complex oncologic procedures. After completion of his fellowship, he plans to join a private practice in Alexandria, Virginia where he will be helping expand a robotics program at a new facility. His wife, Paola, whom he met while at medical school, is a current gastroenterology fellow at St. Peter’s University Hospital. The fellowship is partially funded by a grant from Boston Scientific. CASSRA CLARK, MD, MS Dr. Clark is a 2021 Sidney Kimmel Medical College Graduate and he joined us this year as a Research Fellow in the Department of Urology. He is a graduate of the University of Washington in Seattle in 2011 with a BS in biology. He then went on to Tulane University and earned a Master’s in medical genetics and genomics from 2013-2014. Cass has previously worked in the Seattle Children's Research Institute in their therapeutic cell production core involved in the development of CAR-T immunotherapy for a variety of a pediatric malignancies. So far it has been a productive year with multiple abstracts and manuscripts published. Being able to attend and present at the Mid-Atlantic AUA conference was one of his highlights since it was his first in person opportunity because of the pandemic. Much of Cass’s research work this year has focused on our VPAC prostate cancer urine detection work in Dr. Thakur’s lab. In his spare time, he was able to participate in the Broad Street Run and Philadelphia Marathon. Cass is looking forward to participating in the upcoming 2022 Urology match.

FELLOW IN ENDOUROLOGY & ROBOTICS Aseem Malhotra, MD

UROLOGY RESEARCH FELLOW Cassra Clark, MD, MS

Welcome New Urology Interns We are pleased to welcome our new Interns to the Department of Urology. Mauro Dispagna, MD, Zachary Prebay, MD and Sage Vincent, MD started their training on June 20, 2021. Mauro is a graduate of SUNY Upstate Medical University's College of Medicine in Syracuse, New York. Zack earned his medical degree from the Medical College of Wisconsin in Milwaukee. Sage is a Sidney Kimmel Medical College graduate.

Drs. Zack Prebay, Sage Vincent and Mauro Dispagna, Department of Urology 2021 Intern class. Jefferson Urology

59


Jefferson Urology Regional and Enterprise Updates JUP Urology Regional Expansion: Abington/Asplundh In 2016, our Department was asked to establish a practice on the Abington campus. Three years ago we began outpatient office hours at the SKCC Asplundh Cancer Pavilion in Willow Grove. Our Jefferson Urology academic faculty has provided outpatient cancer and non-cancer consultation and care since that time. With the support of Jefferson Health and the Abington Hospital Division leadership we established our full time practice on August 1, 2021 at Jefferson-Abington Hospital. Initially working out of the Asplundh Cancer Pavilion, our fully functioning office in the Price Building will open in early 2022. This expansion included the addition of two new Abington dedicated JUP faculty, Drs. Whitney Smith and Patrick Gomella (see page 35). Dr. Thenu Chandrasekar is our Abington/ Asplundh Site Director working with urologic oncologists Drs. Mark Mann and Costas Lallas. We are also joined by our new Advanced Practice Provider Vivian Ngo, PA (see page 43). We are pleased to work with Temple urology residents that rotate at Abington and have coordinated this closely with Temple Urology Chair Dr. Jack Mydlo and Residency Program director Dr. Adam Reese. Our thanks to Peg O’Grady and Pam Frazier in particular for supporting and helping establish our new full time practice on the main Abington campus.

Our Asplundh/Abington Urology team members include (left to right): Pam Frazier, Asplundh Practice Manager; Peg O’Grady,RN Administrative Director, Oncology Service Line; Noreen Weilgus, RN, MSN Nurse Navigator; Morgan Boetefeur, RN, Nursing; Marianne Keebler, Urology Registrar and Deidre Wayns, Medical Assistant. Vivian Ngo is our new Physician’s Assistant who is introduced on page 43.

Marlene Vallett New Ambulatory Operations Project Manager This newly created position was essential as Jefferson University Urology expands beyond center city. Marlene primarily works with and reports to Dr. Gomella and Mr. Adam Messer, Urology Service Line VP, across the entire Urology enterprise. She will continue to support our center city practice coordinating with Scott Bowes, Janelle Browning and Anne Calvaresi in regards to operational issues. She will work in coordination with the center city leadership team to ensure systemwide practice alignment. Some of Marlene’s specific roles include coordinating all aspects of new urology practice set ups, training new practice staff on organizational and departmental policies and procedures, and providing ongoing support for and engaging with local Practice Managers throughout the Jefferson Health Urology Service Line. Marlene has been instrumental in her new role setting up both our Cherry Hill and Abington offices.

Marlene Vallett, Ambulatory Operations Project Manager, outside our new Cherry Hill Office. 60

Year in Review


Jefferson Buxmont Urology

Jefferson Urology Buxmont providers include Drs. David Altman and Lee Blatstein, Nurse Practitioner Carolyn Stalhut and Drs. Rich Landau and Matt Gerstein. Next year marks the 4th year that our colleagues at Buxmont Urology joined Jefferson Health. Their well-established practice covers portions of Montgomery and Bucks Counties. Dr. David Altman is a Jefferson Medical College/Sidney Kimmel Medical College graduate who completed training in urology at Geisinger medical

center. Dr. Lee Blatstein, recognized in 2021 as a Philadelphia Magazine “Top Doctor”, graduated from Philadelphia College of Osteopathic medicine where he also completed his Urology residency. Dr. Matt Gerstein graduated from SUNY Brooklyn College of Medicine and completed his urology residency at Temple. Dr. Rich Landau attended

JUP Urology Regional Expansion: Jefferson New Jersey In April, 2021 our New Jersey Urology practice relocated from the Jefferson New Jersey Cherry Hill Primary & Specialty Care location to a new dedicated Jefferson Health Urology practice located at the intersection of Chapel Avenue and Kings Highway. Located 1 mile away from Jefferson Cherry Hill Hospital, the new office address is 511 Kings Highway North, Cherry Hill, NJ. Our JUP providers who work in the new expanded office include Paul Chung, MD, Deborah Glassman, MD, James Mark, MD, and Perry Weiner, DO. The office has a dedicated full time urology staff (see group photo) that includes our new Physician Assistant, Leah McDermott (see page 43). The Department is most appreciative of the support provided by Jefferson New Jersey leadership in making this free standing office a reality.

the George Washington University School of Medicine and completed his general surgery and Urology residency training at Jefferson. The practice is fortunate to have an experienced CRNP supporting their busy practice. Carolyn Stalhut, CRNP completed her professional training at Gwynedd-Mercy College.

JEFFERSON HEALTH UROLOGY COMMUNITY PROVIDER LOCATIONS Aria Jefferson Urology Bucks 240 Middletown Boulevard, Suite 107 Langhorne, PA 19047 267-560-1001 Aria Jefferson Urology NE Red Lion 3998 Red Lion Road Philadelphia, PA 19114 215-632-8882 Aria Jefferson Urology NE Cottman 1342 Cottman Avenue Philadelphia, PA 19111 215-745-1612 Aria Jefferson Urology NE Welsh Road 2137 Welsh Road Philadelphia, PA 19115 215-698-7333 Buxmont Urological Specialists 711 Lawn Avenue, Building 2 Sellersville, PA 18960 215-257-1050

Our Jefferson Urology New Jersey office team: (Back Row) Linda Teschko, Sha’Mere Herder, Jonathan Scroggin; Front Row: Ana Pollock-Evans and Linda Terres. See the welcome note for our new Physician Assistant Leah McDermott on page 43.

Buxmont Urological Specialists 125 Medical Campus Drive, Suite 305 Lansdale, PA 19446 215-361-2304

Jefferson Urology

61


Jefferson Urology Regional and Enterprise Updates UROLOGIC ASSOCIATES JOIN JEFFERSON HEALTH The physicians of Urological Associates at Jefferson Northeast/Aria officially joined the Jefferson Health Urology Enterprise on July 1, 2021. Drs. Milton Coll, Howard Altman, David Kraman, Cadence Kim, Marc Lavine, and Andrew Margules have four offices extending from lower Northeast Philadelphia all the way to Bucks County. The group provides routine and complex services in almost all areas of Urology, including advanced endoscopic and robotic surgery. Their offices have the full complement of diagnostics and services including a state of the art Urodynamics lab. Urological Associates just celebrated their 50th year of providing consistent and reliable high quality leading edge care to their community. This group includes several “2021 Top Docs”

We are committed to the best outcomes for our patients. We look forward to continuing this now as fulltime members of Jefferson. Dr. Milt Coll including Drs. Cadence Kim and David Kraman and advanced fellowship trained physicians. In 2022, they will be adding two more Urologists to continue to provide timely excellent care. Dr. MJ (MayJean) Councilman, 2021 Jefferson Chief Resident is completing a Beth Israel Deaconess Boston fellowship in endourology and robotics. Dr. Alex Uhr, current Chief Urology resident at Jefferson will also be joining the group in the summer of 2022.

“We are pleased to have Dr. Coll and associates join as full time members of Jefferson Health”, noted Dr. Edmund Pribitkin , Chief Physician Executive and President of the Jefferson Medical Group. “It is an honor to have their established and well respected Urology practice become part of Jefferson Health. Congratulations on your group’s 50 Year Anniversary.”

According to Dr. Milt Coll, “We look forward to bringing Jefferson Urology’s reputation for stellar care into our community and beyond. We are committed to the best outcomes for our patients. We look forward to continuing this now as full time members of Jefferson.”

Urologic Associates, now part of Jefferson Enterprise Urology, sponsored a gala at the Down Town Club in December to celebrate 50 years of their practice. Seen here from left to right are Dr. Alex Uhr, Jefferson Chief Resident who will join the practice in the summer of 2022; Bridget Borodyansky, PA; Dr. Andy Margules; Dr. Marc Lavine; Dr. Howard Altman; Dr. David Kraman; Dr. Cadence Kim; and Dr. Milt Coll.

62

Year in Review


YEAR IN PHOTOS

Chief Resident Dr. Victor Kucherov in the Hamilton Surgical Simulation center with urology intern Dr. Sage Vincent working on the endoscopic TUR simulator. The simulator was a generous gift of the Rivas family.

A center city celebration in honor of Ms. Caroline Richards 75th Birthday.

Residents and our OR specialty nursing team led by Sonia Hurtardo, RN review the essential elements of the OR travelling cysto cart. The cart is used for urology emergencies throughout TJUH.

Drs. Radhika Ragam (PGY3) and Jean Llenado showing their COVID vaccine spirit at Methodist Hospital.

Our new class of interns, Drs. Zackary Prebay, Sage Vincent and Mauro Dispagna, taking a break from hospital duties.

Every July at the start of the new academic year, the Urology OR team organizes a workshop on urologic instrumentation for the house staff and students. Jefferson Urology

63


Dr. Costas Lallas, Vice Chair for Education and Jefferson Urology Society faculty moderator, addressing a meeting of the group. The society engages SKMC medical students at all levels who are interested in a career in urology. See page 56 for more details on the Jefferson Urology Society.

Dr. Stuart Wolf, Professor, Department of Surgery & Perioperative Care in the Dell Medical School at the University of Texas at Austin giving the Annual Brownstein lecture. See page 47 for more information on the Brownstein Visiting Professor program.

Jefferson Urology Chief residents (Drs. Kucherov, Uhr and Rudnick) capture a OR memory shot with visiting Italian Urology resident Dr. Vittorio Canale. 64

Year in Review

Drs. Mark Mann and Whitney Smith with our Asplundh Pavilion Urology team members showing their support for “Movember” Men’s Health Month with their edible moustaches.

The endoscopic simulator provides visual and tactile feedback when practicing procedures such as a TURP. Here Chief Resident Dr. Alex Uhr is reviewing a procedure with our new interns, Drs. Zack Prebay and Mauro Dispagna.

Halloween fun at our Jefferson New Jersey Urology office courtesy of Linda Terres and Jonathan Scroggins.


Graduating 2021 Chief residents Drs. Tom Hardacker, Chris Caputo and MJ Counsilman share the secret of having DMD Visiting Professor Dr. Colin Dinney ‘almost in person.” See page 44 for a different perspective on Dr. Dinney.

Dr. Anthony Tokarski caught Dr. Gomella taking candid OR images for the 2022 Year in Review.

Urology residents gather for the 2021 virtual graduation.

Dr. Scott Hubosky performing an endourology procedure with Chief Resident Tom Hardacker and Junior Resident Anthony Tokarski.

Signage outside of our new Jefferson New Jersey Urology office that opened in April, 2021. The office is at the corner of Chapel Avenue and North King’s Highway, one mile from the Jefferson Cherry Hill Hospital.

In case you missed it because of all the pandemic news, Hurricaine Ida in September 2021 turned the Vine Street Expressway/676 into a river. Jefferson Urology

65


Congratulations to Dr. JY Leong who won first prize in the residents Halloween contest. Please note: only cherry Kool-Aid was used in making of JY’s costume.

Chief resident Dr. Victor Kucherov and PGY-2 Dr. Courtney Capella working with SKMC students on suturing and knot tying in the Hamilton Surgical Simulation lab.

Thanks to the generosity of Drs. Patrick and Lucille Shenot, our residents, Drs. Radika Ragam, Halle Foss, Eddie Kloneckie and Andrew Salib saw the Eagles vs. the Giants at MetLife Stadium in the Meadowlands.

This year, Covid face masks adorned the urology graduates bobbleheads.

66

Year in Review

The robot sitting quietly in the background during an open surgical case. Urology OR team member Nick Vadino with Drs. Alex Uhr, Leonard Gomella and Ben Rudnick.


Scenes from our 2021 Department of Urology Graduation Celebration in honor of Chief residents Drs. Chris Caputo, MJ Counsilman, and Thomas Hardacker and graduating Endourology Society Fellow Dr. Abhay Singh.

Jefferson Urology

67


68

Year in Review


Jefferson Urology

69


Faculty Listing Department of Urology Faculty, Sidney Kimmel Medical College Thomas Jefferson University Costas D. Lallas, MD, FACS Professor Vice Chair, Education Associate Director Urology Residency Program/CoDirector Fellowship Program Endourology & Laparoscopy Medical School: Sidney Kimmel Medical College Residency: Duke University Fellowship: Robotic Surgery, Mayo Clinic, Scottsdale, AZ Jeanne V. Llenado, DO, FACOS Clinical Assistant Professor Director, South Philadelphia Campus Medical School: UMDNJ-School of Osteopathic Medicine, Stratford, NJ Residency: UMDNJ, Stratford NJ

Leonard G. Gomella, MD, FACS Chairman, Department of Urology The Bernard W. Godwin Professor of Prostate Cancer Sr. Director Clinical Affairs, Sidney Kimmel Cancer Ctr. Vice President Urology, Jefferson Health Medical School: University of Kentucky Residency: University of Kentucky Fellowship: Surgical Oncology, National Cancer Institute, Bethesda, MD Demetrius H. Bagley, Jr. MD, FACS The Nathan Lewis Hatfield Professor of Urology, Professor of Radiology Medical School: Johns Hopkins University School of Medicine, Baltimore, Maryland Residency: Yale-New Haven Hospital Fellowship: Surgical Oncology, National Cancer Institute, Bethesda, MD P. Kenneth Brownstein, MD, FACS Clinical Assistant Professor The Harold A. Honickman Physician Director of Jefferson Signature Services Director of Development Medical School: Hahnemann University (Now Drexel University College of Medicine), Philadelphia, PA Residency: General Surgery – University of California Hospital, San Diego, CA Urology Residency: Thomas Jefferson University, Philadelphia, PA Dolores E. Shupp-Byrne, PhD Assistant Professor Director of Medical Student Education Director Jefferson’s Postbaccalaureate Pre-Professional Program (P4) Graduate School: University of Pittsburgh, Pittsburgh, PA Post-Doctoral Fellowship: Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA Thenappan Chandrasekar, MD Assistant Professor Director of Abington-Jefferson Urology Medical School: Sidney Kimmel Medical College Residency: University of California, Sacramento, California Fellowship: Urologic Oncology, University of Toronto, Toronto, Canada Fellowship: Robotic Surgery and Endourology, Thomas Jefferson University, Philadelphia, PA Paul H. Chung, MD, FACS Associate Professor Co-Director Men’s Health Program Director Reconstructive Urology Trauma and Prosthetics Director Jefferson Urology Alumni Association Medical School: Sidney Kimmel Medical College

70

Year in Review

Residency: University of Texas Southwestern Medical Center, Dallas, Texas Fellowship: Male Genitourinary Reconstructive Surgery and Trauma, University of Washington, Seattle WA Akhil K. Das, MD, FACS Professor Director Postgraduate Continuing Medical Education Medical School: Hahnemann University (Now Drexel Medical School), Philadelphia, PA Residency: Thomas Jefferson University Fellowship: Endourology Tauranga Hospital, Tauranga, New Zealand Deborah T. Glassman, MD, FACS Clinical Associate Professor Director Telehealth Program Medical School: New York University School of Medicine, New York, NY Residency: University of Maryland, Baltimore, Maryland Patrick T. Gomella, MD, MPH Assistant Professor Urology and Surgery Medical School: Sidney Kimmel Medical College Residency: George Washington University Fellowship: Urologic Oncology, National Cancer Institute, Bethesda, MD Irvin H. Hirsch, MD Clinical Professor Co-Director Men’s Health Program Medical School: Mount Sinai School of Medicine, NY, NY Residency: Beth Israel Medical Center, New York, NY Fellowship: Male Reproductive Medicine & Surgery/ Urodynamics & Uroprosthetics Baylor University Medical Center, Houston TX Scott G. Hubosky, MD Demetrius H. Bagley Jr. MD Professor Vice Chair Quality Improvement & Safety Director Division of Endourology/Co-Director Fellowship Program Endourology & Laparoscopy Medical School: Loyola University, Stritch School of Medicine, Chicago Residency: Thomas Jefferson University Fellowship: Robotic Surgery and Endourology, Eastern Virginia Medical School, Norfolk, VA Joseph K. Izes, MD, FACS Clinical Assistant Professor Medical School: Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA Residency: Lahey Clinic Foundation, Burlington, MA Fellowship: Urologic Oncology, Lahey Clinic, Burlington, MA

Mark J. Mann, MD Assistant Professor Director Urologic Diagnostic Center Medical School: College of Physicians & Surgeons at Columbia University, New York Residency: Columbia/NYP, New York, NY Fellowship: Robotic Surgery and Endourology, Thomas Jefferson University, Philadelphia, PA James Ryan Mark, MD Assistant Professor Director of Clinical Trials Medical Director SKCC Biorepository Medical School: Saint Louis University School of Medicine, St. Louis, Missouri Residency: Thomas Jefferson University Fellowship: Urologic Oncology, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC Alana M. Murphy, MD, FACS Associate Professor Associate Director Urology Residency Program Director Female Urology Medical School: College of Physicians & Surgeons at Columbia University, New York Residency: Columbia University Medical Center, NY, NY Fellowship: Female Pelvic Medicine and Reconstructive Surgery, Cleveland Clinic, Cleveland, OH Matthew Schiewer, PhD Assistant Professor, Urology & Cancer Biology Director Urology Research Laboratory Graduate School: Thomas Jefferson University, Philadelphia, PA Postdoctoral Fellowship: Sidney Kimmel Cancer Center, Philadelphia, PA Patrick J. Shenot, MD, FACS Professor Deputy Chair Residency Program Director Medical School: State University of New York Stony Brook Residency: Thomas Jefferson University Fellowship: Neurourology, Thomas Jefferson University Whitney R. Smith, MD Assistant Professor Medical School: Rutgers, The New Jersey Medical School, Newark, NJ Residency: Thomas Jefferson University Fellowship: Female Pelvic Medicine and Reconstructive Surgery Wake Forest Baptist Health, Winston-Salem, NC Edouard J. Trabulsi, MD, MBA, FACS Professor Vice Chair for Research Director of Urologic Oncology Medical School: State University of New York, Buffalo, NY Residency: Thomas Jefferson University Fellowship: Urologic Oncology, Memorial Sloane Kettering Cancer Center, New York, NY


Ethan J. Halpern, MD Professor of Radiology and Urology Vice Chair for Research Department of Radiology

Ahmad Bani-Hani, MD, FAAP, FACS Clinical Associate Professor of Urology and Pediatrics Fellowship: Riley Children’s Hospital of Indiana University, Indianapolis, IN

Scott Bowes, MBA, FACHE, CMPE Administrator

Veda Giri, MD Professor Medical Oncology, Cancer Biology, and Urology Director, Cancer Risk Assessment and Clinical Cancer Genetics Sidney Kimmel Cancer Center

Keara N. DeCotiis, MD Clinical Assistant Professor of Urology Fellowship: The Hospital for Sick Children, Toronto, Canada

JOINT SIDNEY KIMMEL MEDICAL COLLEGE FACULTY Robert Den, MD Associate Professor of Radiation Oncology, Cancer Biology and Urology

William Kevin Kelly, DO Professor, Medical Oncology and Urology Director, Division of Solid Tumor Oncology Associate Director of Clinical Research, Sidney Kimmel Cancer Center

Department of Radiation Oncology Karolynn Echols, MD Associate Professor, Obstetrics and Gynecology and Urology Director, Female Pelvic Medicine & Reconstructive Medicine Department of Obstetrics and Gynecology

Mathew L. Thakur, PhD, FSNMMI, FNAI, FACNM, FICNM, FARR Professor of Radiology, Radiation Oncology and Urology Director, Laboratories of Radiopharmaceutical Research, Molecular Imaging and Biofluid Diagnostics

Perry R. Weiner, DO, MSc, FACOS Clinical Associate Professor Director Men’s Health Program Medical School: New York College of Osteopathic Medicine, Old Westbury, New York Residency: Philadelphia College of Osteopathic Medicine, Philadelphia, PA

Jennifer Hagerty, DO, FAAP Clinical Assistant Professor of Urology and Pediatrics Fellowship: Northwestern University, Ann & Robert H. Lurie Children's Hospital, Chicago, IL Puneeta Ramachandra, MD Clinical Assistant Professor of Urology and Pediatrics Fellowship: Rady Children’s Hospital of San Diego, San Diego, CA

DUPONT NEMOURS PEDIATRIC UROLOGY FACULTY T.E. (Sonny) Figueroa, MD, FAAP, FACS Professor of Urology and Pediatrics Chief, Division of Urology at Nemours/Alfred I. duPont Hospital for Children Fellowship: Children’s Hospital of Michigan, Detroit, MI

Outpatient Practice Locations Jefferson Department of Urology Outpatient Locations

Jefferson’s convenient Navy Yard location at 3 Crescent Drive, with our Department of Urology and Men’s Health Program offices.

Abington/Asplundh Cancer Pavilion Sidney Kimmel Cancer Center Site Contact: Noreen Wielgus, MSN, RN 3941 Commerce Avenue, Willow Grove, PA 19090 215-481-4668 | Fax: 215-481-3200 Abington Hospital Jefferson Health Price Medical Office Building 1245 Highland Avenue, Suite 302 Abington, PA 19001 215 481 7700 | Fax:215-481-7799 GU Multidisciplinary Clinic Sidney Kimmel Cancer Center Site Contact: Crystal Sypherd, CPhT 215-503-0581 111 S. 11th Street, Street Level Philadelphia, PA 19107 215-955-6700 | Fax: 215-955-0412

The Department of Urology participates in the Sidney Kimmel Cancer Center activities at the Asplundh Cancer Pavilion in Willow Grove. In early 2022, our new Urology Offices will open on the Abington campus in the Price Building, Ste. 302.

Center City Office Site Contact: Janelle Browning 33 S. 9th Street, Suite 703 (Formerly 833 Chestnut) Philadelphia, PA 19107 215-955-1000 | Fax: 215-503-2066 Jefferson Urology Cherry Hill Site Contact: Linda Teschko 511 North Kings Highway Cherry Hill, NJ 08034 844-542-2273 | Fax: 856-667-2428

Men’s Health Program at the Navy Yard Site Contact: Alana Flowers 3 Crescent Drive, 2nd Floor Philadelphia, PA 19112 215-503-7240 | Fax: 215-503-3191 Division of Pediatric Urology Nemours Physicians: 302-651-4200 Locations in Delaware, Philadelphia, Main Line and New Jersey

Jefferson Health Navy Yard Site Contact: Tammy Aversa 3 Crescent Drive, 2nd Floor Philadelphia, PA 19112 215-503-7124 | Fax: 215-503-3321

Jefferson Urology

71


Department of Urology Publications 2021 Department of Urology academic productivity was at a high level in 2021 with nearly 70 papers, 21 chapters, 3 books and more than a dozen internet contributions. This does not include meeting abstracts and presentations that are presented on pages 26 through 28. Faculty and residents noted in bold.

Sanford T, Gomella PT, Siddiqui R, Su D, An JY, Bratslavsky G, Ball MW, Linehan WM, Metwalli AR. Long term outcomes for patients with von Hippel-Lindau and Pheochromocytoma: defining the role of active surveillance. Urol Oncol. 2021 Feb;39(2):134. e1-134.e8. doi: 10.1016/j.urolonc.2020.11.019. Epub 2020 Dec 8. PMID: 33303379.

Goldberg H, Noorani R, Benton JZ, Lodh A, Berlin A, Chandrasekar T, Wallis CJD, Ahmad AE, Klaassen Z, Fleshner NE. Is there an association between a history of military service and cancer diagnosis? Results from a US national-level study of self-reported outcomes. Cancer Causes Control. 2021 Jan;32(1):47-55.

Goldberg H, Mohsin FK, Berlin A, Chandrasekar T, Wallis CJD, Klaassen Z, Ahmad AE, Saskin R, Kenk M, Saarela O, Kulkarni GS, Alibhai SMH, Fleshner N. The suggested chemopreventive association of metformin with prostate cancer in diabetic patients. Urol Oncol. 2021 Mar; 39(3):191.e17191.e24. PMID: 32951988.

Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J Jr, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL Jr, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscleinvasive bladder cancer: a single-arm, openlabel, repeat-dose clinical trial. Lancet Oncol. 2021 Jan;22(1):107-117. doi: 10.1016/S14702045(20)30540-4. Epub 2020 Nov 27. PMID: 33253641; PMCID: PMC7988888.

Chandrasekar T, Han TM, Glick L, Leong JY, Teplitsky S, Noorani R, Goldberg H, Klaassen Z, Wallis CJD, Mark JR, Trabulsi EJ, Lallas CD, Gomella LG. Setting the Standards: Examining Research Productivity Among Academic Urologists in the USA and Canada in 2019. Eur Urol Focus. 2021 Mar;7(2):489496. PMID: 32113885.

Eisenbrey JR, Kamaya A, Gummadi S, Bird K, Burrowes D, Arias D, Lallas CD, Trabulsi EJ, Lyshchik A. Effects of Contrast-Enhanced Ultrasound of Indeterminate Renal Masses on Patient Clinical Management: Retrospective Analysis From 2 Institutions. J Ultrasound Med. 2021 Jan;40(1):131-139. PMID: 32657452. Shafi AA, McNair CM, McCann JJ, Alshalalfa M, Shostak A, Severson TM, Zhu Y, Bergman A, Gordon N, Mandigo AC, Chand SN, Gallagher P, Dylgjeri E, Laufer TS, Vasilevskaya IA, Schiewer MJ, Brunner M, Feng FY, Zwart W, Knudsen KE. The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair. Nat Commun. 2021 Jan 15;12(1):401. doi: 10.1038/ s41467-020-20513-5. PMID: 33452241; PMCID: PMC7810852. Salib A, Mark JR. DNA analysis for prostate specimen verification: How I Do It. Can J Urol. 2021 Feb;28(1):10568-10573. PMID: 33625350. Teplitsky SL, Leong JY, Calio B, Hubosky SG, Bagley D. Ergonomics in Endourology: Measurement of Force for Deflection in Contemporary Ureteroscopes. J Endourol. 2021 Feb;35(2):215-220. PMID: 32993396. 72

Year in Review

Hoffman-Censits J, Choi W, Bivalacqua TJ, Pierorazio P, Kates M, Lombardo K, Parini V, McConkey D, Trabulsi EJ, Hahn N, Matoso A. Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience. Clin Genitourin Cancer. 2021 Apr;19(2):176-181. PMID: 33358150. Gómez Rivas J, Carrion DM, Chandrasekar T, Álvarez-Maestro M, Enikeev D, MartínezPiñeiro L, Barret E. The role of multiparametric magnetic resonance imaging in the selection and follow-up of patients undergoing active surveillance for prostate cancer. An European Section of Uro-Technology (ESUT) review. Actas Urol Esp (Engl Ed). 2021 Apr;45(3):188197. Ahdoot M, Lebastchi AH, Long L, Wilbur AR, Gomella PT, Mehralivand S, Daneshvar MA, Yerram NK, O'Connor LP, Wang AZ, Gurram S, Bloom J, Siddiqui MM, Linehan WM, Merino M, Choyke PL, Pinsky P, Parnes H, Shih JH, Turkbey B, Wood BJ, Pinto PA; Trio Study Group. Using Prostate Imaging-Reporting and Data System (PIRADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study. Eur Urol Oncol. 2021 Apr 10:S2588-9311(21)00048-1. doi: 10.1016/j. euo.2021.03.004. Epub ahead of print. PMID: 33846112.

Chandrasekar T, Ahmad AE, Sayyid R, Saarela O, Penn L, Alibhai SMH, Fleshner NE.. The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer. Eur Urol Focus. 2021 May;7(3):537-545. Capella C, Godovchik J, Chandrasekar T, Al-Kouatly HB. Non-obstetrical roboticassisted laparoscopic surgery in pregnancy, an underutilized approach: a systematic literature review. Urology. 2021 May;151:58-66. Welti J, Sharp A, Brooks N, Yuan W, McNair C, Chand SN, Pal A, Figueiredo I, Riisnaes R, Gurel B, Rekowski J, Bogdan D, West W, Young B, Raja M, Prosser A, Lane J, Thomson S, Worthington J, Onions S, Shannon J, Paoletta S, Brown R, Smyth D, Harbottle GW, Gil VS, Miranda S, Crespo M, Ferreira A, Pereira R, Tunariu N, Carreira S, Neeb AJ, Ning J, Swain A, Taddei D; SU2C/PCF International Prostate Cancer Dream Team, Schiewer MJ, Knudsen KE, Pegg N, de Bono JS. Targeting the p300/CBP Axis in Lethal Prostate Cancer. Cancer Discov. 2021 May;11(5):1118-1137. doi: 10.1158/2159-8290.CD-20-0751. Epub 2021 Jan 11. PMID: 33431496; PMCID: PMC8102310. Capella C, Chandrasekar T, Counsilman MJ, Sebastiano C, Lallas CD, Al-Kouatly HB. Robotic adrenalectomy for functional adenoma in second trimester treats worsening hypertension. Urology. 2021 May;151: 67-71. Zhang Z, Lampotang S, Yu Y, Acar YA, Wakim J, Mei V, Ahmad AE, Shenot P, Lee J, Perlis N, Moy L, Johnson WT, DeStephens A, Bigos AK, Lizdas DE, Stringer T. Attitude is everything: Keep probe pitch neutral during side-fire prostate biopsy.A simulator study. BJU Int. 2021 May 7 Goldberg H, Glicksman R, Woon D, Hoffman A, Shaikh H, Chandrasekar T, Klaassen Z, Wallis CJD, Ahmad AE, Sanmamed-Salgado N, Qu X, Moraes FY, Diamandis EP, Berlin A, Fleshner NE. Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer? BJU Int. 2021 Jun;127(6):654-664. Shenot PJ. Rethinking the approach to evaluation and management of overactive bladder. Can J Urol. 2021 Jun;28(3):10705. PMID: 34129466.

Capella C, Schlegel L, Shenot P, Murphy A. Female Representation at High-profile Urology Conferences, 2014-2019: A Leadership Metric. Urology. 2021 Apr;150:72-76.

Goldberg H, Glicksman R, Hoffman A, Chandrasekar T, Klaassen Z, Wallis CJD, Ahmad AE, Woon DTS, Herrera-Caceres JO, Shaikh H, Salgado N, Qu M, Moraes FY, Diamandis E, Berlin A, Fleshner NE. “Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?” BJU Int. 2021 Jun;127(6):654-664.

Goldberg H, Mohsin FK, Saskin R, Kulkarni GS, Berlin A, Kenk M, Wallis CJD, Klaassen Z,

Ho M, Park BY, Rosenblum NG, Al Mukaddam M, Kaplan FS, Kucherov V, Hubosky SG, Kane


G, Desai V, Kramer MR, Ku BS, Schwenk ES, Baratta JL, Harshavardhana D, Grunwald Z. Surgical and Radiological Management of Complicated Uterine Leiomyoma Aided by 3D Models in a Patient with Fibrodysplasia Ossificans Progressiva. Am J Case Rep. 2021 Jun 10;22:e931614. doi: 10.12659/AJCR.931614. PMID: 34108438; PMCID: PMC8207543. Goldberg H, Spratt D, Chandrasekar T, Klaassen Z, Wallis CJD, Santiago-Jimenez M, Fishbane N, Davicioni E, Noorani R, Ahmad AE, Herrera Cáceres JO, Alibhai S, Berlin A, Fleshner NE. Clinical-genomic Characterization Unveils More Aggressive Disease Features in Elderly Prostate Cancer Patients with Low-grade Disease. Eur Urol Focus. 2021 Jul;7(4):797-806. PMID: 32156491. Das A, Han TM, Rudnick B, Hardacker T, Shenot PJ, Shvero A. Holmium Laser Enucleation of the Prostate Following Previous Prostatic Urethral Lift. J Endourol. 2021 Jul 8. doi: 10.1089/end.2021.0351. Epub ahead of print. PMID: 34235977. Leong JY, Pinkhasov R, Chandrasekar T, Shapiro O, Daneshvar M, Jacob J, Sanford T, Bratslavsky G, Goldberg H. Prostate-specific Antigen Testing in Men with Disabilities: A Cross-sectional Analysis of the Health Information National Trends Survey. Eur Urol Focus. 2021 Jul 28:S2405-4569(21)00189-9. PMID: 34332951. Gonzalez D, Mateo J, Stenzinger A, Rojo F, Shiller M, Wyatt AW, Penault-Llorca F, Gomella LG, Eeles R, Bjartell A. Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer. J Pathol Clin Res. 2021 Jul;7(4):311-325. PMID: 33630412; PMCID: PMC8185363. Gomella LG, Giri VN. Prostate Cancer Genetics: Changing the Paradigm of Care. Urol Clin North Am. 2021 Aug;48(3):xiii-xiv. PMID: 34210497. Mark JR, McDougal C, Giri V. Genetic testing guidelines and education of health care prostate providers involved in prostate cancer care. Urol Clin N Am. 2021 Aug;48:311-322. Schiewer MJ, Knudsen KE. Basic Science and Molecular Genetics of Prostate Cancer Aggressiveness. Urol Clin North Am. 2021 Aug;48(3):339-347. PMID: 34210489. Clark BS, Chandrasekar T. Case of the Month from Thomas Jefferson University, Philadelphia, PA, USA: a large renal pseudoaneurysm masquerading as advanced renal cell carcinoma. BJU Int. 2021 Aug;128 (2):158-161. Chandrasekar T, Kelly WK, Gomella LG. Overview of Prostate Cancer Genetic Testing. Urol Clin North Am. 2021 Aug;48(3):279-282.

Shvero A, Kloniecke E, Capella C, Das AK. HoLEP techniques - lessons learned. Can J Urol. 2021 Aug; 28(S2):11-16. PMID: 34453423. Clark CB, Ragam R, Das AK, Shenot PJ. Management of neurogenic detrusor overactivity. Can J Urol. 2021 Aug; 28(S2):3337. PMID: 34453427. Tokarski AT, Leong JY, Roehrborn CG, Shvero A, Das AK. Aquablation of the prostate: a review and update. Can J Urol. 2021 Aug; 28(S2):17-21. PMID: 34453424. Clark CB, Kucherov V, Kloniecke E, Shenot PJ, Das AK. Management of urinary incontinence following treatment of prostate disease. Can J Urol. 2021 Aug; 28(S2):38-43. PMID: 34453428. Shvero A, Calio B, Humphreys MR, Das AK. HoLEP: the new gold standard for surgical treatment of benign prostatic hyperplasia. Can J Urol. 2021 Aug; 28(S2):6-10. PMID: 34453422. Leong JY, Tokarski AT, Roehrborn CG, Das AK. UroLift and Rezum: minimally invasive surgical therapies for the management of benign prostatic hyperplasia. Can J Urol. 2021 Aug; 28(S2):2-5. PMID: 34453421. Vincent SA, Christensen D, Weiner PR. Gross hematuria: An unusual presenting symptom of systemic wild-type transthyretinamyloidosis. Urol Case Rep. 2021 Aug 18;39:101811. doi: 10.1016/j.eucr.2021.101811. PMID: 34471604; PMCID: PMC8387744. Gomella LG. Surgical mesh: not as bad as you think. Can J Urol. 2021 Aug;28(4):10733 Thederan I, Chandrasekar T, Tennstedt P, Knipper S, Kuehl L, Tilki D, Augustin M, Heinzer H, Zyriax BC. Circulating Vitamin D and Selenium Levels and Outcome in Prostate Cancer Patients: Lessons from the MARTINILifestyle Cohort. Eur Urol Focus. 2021 Sep;7(5):973-979. PMID: 33408047. Glick L, Vincent SA, Squadron D, Han TM, Syed K, Danella JF, Ginzburg S, Guzzo TJ, Lanchoney T, Raman JD, Smaldone M, Uzzo RG, Tomaszweski JJ, Reese A, Singer EA, Jacobs B, Trabulsi EJ, Gomella LG, Mann MJ. Preventing Prostate Biopsy Complications: to Augment or to Swab? Urology. 2021 Sep;155:12-19. doi: 10.1016/j. urology.2021.02.043. Epub 2021 Apr 18. PMID: 33878333. Glick L, Vincent SA, Squadron D, Han TM, Syed K, Danella JF, Ginzburg S, Guzzo TJ, Lanchoney T, Raman JD, Smaldone M, Uzzo RG, Tomaszweski JJ, Reese A, Singer EA, Jacobs B, Trabulsi EJ, Gomella LG, Mann MJ. EDITORIAL COMMENT. Urology. 2021 Sep;155:18. PMID: 34489002.

Chandrasekar T, Bowler N, Schneider A, Goldberg H, Mark JR, Trabulsi EJ, Lallas CD, Gomella LG. Outcomes of Active Surveillance for Men With Intermediate Risk Prostate Cancer: A Population-Based Analysis. Urology. 2021 Sep;155:101-109. Handley NR, Feng FY, Guise TA, D'Andrea D, Kelly WK, Gomella LG. Preserving Wellbeing in Patients With Advanced and Late Prostate Cancer.Urology.2021 Sep;55:199-209. PMID:33373704. Russo J, McDougall C, Bowler N, Shimada A, Gross L, Hyatt C, Kelly WK, Calvaresi A, Handley NR, Hirsch IH, Izes JK, Lallas CD, Mann M, Mark JR, Mille PJ, Preate D Jr, Trabulsi EJ, Tsang M, Chandrasekar T, Weiner PR, Gomella LG, Giri VN. Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs. JCO Precis Oncol. 2021 Sep 1;5 Chandrasekar T, Bowler N, Schneider A, Goldberg H, Mark JR, Trabulsi EJ, Lallas CD, Gomella LG. AUTHOR REPLY. Urology. 2021 Sep; 155:109. doi: 10.1016/j. urology.2021.05.074. PMID: 34488992. Lurz K, Santarelli S, Hager S, Hani AB. Pediatric intratesticular abscess managed with a testicular sparing approach: A case report. Urol Case Rep. 2021 Sep 30;40 Mandigo AC, Yuan W, Xu K, Gallagher P, Pang A, Guan YF, Shafi AA, Thangavel C, Sheehan B, Bogdan D, Paschalis A, McCann JJ, Laufer TS, Gordon N, Vasilevskaya IA, Dylgjeri E, Chand SN, Schiewer MJ, Domingo-Domenech J, Den RB, Holst J, McCue PA, de Bono JS, McNair C, Knudsen KE. RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease. Cancer Discov. 2021 Sep;11(9):2334-2353. Mandigo AC, Shafi AA, McCann JJ, Yuan W, Laufer TS, Bogdan D, Gallagher L, Dylgjeri E, Semenova G, Vasilevskaya IA, Schiewer MJ, McNair C, de Bono JS, Knudsen KE. Novel oncogenic transcription factor cooperation in RB-deficient cancer. Cancer Res. 2021 Oct 8:canres.1159.2021. doi: 10.1158/0008-5472. CAN-21-1159. Epub ahead of print. PMID: 34625422. Scott ER, Singh A, Quinn A, Boyd K, Lallas CD. How I Do It: Cost-effective 3D printed models for renal masses. Can J Urol. 2021 Oct;28(5):10874-10877. PMID: 34657662. Allen AZ, Zhu D, Shin C, Glassman DT, Abraham N, Watts KL. Patient Satisfaction with Telephone Versus Video-Televisits: A CrossSectional Survey of an Urban, Multiethnic Population. Urology. 2021 Oct;156:110-116. PMID: 34333039.

Jefferson Urology

73


Department of Urology Publications 2021 Nerli RB, Ghagane SC, Bidi SR, Thakur ML, Gomella L. Voided urine test to diagnose prostate cancer: Preliminary report. Cytojournal. 2021 Oct 2;18:26. PMID: 34754324; PMCID: PMC8571200. Nerli RB, Ghagane SC, Rangrez S, Chandra S, Thakur ML, Gomella L. Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors. Indian J Urol. 2021 Oct-Dec;37(4):345-349. doi: 10.4103/iju.iju_132_21. Epub 2021 Oct 1. PMID: 34759527; PMCID: PMC8555562. Chandrasekar T, Boorjian SA, Capitanio U, Gershman B, Mir MC, Kutikov AK. Collaborative Review: Factors influencing treatment decisions for patients with a localized solid renal mass. Eur Urol. 2021 Nov;80(5):575588. Williams C, Khondakar NR, Daneshvar MA, O'Connor LP, Gomella PT, Mehralivand S, Yerram NK, Egan J, Gurram S, RompréBrodeur A, Webster BR, Owens-Walton J, Parnes H, Merino MJ, Wood BJ, Choyke P, Turkbey B, Pinto PA. The Risk of Prostate Cancer Progression in Active Surveillance Patients with Bilateral Disease Detected by Combined Magnetic Resonance ImagingFusion and Systematic Biopsy.J Urol. 2021 Nov;206(5):1157-1165. Epub 2021 Jun 28. PMID: 34181465 Panzone J, Welch C, Morgans A, Bhanvadia SK, Mossanen M, Goldberg RS, Chandrasekar T, Pinkhasov R, Shapiro O, Jacob JM, Basnet A, Bratslavsky G, Goldberg H. Association of Race With Cancer-Related Financial Toxicity. JCO Oncol Pract. 2021 Nov 9:OP2100440. doi: 10.1200/OP.21.00440. Epub ahead of print. PMID: 34752150. McCann JJ, Vasilevskaya IA, McNair C, Gallagher P, Neupane NP, de Leeuw R, Shafi AA, Dylgjeri E, Mandigo AC, Schiewer MJ, Knudsen KE. Mutant p53 elicits contextdependent pro-tumorigenic phenotypes. Oncogene. 2021 Nov 12. doi: 10.1038/s41388021-01903-5. Epub ahead of print. PMID: 34773073. Chandrasekar T, Bowler N, Schneider A, Goldberg H, Mark JR, Trabulsi EJ, Lallas CD, Gomella LG. Outcomes of Active Surveillance for Men With Intermediate Risk Prostate Cancer: A Population-Based Analysis. Urology. 2021 Sep;155:101-109. Russo J, McDougall C, Bowler N, Shimada A, Gross L, Hyatt C, Kelly WK, Calvaresi A, Handley NR, Hirsch IH, Izes JK, Lallas CD, Mann M, Mark JR, Mille PJ, Preate D Jr, Trabulsi EJ, Tsang M, Chandrasekar T, Weiner PR, Gomella LG, Giri VN. Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs JCO Precis 74

Year in Review

Oncol. 2021 Sep 1;5:PO.21.00238. doi: 10.1200/ PO.21.00238. eCollection 2021. Handley NR, Feng FY, Guise TA, D'Andrea D, Kelly WK, Gomella LG. Preserving Wellbeing in Patients With Advanced and Late Prostate Cancer.Urology.2021 Sep;55:199-209. PMID:33373704. Matin SF, Pierorazio PM, Kleinmann N, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky SG, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Seltzer E, Schoenberg M, Lerner SP. Durability of Response to Primary Chemoablation of LowGrade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report. J Urol. 2021 Dec 17: Epub ahead of print. PMID: 34915741. Gomella LG: Aligning prostate cancer screening recommendations for patients and providers (Editorial). Can J Urol 2021 Dec; 28 (6): 10880. Shvero A, Teplitsky S, Kloniecke E, Das AK. Incidental prostate cancer at holmium laser enucleation of prostate. Can J Urol 2021 Dec; 28 (6): 10900-10906. Mitra AP, Narayan VM, Mokkapati S, Miest T, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown GA, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL, Sankin AI, Boyd A, O'Donnell MA, Philipson R, Ylä-Herttuala S, Sawutz D, Parker NR, McConkey DJ, Dinney CPN. Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscleinvasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial Eur Urol . 2021 Dec 18;S0302-2838(21)02217-X. doi: 10.1016/j. eururo.2021.12.009. Online ahead of print Williams C, Ahdoot M, Daneshvar MA, Hague C, Wilbur AR, Gomella PT, Shih J, Khondakar N, Yerram N, Mehralivand S, Gurram S, Siddiqui M, Pinsky P, Parnes H, Merino M, Wood B, Turkbey B, Pinto PA. Why Does Magnetic Resonance Imaging-Targeted Biopsy Miss Clinically Significant Cancer? J Urol. 2022 Jan;207(1):95-107. Epub 2021 Aug 26. PMID: 34433302 Chung PH, Leong JY, Machado P, Wessner CE, Trabulsi EJ, Halpern EJ, Eisenbrey JR, Forsberg F. Contrast-Enhanced Ultrasound and

Shear Wave Elastography: Novel Methods for the Evaluation of Urethral Stricture Disease. J Urol. 2022 Jan;207(1):152-160. Epub 2021 Aug 24. PMID: 34428090. Nerli RB, Ghagane SC, Rangrez SS, Chandra S, Thakur ML, Gomella L. Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors; Reply, Indian J Urol 2021 (in press) BOOKS, BOOK CHAPTERS Hubosky SG, Grasso M, Traxer O, Bagley DH: Advanced Ureteroscopy: Treating Difficult Problems. Springer 2021. The following Jefferson faculty, residents and staff contributed to Advanced Ureteroscopy: Treating Difficult Problems: Bagley DH and Hubosky SG: Difficult Access to the Ureter Scotland KB, Limbrick B, Bagley DH: Instruments: Stone Retrieval Devices Hubosky SG and Hardacker TJ: Instruments: Intracorporeal Lithotripters for Ureteroscopy Doizi S, Keller EX, Traxer O, Hubosky SG: Basic Techniques: Fundamental Maneuvering During Ureteroscopy Kloniecke EJ and Hubosky SG: Basic Techniques: Safety Considerations During Ureteroscopy in Hubosky Shvero A, Kleinmann N, Hubosky SG: Stones: Flexible Ureteroscopic Treatment of Renal Stones Hardacker TJ and Hubosky SG: Stones: Techniques for Ureteroscopic Holmium Laser Lithotripsy Bagley DH, Sonzogni-Cella M, Hubosky SG: Stones: Positioning for Ureteroscopy Rudnick BH, Hubosky SG, HooKim K, Bagley DH: Upper Tract Urothelial Carcinoma: Diagnosis of Upper Tract Urothelial Carcinoma Grasso M, Sharma N, Fishman I, Izes JK, Bagley DH, Hubosky SG: Upper Tract Urothelial Carcinoma: Ureteroscopic Treatment Grasso M, Izes JK, Komorowski AW: Upper Tract Urothelial Carcinoma: Adjuvant Treatment for Upper Tract Urothelial Carcinoma: Topical and Systemic Hubosky SG and Bagley DH: Ureteroscopic Management of Upper Urinary Tract Obstruction


Singh AA, Hubosky SG, Tanimoto R, Bagley DH: Ureteroscopic Treatment of Chronic Unilateral Hematuria Tokarski AT and Bagley DH: Antegrade Ureteroscopy Hubosky SG and Calio BP: Complications of Ureteroscopy Trabulsi EJ, Lallas CD, Lizardi-Calvaresi AE (eds) Chemotherapy and Immunotherapy in Urologic Oncology 2021. Springer The following faculty and staff contributed chapters to Chemotherapy and Immunotherapy in Urologic Oncology: Gomella LG, Introduction: Integration of APP into Urologic Oncology Practice Izes JK, McBride TP. Overview and Active Surveillance of Prostate Cancer Barron S, Mann MJ. Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer Izes JK, Oh S. Novel and Experimental Strategies in the Treatment of Metastatic Urothelial Carcinoma Lizardi-Calvaresi AE, Bagley D, Smentkowski K. Upper Tract Urothelial Carcinoma Mark JR, Squadrito D. Penile Cancer Gomella LG and Haist SA: Clinicians Pocket Reference 12th Edition (2022) McGraw Hill Medical, New York The following Jefferson faculty and staff contributed chapters to: Clinicians Pocket Reference 12th: Lallas CD. The Language of Health Care Calvaresi AE. Multidisciplinary Health Care Teams Murphy AM. Urologic Diagnostic Procedures Gomella PT. Common Emergencies Mark JR, Hurwitz MD, Wm K Kelly, Gomella LG. Cancer of the Urethra and Penis. CANCER: Principles and Practice of Oncology 12th ed. DeVita VT, Lawrence TS, Rosenberg SA, eds. (2022) Wolters Kluwer. Mark JR, Gomella LG. Creating a Multidisciplinary GU Cancer Clinic. In: Urologic Oncology: Multidisciplinary care for patients. Ed. Stratton KL, Morgans, AK. (2022) Springer.

MONOGRAPHS/INTERNET Gomella LG. Comparison of Multiparametric Magnetic Resonance Imaging–Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial. PracticeUpdate website. Available at: https://www.practiceupdate.com/ content/systematic-trus-biopsy-vs-mmritargeted-biopsy-for-biopsy-naive-men-at-riskfor-prostate-cancer/113309/65/3/1. Accessed February 26, 2021 Gomella LG. Commentary on: Managing Discordant Findings Between Multiparametric Magnetic Resonance Imaging and Transrectal Magnetic Resonance Imaging–Directed Prostate Biopsy—The Key Role of Magnetic Resonance Imaging–Directed Transperineal Biopsy. PracticeUpdate website. Available at: https://www.practiceupdate.com/content/ the-key-role-of-mri-directed-transperinealbiopsy/120271/65/3/1. Accessed July 22, 2021 Gomella LG. Commentary on: Optimizing Spatial Biopsy Sampling for the Detection of Prostate Cancer. PracticeUpdate website. Accessed September 20, 2021 at: https://www. practiceupdate.com/content/optimizingbiopsy-sampling-for-detection-of-prostatecancer/123051/65/3/1.

Gomella, LG. Commentary on: Association of Inherited Mutations in DNA Repair Genes With Localized Prostate Cancer. PracticeUpdate website. Available at: https:// www.practiceupdate.com/content/associationof-inherited-mutations-in-dna-repair-geneswith-localized-prostate-cancer/126042/12/3/1 Accessed November 21, 2021 Hirsch IH, Male Reproductive Endocrinology and Related Disorders, published in The Merck Manual-professional version at https:// www.merckmanuals.com/professional/ genitourinary-disorders/male-reproductiveendocrinology-and-related-disorders, last updated March 2021. Hirsch IH, Male Sexual Dysfunction, published in The Merck Manual-professional version at https://www.merckmanuals.com/ professional/genitourinary-disorders/malesexual-dysfunction. Hirsch IH, Biology of the Male Reproductive System, published in The Merck Manualconsumer version at https://www. merckmanuals.com/home/men-s-healthissues/biology-of-the-male-reproductivesystem.

Gomella LG. Merck Manuals Consumer Homepage: Tackling Prostate Cancer Screening Controversies – 5 Things Men Should Know https://www.merckmanuals.com/home/kidneyand-urinary-tract-disorders/cancers-of-thekidney-and-genitourinary-tract/prostatecancer?query=prostate%20cancer September 2021 Editorial Gomella LG. CNN On Line Interview “Doctors see advanced cancer cases in the wake of the pandemic-delayed screenings and treatment”. October 13, 2021 Schiewer MJ, Chandrasekar T, and Gomella, LG. Germline Testing for Prostate Cancer. AUA UPDATE SERIES 2021; Volume 40, Lesson 3 Gomella, LG. Commentary on: Local Anesthetic Transperineal Prostate Biopsy Using a Probe-Mounted Transperineal Access System. PracticeUpdate. Available at: https:// www.practiceupdate.com/content/localanesthetic-transperineal-prostate-biopsyusing-a-probe-mounted-transperineal-accesssystem/124385/12/3/1 Accessed November 6, 2021

Jefferson Urology

75


76

Year in Review


Turn static files into dynamic content formats.

Create a flipbook
Jefferson Urology Year In Review 2021 by Jefferson Urology - Issuu